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ABSTRACT
Guillain-Barré Syndrome (GBS) is a debilitating inflammatory autoimmune
disease of the peripheral nervous system that is characterized by rapid-onset paraparesis
with areflexia progressing, in some patients, to neuromuscular paralysis. GBS occurs
with an incidence of 2-4 cases per 100,000, similar to that reported for multiple sclerosis.
Recognized as a heterogeneous disorder, the most common (85-90%) form of GBS
observed in North America and Europe is acute inflammatory demyelinating
polyneuropathy (AIDP). Enhanced infiltration of pro-inflammatory type 1 helper T (Th1)
cells into peripheral nerves of AIDP patients is strongly suggestive of an immunemediated pathogenic process. Cellular immunity directed against specific constituents of
the peripheral nerve myelin is considered causal in AIDP, leading to segmental
demyelination and secondary axonal loss. The treatment of AIDP is currently palliative
and utilizes non-specific immune-modulating therapies.
Increasing evidence now supports the application of exercise as a safe and
effective non-pharmacological rehabilitative intervention strategy. Exercise attenuates the
onset and progression of some autoimmune diseases and improves some measures of
peripheral nerve function in diabetic neuropathy. In type 1 diabetes mellitus, exercise
diminishes disease severity by promoting a type 2 helper T (Th2) protective immune
response. In patients with GBS, exercise has been shown to increase muscle strength
recovery and aerobic exercise capacity, decrease fatigue, and improve quality of life.
xvi

Whether exercise alters the progression of GBS remains unclear.
In this study, we determined the effects of forced-exercise on development and
progression of experimental autoimmune neuritis (EAN), an established animal model of
AIDP. We report that a moderate regimen of forced-exercise significantly attenuates the
severity of actively induced EAN in Lewis rats. We also investigated the mechanism by
which forced-exercise alters the development of EAN. Adult male Lewis rats were
randomized to three groups: sedentary adjuvant control, sedentary EAN, and forcedexercise EAN. Rats assigned to the forced-exercise group were trained on a motorized
treadmill (6 km per week) for three weeks. Sedentary rats were allowed to explore the
treadmill for the same duration of time without exercise. After three weeks, rats received
a single injection of complete Freund’s adjuvant (CFA controls) or were actively
immunized with an emulsified mixture of complete Freund’s adjuvant containing P2
peptide fragment (53-78, EAN). CFA control-injected rats did not develop EAN. By
comparison, sedentary rats immunized with CFA containing P2 peptide developed a
monophasic course of EAN. In contrast, rats subjected to forced-exercise and injected
with CFA containing P2 peptide exhibited a significantly attenuated course of EAN. In
addition, during severe EAN, forced-exercise rats lost less weight than sedentary rats.
This attenuation was most likely not due to stress hormone levels since levels were
similar in sedentary and forced-exercise EAN rats. Near peak of disease, evoked
compound muscle action potential amplitudes were significantly reduced in sedentary
rats compared to forced-exercise rats with mild EAN. In contrast, forced-exercise did not
protect against deficits in evoked compound muscle action potential amplitudes, or
conduction velocities, and in sciatic nerve pathology in sedentary and forced-exercise rats
xvii

with severe EAN. Lymphocytes recovered from the popliteal lymph nodes of forcedexercise EAN rats exhibited increased proliferative response to P2 peptide compared to
sedentary EAN controls. Moreover, the supernatant obtained from the lymphocyte
proliferation assays of forced-exercise EAN rats near onset and peak of disease show a
marked increase in the anti-inflammatory cytokine interleukin-10. When analyzed by
flow cytometry, the percentage of Th1 lymphocytes present in lymph nodes, spleen, and
blood of forced-exercise EAN rats were reduced compared with sedentary EAN controls.
Collectively, these data support a protective effect of forced-exercise against the
development of EAN, in part, by selectively enhancing anti-inflammatory cytokine
release and decreasing percent distribution of pro-inflammatory autoreactive Th1
lymphocytes.

xviii

CHAPTER I
INTRODUCTION
Statement of the Problem
Human peripheral neuropathies affect approximately 2.4% of the population,
causing a burden on the healthcare system (White et al., 2004). Peripheral neuropathies
are a disparate group of diseases that are heterogeneous in etiology, diverse in pathology,
and varied in severity (Martyn and Hughes, 1997). Current interventions for treating
peripheral neuropathies are largely limited to management of discomfort and pain
(Martyn and Hughes, 1997; White et al., 2004).
Guillain-Barré Syndrome (GBS) is an acute acquired autoimmune mediated
human peripheral neuropathy with an incidence of about four cases per 100,000 people.
Males are more commonly affected than females (Alter, 1990; Hughes and Rees, 1997;
Cosi and Versino, 2006; Vucic et al., 2009). GBS encompasses a spectrum of clinical
disorders characterized by acute and sub-acute progressive weakness of at least two
limbs, usually beginning in the legs, for up to four weeks (Asbury et al., 1978; Hughes
and Rees, 1997; Vucic et al., 2009). GBS affects motor and sensory nerves of the arms
and legs and may involve the respiratory muscles and the facial, bulbar, and ocular motor
nerves (Hughes and Rees, 1997). Autonomic nerve involvement can occur causing urine
retention, ileus, sinus tachycardia hypertension, cardiac arrhythmia, and postural
hypotension. Respiratory failure occurs in 25% of patients with GBS, with general
1

2
supportive therapy needed (Hughes and Cornblath, 2005; Vucic et al., 2009).
In North America and Europe, GBS typically presents in the form of acute
inflammatory demyelinating polyneuropathy (AIDP) (Hadden et al., 1998; Hughes and
Cornblath, 2005; Vucic et al., 2009). This common variant of GBS involves multifocal
mononuclear cell infiltration of the peripheral nervous system (Asbury et al., 1969;
Hughes and Cornblath, 2005; Vucic et al., 2009). Autoreactive pro-inflammatory
lymphocytes and macrophages invade the myelin, thus demyelinating and damaging the
axon, leading to paraparesis, paralysis, and areflexia of the limbs. Similar disease
pathology has been shown to occur in experimental autoimmune neuritis (EAN), an
established animal model of GBS (Hughes and Cornblath, 2005; Vucic et al., 2009).
The treatment of AIDP/GBS is currently palliative and utilizes non-specific
immune-modulating therapies. Plasmapheresis or intravenous immunoglobulin therapies
currently benefit the GBS patient by reducing the need for supportive care and expediting
recovery. However, these benefits are generally observed only if treatment is
administered early in the course of the disease (Hughes and Cornblath, 2005; Vucic et al.,
2009). While most patients recover from GBS, there is a mortality rate of about 10% in
population-based studies, and at least 10% of survivors are left with severe disability
(Hughes and Rees, 1997; Plasma Exchange/Sandoglobulin Guillain-Barre Syndrome
Trial Group, 1997; Vucic et al., 2009). Advancement of care for these affected patients
waits on the development of new selective immune-modulating agents or the novel
application of existing therapeutic strategies.
Increasing evidence now supports the application of exercise as a safe and

3
effective non-pharmacological rehabilitative intervention. Exercise decreases
inflammatory diseases by increasing anti-inflammatory and decreasing pro-inflammatory
cytokines, and by reducing pro-inflammatory toll-like receptor signaling on innate
immune cells (Gleeson et al., 2006; Gleeson, 2007; Rosa Neto et al., 2010). Exercise
attenuates the onset and progression of autoimmune diseases and peripheral neuropathies
(Le Page et al., 1994; Le Page et al., 1996; White et al., 2004; Lowder et al., 2010;
Navarro et al., 2010). In multiple sclerosis, exercise improves the quality of life, in part,
by attenuating pro-inflammatory cytokine production (Schulz et al., 2004; White et al.,
2006a; White et al., 2006b). Exercise also decreases peripheral neuropathy in type 2
diabetes mellitus by decreasing pro-inflammatory cytokines and leukocyte-endothelial
interactions and adhesion (Fisher et al., 2003; Balducci et al., 2006; Gleeson et al., 2006;
Roberts et al., 2006; Fisher et al., 2007; Hopps et al., 2011; Teixeira-Lemos et al., 2011a).
In patients with GBS, exercise has been shown to increase muscle strength recovery and
aerobic exercise capacity, decrease fatigue, and improve the quality of life (Garssen et al.,
2004; El Mhandi et al., 2007). However, the effects of exercise on immune parameters of
GBS were not studied. In this dissertation research study, we determined the mechanism
by which exercise attenuates the onset and progression of experimental autoimmune
neuritis.
Hypothesis
Forced-exercise protects against the onset and progression of experimental
autoimmune neuritis, in part, by suppressing pro-inflammatory type 1 helper T (Th1) cellmediated autoimmunity.

4
Specific Aims
The hypothesis was tested with the following two specific aims.
Specific Aim 1
We determined whether forced-exercise protects against the onset and progression
of EAN in adult male Lewis rats. This was accomplished with the following sub-aims:
1A. Effects of forced-exercise on the clinical onset and progression of EAN, compared
with sedentary controls, were quantified using established blinded scoring criteria.
1B. Effects of forced-exercise on EAN-induced changes in peripheral nerve function,
compared with sedentary controls, were quantified by evoked-response
electrophysiology.
1C. Effects of forced-exercise on EAN-induced changes in peripheral nerve pathology,
compared with sedentary controls, were semi-quantified by light microscopy.
Specific Aim 2
We determined whether forced-exercise protects against the onset and progression
of EAN in adult male Lewis rats by a mechanism that alters pro-inflammatory Th1 and
anti-inflammatory type 2 helper T (Th2) cell activation. This was accomplished with the
following sub-aims:
2A. Effects of forced-exercise on EAN-induced changes in P2 peptide or lectinstimulated nodal and splenic lymphocyte proliferation, compared with sedentary
controls, were quantified by [3H]thymidine uptake.
2B. Effects of forced-exercise on EAN-induced changes of Th1 and Th2 cell
populations in the spleen, popliteal lymph nodes, or blood, compared with
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sedentary controls, were quantified by flow cytometric analyses.
2C. Effects of forced-exercise on EAN-induced changes in P2 peptide or lectinstimulated nodal and splenic lymphocyte cytokine production, compared with
sedentary controls, were quantified by multiplex immunoassay.
2D. Effects of forced-exercise on corticosterone and corticosteroid-binding globulin,
compared with sedentary controls, were quantified by enzyme-linked
immunosorbent assay and radioimmunoassay, respectively.
A major finding of this dissertation is that a pre-induction three-week regimen of
moderate forced-exercise attenuates the clinical severity, weight loss, and peripheral
nerve damage of P2 peptide induced EAN in Lewis rats, an animal model of GBS. Our
results show that in forced-exercise EAN rats, there is increase retention of adaptive
immune cells in the popliteal lymph nodes and spleens. Lymphocytes obtained from
popliteal lymph nodes of forced-exercise EAN rats have increased capacity to proliferate
near peak of disease when stimulated with P2 peptide. Moreover, the supernatant
obtained from the lymphocyte proliferation assays of forced-exercise EAN rats show a
marked increase in the anti-inflammatory cytokine interleukin-10. Lymphocytes obtained
from spleens of forced-exercise EAN rats have an increased capacity to proliferate when
stimulated with ConA. Flow cytometric analysis of adaptive immune cells obtained from
popliteal lymph nodes, spleens, and blood of forced-exercise EAN rats show a clear
decrease in pro-inflammatory Th1 cells. These results illustrate that forced-exercise has
anti-inflammatory effects that can attenuate EAN in rats. To our knowledge, this is the
first study to show attenuation of the clinical severity of EAN by moderate intensity

6
forced-exercise.

CHAPTER II
LITERATURE REVIEW
Human Peripheral Neuropathies
Peripheral neuropathies affect approximately 2.4% of the population, causing a
burden on the national healthcare systems (Martyn and Hughes, 1997; White et al.,
2004). Peripheral neuropathies are a heterogeneous group of genetic or acquired disorders
where one or all parts of the peripheral nervous system are damaged. Patients with
peripheral neuropathies develop symptoms of numbness or altered sensation, usually
starting at the extremities and progressing proximally, and muscle weakness (White et al.,
2004). Peripheral neuropathies are disabling, and improved interventions to alleviate the
symptoms of peripheral neuropathies are critically needed.
Autoimmunity
Autoimmune diseases are a family of more than 80 chronic, and often debilitating,
diseases affecting more than 14.7 million people in the United States (The Autoimmune
Diseases Coordinating Committee, 2005). The prevalence of these diseases is rising. A
better understanding of autoimmunity is crucial for future treatments.
In a normal immune response, a foreign antigen is recognized and endocytosed by
antigen presenting cells (APCs). These foreign antigens are recognized by toll-like
receptors (TLRs) expressed on APCs, which are pattern recognition receptors that
recognize pathogenic antigens (Toubi and Shoenfeld, 2004; Waldner, 2009; Torres7
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Aguilar et al., 2010). APCs, such as dendritic cells, macrophages, and B cells, migrate to
secondary lymphoid organs where these APCs present the foreign antigen in the context
of major histocompatibility complex class II (MHC II) and co-stimulatory signals, CD80
and CD86, to naïve T cells with specific T cell receptors to that foreign antigen
(Romagnani, 2006; Mackay, 2008). These T cells clonally expand. After clonal
expansion, naïve T cells differentiate into a specific subset of helper T cells that
participate in cell-mediated or humoral-mediated immune responses (Zhu and Paul, 2008;
Veldhoen, 2009). The differentiated helper T cells then egress from the lymph nodes into
circulation to survey and attack the foreign antigen (Mackay, 2008). Eventually, these
activated and differentiated immune cells will encounter the foreign antigen at the
affected target organ and will initiate a cascade of events, including release of cytokines
and activation of macrophages and B cells to dispose of the foreign antigen (Romagnani,
2006; Mackay, 2008; Veldhoen, 2009; Torres-Aguilar et al., 2010). When this process
involves a self-antigen, then the immune response is targeted at self-tissue and/or organs.
This is defined as autoimmunity (Toubi and Shoenfeld, 2004; Romagnani, 2006; Mackay,
2008; Veldhoen, 2009; Waldner, 2009; Torres-Aguilar et al., 2010).
The immune system has in place a set of checkpoints to prevent the
development of an immune response against a self-antigen (Goodnow et al., 2005; Parish
and Heath, 2008). In the first checkpoint against autoimmunity, thymic T cells undergo
central tolerance, a process of selecting T cells that strongly recognize self-antigen.
Thymic T cells that strongly recognize self-antigen either undergo further rearrangement
of antigen-receptor genes to avoid reactivity to self-antigen or face deletion by apoptosis
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(Fathman and Lineberry, 2007; von Boehmer and Melchers, 2010). However, central
tolerance is only 60 to 70 percent efficient, with many of the autoreactive T cells
escaping to the secondary lymphoid organs (Parish and Heath, 2008).
Autoreactive T cells that escape central tolerance are naïve (ignorant) but can be
activated by APCs that have processed and presented a self-antigen to the T cells in the
context of MHC II (Parish and Heath, 2008). In the second checkpoint against
autoimmunity, autoreactive T cells can undergo peripheral tolerance, involving anergy,
deletion by apoptosis, or suppression when presented with a self-antigen by an APC
(Goodnow et al., 2005; Romagnani, 2006; Parish and Heath, 2008). Through anergy,
APCs present to the T cells the self-antigen in the context of MHC II without the
necessary co-stimulatory receptors CD80 and CD86, thus making the T cells functionally
inactive to future interactions with an APCs (Romagnani, 2006). Deletion through
apoptosis (activation-induced cell death) occurs when T cells encounter high antigen
concentrations or when T cells are heavily activated, and is mediated by high expression
of Fas and its ligand Fas ligand (Romagnani, 2006). Finally, peripheral tolerance can
occur through suppression. Autoreactive T cells can be suppressed by type 1 regulatory T
cells (Tr1), a subset of helper T cells known to control immune response to antigens by
secreting the anti-inflammatory cytokine IL-10 (Romagnani, 2006).
Peripheral tolerance can be overcome by bystander activation or molecular
mimicry (Romagnani, 2006). In bystander activation, pathogenic microbes induce
inflammation and release of sequestered self-antigens from apoptotic cells. These selfantigens are then processed by APCs and presented to autoreactive T cells causing
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autoimmunity (Romagnani, 2006). In molecular mimicry, foreign antigens from
pathogenic microbes can strongly resemble self-antigens. When APCs process and
present these foreign antigens to autoreactive T cells, the resulting immune response will
not be able to distinguish between the foreign and self-antigens, and self-tissues and/or
organs will be compromised (Rose and Mackay, 2000; Romagnani, 2006; Ryan et al.,
2007). Both bystander activation and molecular mimicry are dependent on the selfantigens being recognized by TLRs on the APCs. The levels of TLRs on APCs differ
depending on the inflammatory milieu encountered by APCs. For example, inflammation
caused by an infection of pathogenic microbes can increase surface expression of TLRs
causing robust processing of the self-antigen by the APCs (Toubi and Shoenfeld, 2004;
Waldner, 2009; Torres-Aguilar et al., 2010).
The final checkpoint to autoimmunity is whether activated T cells to selfantigens differentiate into helper T cells that participate in pro-inflammatory cellmediated or anti-inflammatory humoral-mediated immunity (Figure 1). The proinflammatory cell-mediated immunity is represented by type 1 helper T (Th1) and T
helper 17 (Th17) cells, and is responsible for the pathogenesis of autoimmune
disorders(Zhu and Paul, 2008). The up regulation of T-bet transcription factor
differentiates naïve T cells to become a Th1 cells, which are characterized by secretion of
pro-inflammatory cytokine interferon-γ (IFN-γ), and the proliferative cytokine
interleukin-2 (IL-2) (Zhu and Paul, 2008). The up regulation of ROR-γ transcription
factor differentiates naïve T cells to become Th17 cells, which are characterized by
secretion of pro-inflammatory cytokine interleukin-17 (IL-17) and the cytokine
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Figure 1. Naïve T cell fates. Adapted from (La Cava, 2008; Zhu and Paul, 2008).
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interleukin-6 (IL-6) (Zhu and Paul, 2008). The anti-inflammatory arm of cellular
immunity is represented by type 2 helper T (Th2) and regulatory T (Treg) cells, and is
responsible for allergic diseases (La Cava, 2008; Zhu and Paul, 2008; Veldhoen, 2009;
Steward-Tharp et al., 2010). The up regulation of GATA-3 transcription factor
differentiates naïve T cells to become Th2 cells, which is characterized by secretion of
anti-inflammatory cytokines interleukin-4 (IL-4) and IL-10 (Zhu and Paul, 2008). The up
regulation of Foxp3 transcription factor differentiates naïve T cells to become Treg cells,
which are characterized by secretion of anti-inflammatory cytokine IL-10 and the
cytokine transforming growth factor-β (TGF-β) (Zhu and Paul, 2008).
Differentiation of pro-inflammatory or anti-inflammatory autoreactive T cells
during self-antigen presentation by APCs is determined by the activation status of APCs
and cytokine milieu. For example, immature and mature dendritic cells can present the
self-antigen to autoreactive naïve T cells. However, the immature and semi-mature
dendritic cells express low levels of MHC II and the co-stimulatory molecules CD80 and
CD86 and secrete less pro-inflammatory cytokines. This leads to decreases in
differentiation of pro-inflammatory T cells, or increases in differentiation of autoreactive
naïve T cells into Tregs that suppress pro-inflammatory cell-mediated immune responses.
In contrast, mature dendritic cells expressing high levels of MHC II and the costimulatory molecules CD80 and CD86 differentiate autoreactive naïve T cells into Th1
and Th17 cells (Fehervari and Sakaguchi, 2004; Toubi and Shoenfeld, 2004; Romagnani,
2008; Torres-Aguilar et al., 2010). Moreover, the cytokine milieu derived from dendritic
cells, macrophages, and contracting muscles (Nielsen and Pedersen, 2008), can
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differentiate autoreactive naïve T cells into specific subsets (La Cava, 2008; Zhu and
Paul, 2008; Torres-Aguilar et al., 2010). For example, during APC presentation of selfantigen, IFN-γ, interleukin-12 (IL-12), and interleukin-18 (IL-18) can differentiate
autoreactive naïve T cells into Th1 cells, while IL-4 and IL-2 can differentiate
autoreactive naïve T cells into Th2 cells. Moreover, TGF-β and IL-2 can differentiate
autoreactive naïve T cells into Treg cells, while TGF-β, IL-6, interleukin-21, and
interleukin-23 differentiate autoreactive naïve T cells into Th17 cells (Zhu and Paul,
2008).
Guillain-Barré Syndrome
The autoimmune disease Guillain-Barré Syndrome (GBS) encompasses a
heterogeneous set of clinical syndromes in which idiopathic autoimmune peripheral
neuropathy causes acute or sub-acute weakness of at least two limbs, usually starting in
the legs, which progresses for up to four weeks and then reaches plateau (Hughes and
Rees, 1997; Hughes and Cornblath, 2005; Vucic et al., 2009). GBS symptoms also
include: parasthesia/dysaesthesia, backache/root pain, meningism, and muscle, joint, or
visceral pain, though most cases of pain recover spontaneously at varying intervals after
the onset of disease (Pentland and Donald, 1994). GBS can be divided into several
patterns of pathology (Figure 2) (Ho et al., 1998).
Two patterns of mainly axonal involvement can be categorized in GBS: acute
motor axonal neuropathy (AMAN) and acute motor sensory axonal neuropathy
(AMSAN). AMAN is due to axonal degeneration without a prior demyelination of the
peripheral motor nerves (Ho et al., 1998; Hughes and Cornblath, 2005; Vucic et al.,
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2009). Generally, AMAN is characterized by weakness or paralysis without sensory loss.
AMAN is diagnosed when electrophysiological studies of patients with GBS show a
reduction in compound muscle action potential (CMAP) amplitudes without prominent
conduction slowing. AMAN most commonly occurs in children in Asian countries, with
antecedent Campylobacter jejuni infection, which suggests molecular mimicry (Ho et al.,
1998; Kuwabara, 2004; Hughes and Cornblath, 2005; Kuwabara, 2007; Vucic et al.,
2009). In fact, antigens on the C. jejuni are similar to those located at the nodes of
Ranvier, signifying that AMAN is most likely a humoral-mediated immune response
against the axon. Autoantibodies to gangliosides, such as GM1, GM1b, or GD1a, bind at
the nodes of Ranvier leading to complement-mediated destruction and macrophage
invasion, resulting in Wallerian-like degeneration (Li et al., 1996; Ho et al., 1998;
Hughes and Cornblath, 2005; Vucic et al., 2009).
AMSAN is similar to AMAN in that it involves Wallerian-like degeneration
and/or conduction block of peripheral motor nerves. Where AMSAN differs is that
peripheral sensory nerves also undergo Wallerian-like degeneration and/or conduction
block (Ho et al., 1998; Kuwabara, 2004, 2007). The incidence of AMSAN is very low,
being less than 10 percent of AMAN (Kuwabara, 2004, 2007; Vucic et al., 2009).
Another variant of GBS is Miller-Fisher Syndrome (MFS), which is characterized
by acute onset of unstable gait (ataxia), loss of reflexes (areflexia), and inability to move
the eyes (ophthalmoplegia). Autoantibodies to the gangliosides GQ1b and GT1a are
heavily distributed on oculomotor nerves and to a lesser extent on motor nerve terminals
of somatic musculature, sensory neurons in the dorsal root ganglion, and a population of
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Figure 2. An operational classification of GBS and related syndromes. Adapted from
(Ho et al., 1998).
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cerebellar neurons. Some cases of MFS are preceded by an antecedent infection of C.
jejuni, which bear epitopes similar to GQ1b and GT1a, thus implicating molecular
mimicry (Ho et al., 1998; Kuwabara, 2004; Hughes and Cornblath, 2005; Kuwabara,
2007; Vucic et al., 2009).
When GBS was first described, it was previously characterized only by
lymphocytic infiltration/inflammation and peripheral nervous system (PNS)
demyelination. With the realization that GBS encompasses many subtypes, the GBS form
of lymphocytic infiltration/inflammation and PNS demyelination is now clinically
defined as acute inflammatory demyelinating polyneuropathy (AIDP) (Ho et al., 1998).
AIDP is the most common form of GBS in developed countries and is responsible for 8590% of the patients with GBS (Kuwabara, 2004, 2007; Vucic et al., 2009).
AIDP is characterized by demyelination, and pro-inflammatory lymphocyte and
macrophage infiltration. In some cases of AIDP, axonal degeneration may follow
demyelination. Clinically, patients present with flaccid paralysis, areflexia, and some
sensory loss (Hughes and Cornblath, 2005; Kuwabara, 2007; Vucic et al., 2009).
Electrophysiological studies of the peripheral nerves usually reveal increases in distal
latencies and absence of F waves or increases in F wave latencies, and reductions in
nerve conduction velocities and CMAP amplitudes (Hughes and Cornblath, 2005; Vucic
et al., 2009; Uncini et al., 2010). Also, early in AIDP, there are decreased proximal-todistal CMAP amplitude ratios that, later in the disease, return to normal (Uncini et al.,
2010). This signifies length-dependent CMAP amplitude reduction, and is thought to be
due to demyelinating lesions scattered along the nerve followed by axonal degeneration
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(van der Meche et al., 1988; Uncini et al., 2010). Many markers of pro-inflammatory T
cell activation, including soluble IL-2 receptor, IL-12, IL-18, and tumor necrosis factor-α
(TNF-α), are found in the serum of AIDP patients (Ho et al., 1998; Lu and Zhu, 2010).
Moreover, GBS patients have decreased percentages of anti-inflammatory regulatory T
cells that may cause a dysregulation of pro-inflammatory Th1 cells (Pritchard et al., 2007;
Vucic et al., 2009). An alternative, but not mutually exclusive, hypothesis is that the
binding of autoantibodies to the Schwann cell is followed by complement-mediated
destruction of peripheral myelin (antibody-dependent cell-mediated cytotoxicity)
(Hughes and Cornblath, 2005; Vucic et al., 2009). Evidence for this theory comes from
low incidence of antecedent infection of C. jejuni. It is thought that unknown antibodies
against C. jejuni cross-reacts with self-antigens expressed on Schwann cells, thus
implicating molecular mimicry (Ho et al., 1998; Hughes and Cornblath, 2005; Kuwabara,
2007; Vucic et al., 2009).
Treatment for Guillain-Barré Syndrome
A multidisciplinary approach is needed to prevent and manage potentially fatal
complications of GBS. Respiratory failure occurs in about 25% of patients and early
transfer to an intensive care unit for pre-induction intubation is required. Patients are also
monitored for cardiac arrhythmia, autonomic failure, and vein thrombosis. Other
complications requiring medical care are pain, urinary retention, and ileus (Hughes and
Cornblath, 2005; Kuwabara, 2007; Vucic et al., 2009).
Immunotherapy is used as a treatment for GBS. These non-specific immunemodulating therapies are indicated for patients who are unable to walk, and they consist
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of plasmapheresis (PES) or intravenous immunoglobulin (IVIg) infusion (Ho et al.,
1998). Both treatments help to speed the recovery of the patient, but only if the
treatments are implemented early (before 4 weeks for PES and before 2 weeks for IVIg)
in the disease (Hughes and Cornblath, 2005; Vucic et al., 2009). IVIg and PES have
similar outcomes and either should be offered to patients who are considered immobile
(Cortese et al., 2011).The mechanism of IVIg therapy remains to be understood, but it is
thought that IVIg modulates complement activation products, neutralizes idiotypic
antibodies, saturates the Fc receptors on macrophages, and suppresses various proinflammatory mediators, such as cytokines, chemokines, and matrix metalloproteinases
(Kuwabara, 2004, 2007). The combination of PES and IVIg does not add an extra benefit
to the recovery of GBS (Hughes et al., 2007; Kaida and Kusunoki, 2009; Vucic et al.,
2009).
Corticosteroids are widely used as a therapy in autoimmune disorders. However,
in studies with GBS patients, corticosteroids failed to modulate the course of the disease
(Kuwabara, 2004; Kaida and Kusunoki, 2009; Vucic et al., 2009). One possible
explanation for the lack of benefit seen in corticosteroid treatment is that corticosteroids
might adversely affect the recovery process by inhibiting macrophage clearance of
myelin debris and hinder remyelination of the peripheral nerves (Hughes and Cornblath,
2005; Kaida and Kusunoki, 2009).
Even though current therapies help to speed the recovery process, there is a
pressing need to find more effective and specific immune modulating therapies for the
treatment of GBS and related neuropathies.
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Experimental Autoimmune Neuritis
Experimental autoimmune Neuritis (EAN) is an animal model that closely
resembles AIDP. It is induced by immunization with peripheral nerve myelin or its
proteins, P2, P0, or PMP22 (Hughes and Cornblath, 2005; Kaida and Kusunoki, 2009). It
is also induced by adoptive transfer of autoreactive T cells reactive towards P2, P0, or
PMP22 protein (Gold et al., 2000; Hughes and Cornblath, 2005). The main mechanism of
EAN is a pro-inflammatory autoreactive Th1 cell-mediated response against one or more
of the myelin proteins (Figure 3). Due to activation of the adaptive immune response by
innate immune cells, the activated pro-inflammatory autoreactive Th1 cells , as part of
normal immune surveillance, egress from secondary lymphoid organs into the circulation,
cross the blood-nerve barrier (BNB), encountering a cross-reactive antigen in the
endoneurium (Spies et al., 1995a; Maurer and Gold, 2002; Hughes and Cornblath, 2005;
Schwab and Cyster, 2007). The activated autoreactive Th1 cells release pro-inflammatory
cytokines, which break down the BNB, and recruit and stimulate macrophages and
autoreactive cytotoxic T cells. Macrophages are the effector cells invading the myelin
sheaths and causing demyelination (Maurer and Gold, 2002; Hughes and Cornblath,
2005; Lu and Zhu, 2010). Autoreactive cytotoxic T cells play a role in EAN by migrating
to peripheral nerves and releasing the cytotoxins perforin, granzymes, and granulysin
(Constantinescu et al., 1998; Pelidou et al., 2000; Yun et al., 2007). In addition,
autoantibodies against the myelin proteins produced by autoreactive T cell-activated B
cells can enter the compromised BNB and cause conduction block of the peripheral
nerves. The autoantibodies can also activate complement-mediated destruction of
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peripheral nerve myelin (Hughes et al., 1981; Spies et al., 1995b; Maurer and Gold, 2002;
Vucic et al., 2009).
EAN, similar to AIDP, is a monophasic disease (Gold et al., 2000). It is induced
in Lewis rats. Starting as early as ten days after active immunization with purified P2
peptide fragment, animals begin to lose muscle tone in the tail. Progression of EAN is
characterized by weakness (paraparesis) or paralysis in the hind limbs. In severe cases,
paraparesis or paralysis of the fore limbs and respiratory muscles can occur, leading to
death. Weight loss is common, and begins before the clinical symptoms of EAN appear.
Tactile sensitivity testing of the hind paws reveals tactile hypersensitivity before onset of
clinical symptoms (Moalem-Taylor et al., 2007; Luongo et al., 2008; Zhang et al.,
2008b). Electrophysiological studies show a reduction in motor nerve conduction
velocity, and CMAP amplitudes at peak EAN severity compared to pre-immunization
responses. The neuropathological features of EAN include demyelination of the
peripheral nerves and nerve roots, infiltration of lymphocytes and macrophages, and
nerve edema. In severe EAN, axonal damage may follow demyelination (Harvey and
Pollard, 1992; Sarkey et al., 2007). Many of the immunopathological mechanisms of EAN
are well understood, making it important tool for the development of specific therapies in
autoimmune disease.
Exercise, Autoimmunity and Guillain-Barré Syndrome
Exercise has potent anti-inflammatory effects on the innate and adaptive immune
systems (Figure 4).Regarding innate immunity, exercise is known to alter innate
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Figure 3. Pathogenesis of AIDP/EAN. m, macrophage; T (blue), autoreactive naïve T
cell; T (red), autoreactive activated T cell; B, autoreactive activated B cell; C5-9,
complement activation by autoantibody; NO, nitric oxide. Adapted from (Hughes and
Cornblath, 2005; La Cava, 2008).
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immune cell trafficking (Woods et al., 1999; Sugiura et al., 2000; Ho et al., 2001; Chiang
et al., 2010; Suchanek et al., 2010), decrease TLRs, and alter APC function (Woods et al.,
1999; Lancaster et al., 2005; Flynn and McFarlin, 2006; Gleeson et al., 2006; McFarlin et
al., 2006; Lambert et al., 2008; Timmerman et al., 2008; Simpson et al., 2009; Oliveira
and Gleeson, 2010).
Regarding adaptive immunity, exercise is known to increase (Sugiura et al., 2000;
Rogers et al., 2008), or decrease (Moraska et al., 2000; Nielsen, 2003; Gleeson et al.,
2006; Gleeson, 2007; Rosa Neto et al., 2010) lymphocyte proliferation, increase
differentiation of anti-inflammatory T cells and secretion of anti-inflammatory cytokines
while decreasing pro-inflammatory T cells and cytokines (Lancaster et al., 2004; Pastva
et al., 2004; Yeh et al., 2006; Flynn et al., 2007; Gleeson, 2007; da Silva Krause and de
Bittencourt, 2008; Donnikov et al., 2008; Haaland et al., 2008; Nielsen and Pedersen,
2008; Yeh et al., 2008; Hewitt et al., 2009b; Lowder et al., 2010; Rosa Neto et al., 2010),
and impair the T cell-mediated induction phase of an in vivo immune response (Harper
Smith et al., 2011). Moreover, exercise can increase catecholamines and glucocorticoids
(Woods et al., 1999; Pastva et al., 2005; Ortega et al., 2007; Hewitt et al., 2009a)
decreasing a pro-inflammatory immune response. Exercise can also alter immune cell
trafficking by promoting lymphocyte egress into peripheral tissues (Chen et al., 2010;
Turner et al., 2010; Adams et al., 2011). With many pleiotropic anti-inflammatory effects
on the innate and adaptive immune systems, exercise can be a safe and effective nonpharmacological rehabilitative intervention for inflammatory diseases.
Exercise reduces the complications associated with type 2 diabetes. Exercise
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increases the release of anti-inflammatory cytokines from muscles, and decreases the
release of pro-inflammatory cytokines from adipose tissue (Nielsen and Pedersen, 2008;
Hopps et al., 2011), thus decreasing inflammation. Diabetic men who exercised had
significant reductions in pro-inflammatory cytokines, leukocyte-endothelial interactions
and adhesion, and peripheral neuropathy (Fisher et al., 2003; Balducci et al., 2006;
Roberts et al., 2006; Fisher et al., 2007). Similarly, in a rat model of type 2 diabetes
mellitus, exercise was shown to decrease pro-inflammatory cytokines (Teixeira de Lemos
et al., 2009; Teixeira-Lemos et al., 2011a).
Exercise is known to affect autoimmune and inflammatory diseases in humans. In
asthma, an inflammatory disease of the airways, exercise decreases disease-related
hospital admission of asthmatics (Lucas and Platts-Mills, 2005). In patients with
rheumatoid arthritis (RA), an inflammatory cell-mediated autoimmune disease with signs
and symptoms of joint and systemic inflammation, exercise increases strength and quality
of life, and decreases pain, fatigue, and inflammation (Metsios et al., 2010; Hurley et al.,
2011). In patients with multiple sclerosis (MS), an inflammatory cell-mediated
autoimmune demyelinating disease of the central nervous system, exercise increases
fitness parameters and quality of life, and decreases fatigue and pro-inflammatory
cytokines (TNF-α, IFN-γ,) (Schulz et al., 2004; White et al., 2006a; White et al., 2006b;
Castellano et al., 2008). Patients suffering from GBS also benefit from exercise. For these
patients, exercise improves physical fitness and muscle strength and decreases recovery
time, fatigue, anxiety, and depression (Garssen et al., 2004; El Mhandi et al., 2007).
However, the effects of exercise on immune parameters have not been investigated
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in GBS patients.
In the mouse model of MS, experimental autoimmune encephalomyelitis (EAE),
forced-exercise has been shown to decrease the clinical severity and delay the onset of
symptoms (Le Page et al., 1994; Le Page et al., 1996; Rossi et al., 2009). Three weeks of
exercise in rats has been shown to increase blood-brain barrier function by decreasing
expression of matrix metalloproteinases (Guo et al., 2008). In studies of EAE, the bloodbrain barrier becomes permeable to lymphocytes (Engelhardt, 2006), and thus exercise
might have a therapeutic role in MS. In an animal model of RA, collagen-induced
arthritis (CIA), exercise has been shown to decrease severity of CIA by decreasing
immune cell activation and increasing blood glucocorticoids (Navarro et al., 2010). In the
mouse model of asthma, ovalbumin-induced asthma, exercise has been shown to decrease
severity of asthma by increasing glucocorticoids, and increasing the percentage and
suppressive activity of anti-inflammatory Tregs with a concomitant increase in antiinflammatory cytokines, while decreasing pro-inflammatory cytokines and transcription
factors (Pastva et al., 2004; Pastva et al., 2005; Hewitt et al., 2009b; Lowder et al., 2010).
There have been no studies on the effects of exercise on EAN. However, due the
anti-inflammatory effects of exercise, EAN might be attenuated. Moreover, further
beneficial effects of exercise in the PNS are increased capacity of axonal regeneration
and sprouting after peripheral nerve injury and decreased age-related apoptosis of
Schwann cells (Ilha et al., 2008; Sabatier et al., 2008; Shokouhi et al., 2008). Promoting
regeneration or decreasing Schwann cell apoptosis in EAN or GBS would be ideal as a
therapeutic intervention. To our knowledge, the effect of exercise on EAN has not been
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investigated, and the beneficial effects of exercise may attenuate this autoimmune
peripheral neuropathy.

CHAPTER III
MATERIAL AND METHODS
This study was conducted using protocols approved by the Edward Hines Jr. VA
Institutional Animal Care and Use Committee in accordance with the principles of
laboratory animal care (Institute for Laboratory Animal Research, 2010). Male Lewis rats
(6-8 weeks of age; 200-220g) were housed two to a cage and allowed free access to
Harlan 2018 rat chow and water ad libitum. Rats were maintained on a 12h/12h light/dark
cycle. Tissue harvest and blood collection were performed between the hours of 0500 and
0800. For induction of experimental autoimmune neuritis (EAN) and for
electrophysiological studies, rats were anesthetized with a combination of ketamine (90
mg/kg) and xylazine (7.5 mg/kg). 0.1 M phosphate-buffered saline (PBS) (pH 7.4) was
used in this study.
Forced-Exercise Experimental Design
Rats were randomized to two groups: sedentary control or forced-exercise. Rats
randomized to the forced-exercise group were acclimated to treadmill running using an
Exer-3R motorized treadmill apparatus equipped with a motivational electric shock grid
set at 20 µA (Columbus Instruments, USA). During acclimation, rats were subjected to
treadmill training at 15 m/min x 20 minutes on the first day. Subsequently, rats were
subjected to progressively faster and longer training sessions until the fifth day of
training where the rats ran consistently at 20 m/min x 60 minutes. Rats acclimated to
27
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treadmill training received an additional three weeks of forced-exercise at 20 m/min x 60
minutes, five days a week. Sedentary control rats were allowed to explore a similar
“treadmill” environment for an identical duration of time but without receiving exercise.
Both sedentary and forced-exercise rats were weighed daily throughout this study.
Induction of Mild Experimental Autoimmune Neuritis
At the completion of the three-week sedentary- or forced-exercise program, all
rats were actively induced with experimental autoimmune neuritis (EAN), an established
animal model of acquired inflammatory demyelinating neuropathy (AIDP), the
predominant subtype of Guillain-Barré Syndrome (GBS) occurring in North America and
Europe. EAN was induced (day 0) by injecting in the base of the tail (Figure 5) 100 μl of
an emulsified 1:1 PBS:CFA (Sigma, USA) solution containing a final concentration of 5
mg/ml heat-inactivated H37RA Mycobacteria tuberculosis (Difco, USA) and 100 µg of
commercially prepared P2 peptide (residues 53-78 of bovine P2 myelin protein; DanaFarber Cancer Institute, Harvard University, USA). Forced-exercise rats immunized at
the base of the tail were allowed to continue their training throughout the disease course.
All rats were closely observed for development of EAN. Clinical assessment of
EAN severity was performed by investigators blinded to group assignment and was semiquantified as follows: 0 = normal; 1 = limp tail; 2 = abnormal gait; 3 = mild paraparesis;
4 = severe paraparesis; 5 = hind limb paraplegia. Intermediate scores were assigned using
0.5 increments. Rats were sacrificed near peak (day 18) of EAN.
Induction of Severe Experimental Autoimmune Neuritis
At the completion of the three-week sedentary- or forced-exercise program, all
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rats were actively induced with EAN, an aggressive animal model of AIDP. EAN was
induced (day 0) by injecting in the hind left footpad (Figure 6) 100 μl of an emulsified
1:1 PBS:CFA (Sigma, USA) solution containing a final concentration of 5 mg/ml heatinactivated H37RA Mycobacteria tuberculosis (Difco, USA) and 100 µg of commercially
prepared P2 peptide (residues 53-78 of bovine P2 myelin protein; Dana-Farber Cancer
Institute, Harvard University, USA). Forced-exercised rats immunized in the hind left
footpad were not subsequently subjected to further training due to the local inflammatory
response.
As an immunization antigen-free adjuvant (CFA) control, a subgroup of sedentary
rats were injected in the hind left footpad with 100 μl of an emulsified 1:1 PBS:CFA
solution containing 5 mg/ml of heat-inactivated H37RA Mycobacteria Tuberculosis in
the absence of added antigen.
All rats were weighed daily and closely observed for development of EAN.
Clinical assessment of EAN severity was performed by investigators blinded to group
assignment and was semi-quantified as follows: 0 = normal; 1 = limp tail; 2 = abnormal
gait; 3 = mild paraparesis; 4 = severe paraparesis; 5 = hind limb paraplegia. Intermediate
scores were assigned using 0.5 increments. Rats were further subdivided into two disease
groups, sacrificed either near onset (day 14) or near peak (day 18) of EAN.
Peripheral Nerve Conduction Studies
Evoked-response electrophysiological studies (Figure 7) were performed on rats
prior to induction of (day 0) and near peak (day 18) of mild (Figure 5) and severe EAN
(Figure 6). Evoked compound muscle action potential (CMAP) amplitudes and latencies
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were recorded from the right leg of ketamine/xylazine sedated rats as previously
described (Sarkey et al., 2007). Briefly, evoked responses were elicited from the ankle
(tibial nerve, distal) or the sciatic notch (sciatic nerve, proximal) with unipolar needle
electrodes using supramaximal stimuli (25 mA, 0.05 ms duration). Evoked compound
muscle action potential (CMAP) amplitudes were recorded from the plantar muscles with
needle electrodes. Body temperature of the sedated rat was maintained near 37° C with an
activated thermal heating pad. A series of 25 individual responses were evoked at a
frequency of 1 Hz. Evoked responses were amplified, recorded, and averaged using a
Teca Synergy electromyograph system (CareFusion, USA). Each response series was
repeated three times. Proximal/distal ratios (R ratios) were calculated using the following
formula: proximal CMAP amplitude ∕ distal CMAP amplitude. Motor nerve conduction
velocities (MNCVs) were calculated using the following formula: distance between ankle
and sciatic notch placed electrodes (typically 55 mm) ∕ (sciatic notch latency recording –
ankle latency recording).
Neuropathology
Near peak of severe EAN (day 18) (Figure 6), rats were sacrificed by CO2
asphyxiation, and sciatic nerves were rapidly harvested and immediately post-fixed in
ice-cold 2% paraformaldehyde (Sigma, USA) + 2.5% glutaraldehyde (EMS, USA) PBS
(pH 7.4) solution for 48 hours at 4° C. Fixed nerves were washed in PBS, osmicated by
brief immersion in 1% OsO4, dehydrated by washing with ascending series of alcohol
solutions (50-100%) and propylene oxide. Dehydrated nerves were embedded in Embed812 (Electron Microscopy Sciences, USA). Serial transverse sections (0.5 μm thick) were
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cut using a Reichert Ultracut S microtome and stained with 0.5% toluidine blue/borax
solution. Stained sections were examined by light microscopy using a Leitz DMRB
inverted phase-contrast microscope equipped with a Leica Wild MPS photographic
system (W. Nuhsbaum, USA). Histopathological changes (inflammatory infiltrates,
myelin ovoids, or damaged axons) in sciatic nerves were quantified by two investigators
blinded to group assignment by using a four-point scoring system as follows: 0 = normal;
1 = mild demyelination, axonal damage, or cellular infiltrates; 2 = moderate
demyelination, axonal damage, or cellular infiltrates; 3 = severe demyelination, axonal
damage, or cellular infiltrates (Sarkey et al., 2007).
Proliferation Assay
Rats were sacrificed by CO2 asphyxiation near onset (day 14) or near peak (day
18) of severe EAN, and spleens and popliteal lymph nodes were harvested (Figure 6).
Splenic lymphocytes were cleared of contaminating red blood cells by brief exposure to
ammonium chloride lysing buffer (155 mM NH4Cl, 10 mM KHCO3, 0.1 mM Na2EDTA;
pH 7.4). Lymphocytes were prepared as a single-cell suspension. Prepared splenic or
nodal lymphocytes were cultured at an initial density of 2.0 x 106 cells/ml in RPMI-1640
GlutaMAX-I media supplemented with 9% heat-inactivated fetal bovine serum
(Invitrogen, USA), 0.05 μM 2-mercaptoethenol, 90 U/ml penicillin and 90 μg/ml
streptomycin.
Cells were assayed for 96 hours in either the absence (antigen-free control) or
presence of 10 µg/ml of P2 peptide or 5 µg/ml of the lectin concanavalin A (Sigma,
USA). To determine proliferation indices, 0.5 µCi of [3H]thymidine (6.7 Ci/mmol; MP
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Figure 7. Representative M wave tracings from the rat left plantar muscle
stimulated at the ankle or sciatic notch. A recording electrode was placed in the plantar
muscle of the rat, and M waves were recorded by stimulating distally at the ankle or
proximally at the sciatic notch as described in Materials and Methods (top). Adapted
from (Lawlor et al., 2001). Representative tracing from one rat are shown (bottom).
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Biomedicals, USA) was added to each culture for the final 24 hours of control-, antigen-,
or lectin-stimulation. Cells were briefly trypsinized and collected by centrifugation. DNA
was precipitated with ice-cold 10% (w/v) trichloroacetic acid, solubilized with NaOH,
neutralized with HCl, and an aliquot was added to 5 ml of Beckman Coulter Ready Safe
liquid scintillation counting cocktail. Disintegrations per minute (dpm) of [3H]thymidine
incorporated into the splenic or nodal lymphocyte DNA was quantified using a Tri-Carb
2810 liquid scintillation analyzer (Perkin Elmer, USA). Stimulation indices were
calculated as a ratio of dpm of DNA recovered in antigen- or lectin-stimulated cultures to
dpm of DNA recovered in un-stimulated cultures (Sarkey et al., 2007).
Cytokines
Splenic or nodal leukocytes harvested near onset (day 14) or near peak (day 18) of
severe EAN (Figure 6) were cultured for 96 hours at a density of 2.0 × 106 cells/ml in the
absence or presence of 10 µg/ml of P2 peptide or 5 µg/ml of concanavalin A. Cell culture
supernatants were collected and analyzed for the presence of interleukin-2, interleukin-4
interleukin-6, interleukin-10, interleukin-12p70, interferon-γ, and tumor necrosis factor-α
pro- or anti-inflammatory cytokines. The content of cytokines present in culture
supernatant were quantified simultaneously using multiplex technology with an available
Bio-plex system (Bio-Rad Laboratories, USA) and a commercially available rat-specific
cytokine Milliplex kit (Millipore, USA).
Flow Cytometric Analysis
Splenic, nodal, or blood lymphocytes were prepared from rats sacrificed near
onset (day 14) or near peak (day 18) of severe EAN (Figure 6). Blood was collected in 5
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mM EDTA tubes.
To determine the relative abundance of CD4+ and CD8+ T cells, splenic, nodal, or
blood lymphocyte preparations were co-incubated at a density of 1 x 106 cells for 30 min
at 4° C in the presence of 1 µg each of FITC-conjugated mouse anti-rat CD4 (clone
W3/25), and PE-conjugated mouse anti-rat CD8α (clone G28) monoclonal antibodies
(BioLegend, USA).
To determine the relative abundance of type 1 helper T (Th1, CD4+) cells
(Yamane et al., 2000; Ozenci et al., 2001; McQuaid et al., 2003; Kano et al., 2008) or
activated cytotoxic T (Tc, CD8+) cells (McQuaid et al., 2003; Bontkes et al., 2005),
splenic, nodal, or blood lymphocyte preparations were co-incubated at a density of 1 x
106 cells for 30 min at 4° C in the presence of 1 µg of rabbit anti-rat IL-12Rβ1 (clone C20) monoclonal antibody (Santa Cruz Biotechnology) followed by incubation in the
presence of 1 µg APC-conjugated F(ab')2 fragment goat anti-rabbit IgG (H+L) (Jackson
ImmunoResearch, USA) as a secondary antibody.
To determine the relative abundance of type 2 helper T (Th2, CD4+) cells (Rojo et
al., 2008; Zhu and Paul, 2008; Simpson et al., 2010), prepared splenic, nodal, and blood
lymphocyte preparations were co-incubated at a density of 1 x 106 cells for 30 min at 4°
C in the presence of 1 µg of FITC-conjugated mouse anti-rat CD4 (clone W3/25) and PEconjugated hamster anti-rat CD278 (clone C398.4A) monoclonal antibodies (BioLegend,
USA).
Co-immunostained cells from splenic or nodal lymphocyte preparations were
washed twice with ice-cold serum (5% bovine calf serum)-supplemented PBS. Washed
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cells were re-suspended in 1 ml of ice-cold 4% p-formaldehyde PBS (pH 7.4). After 10
min, fixed cells were washed twice and re-suspended in serum-supplemented PBS.
Co-immunostained cells from blood were incubated with CAL-LYSE red blood
cell lysing solution (Invitrogen, USA) according to manufacturer’s protocol. After
incubation, cells were washed twice and re-suspended in serum-supplemented PBS.
Cytometric data were collected using an available FACS Canto flow cytometer
(BD Biosciences, USA) and analyzed with FlowJo software (Tree Star, Inc., USA).
Lymphocytes were gated according to their forward and side scatter. In all cases, isotype
controls were used to quantify and correct for background fluorescence.
A summary of differentiated T cells and their corresponding cell surface markers
used in flow cytometric analyses are summarized in Table 1.
Corticosterone and Corticosteroid-Binding Globulin
To determine changes in corticosteroid levels in response to forced-exercise,
blood was collected from sedentary control or forced-exercise rats gently sacrificed (CO2
asphyxiation) near onset (day 14) or near peak (day 18) of severe EAN (Figure 6),
plasma prepared and stored at -80º C until use. Rats were sacrificed in the morning
between 0500 and 0800 hours. Plasma corticosterone levels were quantified using a
commercially available competitive radioimmunoassay kit (Siemens Healthcare
Diagnostics, USA).
Corticosteroid-binding globulin (CBG) levels in plasma were similarly quantified
by competitive radioimmunoassay according to (Westphal, 1971; Brown et al., 2007).
Briefly, plasma (20 µl) was pre-clarified with a dextran-coated charcoal (DCC) solution
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Table 1. Summary of differentiated T cells and their corresponding cell
surface markers used for flow cytometric analyses.
Cluster of
Differentiated T cells
Other Names
Differentiation (CD)
Naïve helper T (Th) cell

CD4

-

Type 1 helper T (Th1)
cell

CD4

-

CD212

Interelukin-12 receptor β1
(IL-12Rβ1)

Type 2 helper T (Th2)
cell

CD4

-

CD278

Inducible T cell co-stimulator
(ICOS)

Cytotoxic T (Tc) cell

CD8α

-

CD8α

-

Activated cytotoxic T
(activated Tc) cell

Interelukin-12 receptor β1
(IL-12Rβ1)
Lymph node and spleen cells were prepared as described in Materials and Methods, and
gated for lymphocytes according to forward and side scatter.
CD212
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containing 0.5% activated charcoal (Sigma USA) and 0.05% dextran from Leuconostoc
mesenteroides (Sigma, USA), centrifuged at 3000 g x 15 min, and the resultant clarified
supernatant was diluted 1:2 (v/v) with 10 mM Tris buffer (pH 8.0) containing 1.0 mM
EDTA, 10% glycerol (v/v), and 1.0 mM dithiothreitol. Clarified samples were aliquoted
(100 µl) to four tubes, each containing 45 nM of [3H]corticosterone (70-78 Ci/mmol)
(Perkin Elmer, USA). Unlabeled corticosterone (10 µM, Sigma, USA) was added to two
tubes for determining non-specific binding. All tubes were incubated for 24 hours at 4°C.
Ice-cold DCC (pH 7.4) was added to each tube and incubated for 10 min at 4°C. Samples
were centrifuged at 3,000g at 4°C for 5 minutes to sediment DCC. An aliquot of the
centrifuged sample was added to 5 ml of liquid scintillation Beckman Coulter Ready Safe
counting cocktail. Disintegrations per minute of [3H]corticosterone were quantified using
a Tri-Carb 2810 liquid scintillation analyzer (Perkin Elmer, USA). In all cases, nonspecific binding was subtracted from the total binding to calculate specific CBG content.
Statistical Analyses
Sedentary and forced-exercise EAN data are expressed as mean ± SEM and
sedentary adjuvant control data are expressed as mean, of (n) observations unless
otherwise specified. Statistical significance between parametric multiple groups (between
sedentary and forced-exercise EAN groups, and between post-induction day 14 and 18)
was determined using two-way ANOVA (group × time) followed by a post hoc all
pairwise multiple comparison Holm-Sidak test. This statistical post-hoc test was chosen
because it is more powerful than the Bonferroni post hoc test and has stricter control of
the familywise error rate than Tukey post hoc test (Salkind and Rasmussen, 2007). When
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appropriate, two-way repeated-measures ANOVA (group × time) followed by a post hoc
all pairwise multiple comparison Holm-Sidak test was used. Non-parametric clinical and
neuropathological data were statistically analyzed using a Mann-Whitney non-parametric U
test analysis and one-way ANOVA on ranks followed by a post hoc all pairwise multiple
comparisons Dunn’s test, respectively. Sedentary adjuvant controls were not included in
statistical analyses, but were included in figures as a reference for non-disease values. In all
cases, p < 0.05 was considered significant.

CHAPTER IV
RESULTS
Forced-Exercise Attenuates Mild Experimental Autoimmune Neuritis
Increasing evidence supports the novel use of exercise as a safe adjunctive
strategy for the management of some nervous system disorders, including immunemediated peripheral neuropathies (Fisher et al., 2003; Garssen et al., 2004; Schulz et al.,
2004; Balducci et al., 2006; Roberts et al., 2006; White et al., 2006a; White et al., 2006b;
El Mhandi et al., 2007; Fisher et al., 2007; Castellano et al., 2008). First we sought to
determine whether forced-exercise protects against autoimmune neuropathy by treadmill
exercising adult male Lewis rats three weeks before and during the onset and progression
of actively induced mild (base of the tail injection) experimental autoimmune neuritis
(EAN) (Figure 5), an established animal model of Guillain-Barré syndrome (Hughes and
Cornblath, 2005).
Prior to induction of mild EAN, Lewis rats were randomized to sedentary or
forced-exercise training groups. Rats randomized to the forced-exercise group were
subjected to daily 60 min sessions of running at a constant rate using a motorized
treadmill as described within Methods and Materials. By comparison, rats randomized to
the sedentary control group were allowed to explore a similar environment daily for 60
minutes without forced-exercise.
Following sedentary or forced-exercise training, rats were induced with mild
41
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EAN by injecting into the base of the tail an emulsified solution containing 100 µg of a
neuritogenic peptide fragment of bovine peripheral nerve P2 protein (residues 53-78) as
described within Methods and Materials (Figure 5). Immunization at the base of the tail
was chosen as an optimal injection site given the design of subjecting animals to forcedtreadmill running. Within two-weeks of immunization, rats developed a monophasic
course of paraparesis consistent with mild EAN (Figure 8; Table 1). Sedentary control
rats immunized by injection at the base of the tail (Figure 8) developed clinical signs of
mild EAN (defined here as a clinical score ≥ 0.5), beginning on post-induction day 12.33
± 0.59 (n = 18; clinical score 0.61 ± 0.13) reaching peak severity at post-induction day
15.83 ± 0.35 (n = 18; clinical score 2.42 ± 0.33). By comparison, rats undergoing forcedexercise exhibited an attenuated monophasic course of mild EAN beginning on postinduction day 12.63 ± 0.53 (n = 16; clinical score 0.61 ± 0.17, n = 18) reaching peak
severity on post-induction day 14.69 ± 0.73 (n = 16; clinical score 1.33 ± 0.27, n = 18).
At post-induction days 13 to 18, forced-exercise EAN rats exhibited significantly lower
(improved) clinical scores when compared to sedentary control EAN rats (Figure 8). The
onset of mild EAN in sedentary rats, however, did not differ significantly from that of
forced-exercise rats (p = 0.60) (Table 1). Whereas the clinical severity of mild EAN was
significantly attenuated in rats undergoing forced-exercise, the day at which mild EAN
peaked in these animals did not differ significantly (p = 0.25) compared with sedentary
control EAN rats (Table 1). Two rats from the forced-exercise group failed to develop
clinical signs of mild EAN.
Collectively, these data suggest that forced-exercise attenuates the development of

43
Sedentary
Forced-Exercise

Clinical Score

4

3

2

* * *
1

*
0

8

9

10

11

12

13

*
14

*

15

16

17

18

Day (post-induction)

19

20

21

22

23

Figure 8. Forced-exercise attenuates mild EAN. Sedentary (open circles) or forcedexercise (closed circles) trained rats were immunized with P2 peptide fragment by
injection in the base of the tail at day 0 and were clinically evaluated for signs of mild
EAN. Data shown are the means + SEM (n = 5-18). *p<0.05 vs. sedentary, MannWhitney non-parametric U-test.

Table 2. Effect of forced-exercise on development and clinical severity of
mild EAN induced by injection in the base of the tail.
Mild EAN
Sedentary
(n = 18)

Forced-exercise
(n = 16-18)

Clinical onset
(post-induction day)

12.33 (12) ± 0.59

12.63 (12) ± 0.53

Clinical peak
(post-induction day)

15.83 (16) ± 0.35

14.69 (16) ± 0.73

Peak clinical score

2.42 (2) ± 0.33

1.33 (1) ± 0.27*

Data shown are the means (median) + SEM. Clinical onset is defined as the first day a
minimum clinical score of 0.5 was reached. Clinical peak is defined as the first day a
peak clinical score was reached. *p<0.05 vs. sedentary, Mann-Whitney non-parametric
U-test. EAN, experimental autoimmune neuritis.
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mild EAN. The mechanism by which this occurs was next addressed.
Effect of Forced-Exercise on Mild EAN-Induced Peripheral Nerve Injury
Previous studies demonstrate measurable deficits in peripheral nerve function
following induction of severe EAN, supportive of an autoimmune-mediated
inflammatory demyelinating nerve injury (Gabriel et al., 1997; Taylor and Pollard, 2001,
2003; Lin et al., 2007; Sarkey et al., 2007). Whereas forced-exercise attenuates the
clinical severity of mild EAN (Figure 8), we next determined whether the moderate
training program used in this study would alter mild EAN-induced changes in peripheral
nerve large-fiber function in Lewis rats. The effect of forced-exercise on peripheral nerve
function was determined by evoked-response electrophysiology as described within
Methods and Materials (Figure 5).
As shown in Figure 8, rats immunized by injection in the base of the tail
developed a mild course of EAN. Subjecting these animals to forced-exercise afforded a
measure of protection against EAN-induced peripheral nerve injury (Figure 9). At postinduction day 18, sedentary control rats with mild EAN exhibited a significant reduction
in both ankle- (4.65 ± 0.52 mV, n = 18) [F1, 34 = 5.68, p = 0.02] and sciatic notch- (2.90 ±
0.39 mV, n = 18) [F1, 34 = 4.41, p = 0.04] evoked compound muscle action potential
(CMAP) amplitudes compared with pre-induction (day 0) responses (ankle 7.75 ± 0.46
mV, n = 18; sciatic notch 5.48 ± 0.49 mV, n = 18). In marked contrast, rats with mild
EAN undergoing forced-exercise exhibited preserved ankle- (6.27 ± 0.57 mV, n = 18)
and sciatic-notch- (4.26 ± 0.42 mV, n = 18) evoked CMAP amplitude responses that were
statistically indistinguishable compared with their respective pre-induction (day 0)
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Figure 9. Effect of forced-exercise on evoked peripheral nerve conduction
amplitudes in rats with mild EAN. Relative changes in peripheral nerve CMAP
amplitudes were determined by evoke-response electrophysiology prior to and 18 days
following immunization with P2 peptide fragment by injection into the base of the tail as
described within Methods and Materials. Data shown are the means + SEM (n = 18) of
rats undergoing sedentary (white bars) or forced-exercise (black bars) training. #p<0.05
vs. respective day 0 responses, *p<0.05 vs. respective day 18 sedentary control responses
demonstrating protection; two-way repeated measures ANOVA with post hoc HolmSidak multiple comparison test.
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Figure 10. Effect of forced-exercise on R ratios in rats with mild EAN. Relative
changes in peripheral nerve conduction ankle and notch amplitudes were determined by
evoke-response electrophysiology, and R ratios calculated, prior to and 18 days following
immunization with P2 peptide fragment by injection into the base of the tail as described
within Methods and Materials. Data shown are the means + SEM (n = 18) of rats
undergoing sedentary (white bars) or forced-exercise (black bars) training. These data
were analyzed by two-way repeated measures ANOVA with post hoc Holm-Sidak
multiple comparison test and were found to be statistically indistinguishable.
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Figure 11. Effect of forced-exercise on mild EAN-induced slowing of peripheral
nerve conduction velocity. Peripheral nerve conduction velocities were calculated from
the experimental data shown in Fig. 6. Data shown are the means + SEM (n = 18) of rats
undergoing sedentary (white bars) or forced-exercise (black bars) training. #p<0.05 vs.
respective day 0 responses; two-way repeated measures ANOVA with post hoc HolmSidak multiple comparison test.
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responses (Figure 9). Absolute values of sciatic-notch evoked CMAP amplitudes were
approximately 20% lower in magnitude compared with ankle-evoked responses in
sedentary control and forced-exercise groups; there were no differences in R ratios
between the groups [F1, 34 = 0.23, p = 0.63] or between the post-induction days [F1, 34 =
1.29, p = 0.26] (Figure 10). This could occur because of temporal dispersion or uniform
demyelination (van der Meche et al., 1988; Harvey and Pollard, 1992; Lin et al., 2007;
Daube and Rubin, 2009; Uncini et al., 2010).
Base-of-the-tail injected rats undergoing sedentary (60.15 ± 3.55 m/s, n = 18) or
forced-exercise (59.59 ± 3.08 m/s, n = 18) training exhibited nearly identical rates [F1, 34
= 2.74, p = 0.11] of motor nerve conduction velocities (MNCVs) prior to immunization
(Figure 11, day 0). By comparison, sedentary rats with mild EAN exhibited significant
slowing of MNCV (47.79 ± 1.60 m/s, n = 18) by post-induction day 18. Whereas forcedexercise rats with mild EAN also experienced significant slowing of MNCV (50.75 ±
2.29 m/s, n = 18), this occurred to a lesser degree compared with sedentary controls [F1, 34
= 23.5, p < 0.001] (Figure 11).
Collectively, these data suggest that forced-exercise training program used in this
study significantly attenuates the development of clinically mild EAN and its associated
peripheral nerve electrophysiological deficits.
Pre-Induction Forced-Exercise Attenuates Severe Experimental Autoimmune
Neuritis
We showed that forced-exercise before and during development and progression
of mild EAN can attenuate the clinical and electrophysiological deficits of the disease.
Next, we investigated whether three weeks of pre-induction exercise, in which Lewis rats
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Figure 12. Effect of forced-exercise on weight gain in adult male Lewis rats. Rats
undergoing forced-exercise on a motorized treadmill (solid circles) gained weight at a
rate that was significantly less than sedentary controls (open circles). Data shown are the
means + SEM (n = 27). *p<0.05 vs. sedentary control; two-way repeated measures
ANOVA with post hoc Holm-Sidak multiple comparison test.
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ceased running after induction, would similarly attenuate severe EAN induced by footpad
P2 peptide injection. To determine the mechanism by which pre-induction exercise
protects against autoimmune neuropathy, we challenged adult male Lewis rats to a
moderate regimen of forced-exercise before induction and quantified clinically and
immunologically the onset and progression of actively induced severe (hind left footpad
injection) EAN (Figure 6).
Prior to induction of EAN, male Lewis rats were randomized to sedentary or
forced-exercise training groups. Rats randomized to the forced-exercise group were
subjected to daily 60 min sessions of running at a constant rate using a motorized
treadmill as described within Methods and Materials (Figure 6). By comparison, rats
randomized to the sedentary control group were allowed to explore a similar environment
daily for 60 minutes without forced-exercise. As shown in Figure 12, both groups of rats
steadily gained body weight throughout the three-week sedentary or forced-exercise
training. During this period, sedentary control rats gained body weight at a rate of 2.7 ±
0.1 (n = 27) grams per day, consistent with previously published findings for male Lewis
rats fed chow ad libitum (2.7 g/day, Harlan Lewis growth curve). In contrast, forcedexercise rats exhibited a significantly reduced rate (1.8 ± 0.1 g/day, n = 27) of body
weight gain [F19, 988 = 43.11, p < 0.001] (Figure 12). Post-hoc statistical analysis of these
data revealed a significant difference in body weight gain between sedentary and forcedexercise rats between days 15 to 26. These findings suggest that the forced-exercise
regimen used in this dissertation was of a moderate level of intensity. Importantly, at no
time throughout this study did rats randomized to the forced-exercise group exhibit a
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frank loss of body weight. While food consumption between sedentary and forcedexercise groups was not monitored in this study, rats undergoing forced-exercise gained
body weight. These findings further suggest that secondary complications of confounding
cachexia in response to forced-exercise were minimized.
To determine whether forced-exercise was effective at protecting against a
clinically severe form of EAN, rats were immunized by injection in the hind left footpad
as previously described (Sarkey et al., 2007). Injection into the footpad necessitated a
change in experiment design of particular noteworthy significance. Given the injection
site, rats undergoing forced-exercise were unable to sustain physical activity following
footpad immunization. Thus, the experimental distinction between sedentary and forcedexercise footpad immunized rats was restricted to physical activity performed prior (preinduction) to induction of EAN.
As previously reported (Sarkey et al., 2007), footpad-immunized sedentary
control rats developed severe EAN (Figure 13; Table 2), beginning on post-induction
day 12.33 ± 0.20 (n = 24; clinical score 0.75 ± 0.14) reaching peak severity at postinduction day 17.00 ± 0.33 (n = 12; clinical score 3.99 ± 0.20). Despite cessation of
training prior to EAN induction, rats undergoing pre-induction forced-exercise similarly
exhibited an attenuated course of severe EAN beginning on post-induction day 12.64
±0.22 (n = 21; clinical score 0.54 ± 0.12, n = 23) reaching peak severity on post-induction
day 15.70 ± 0.15 (n = 10; clinical score 2.74 ± 0.32, n=12 ). At post-induction days 13 to
18, rats undergoing pre-induction forced-exercise prior to EAN induction exhibited
significantly lower clinical scores when compared to sedentary control EAN rats (Figure
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13), suggesting a sustained effect of protection elicited by forced-exercise. The onset of
EAN between sedentary and forced-exercise footpad immunized rats did not differ
significantly (p = 0.53) (Table 2). A modest but significant difference in the day at which
EAN peaked was observed between sedentary control and forced-exercise rats (Table 2).
This difference was most likely due to lessening of disease development and severity by
pre-induction forced-exercise. Two rats from the forced-exercise group failed to develop
EAN.
Another reliable and reproducible clinical sign of EAN developmental onset and
progression is body weight loss (Figure 14). A significant difference in the percentage of
body weight between rats injected with complete Freund’s adjuvant (CFA) in the absence
of P2 peptide (adjuvant immunization control) compared with sedentary control and
forced-exercised rats receiving CFA + P2 peptide was observed [F8, 264 = 4.67, p <
0.001]. Post hoc statistical analyses revealed that at post-induction days 13 through 18,
there was a significant attenuation of the percent body weight loss in CFA + P2 peptide
injected forced-exercise rats compared with sedentary controls (Figure 14), consistent
with exercise-facilitated clinical protection (Figure 13).
Collectively, these data suggest that (i) pre-induction forced-exercise attenuates
the development of severe EAN and (ii) the protective effect of pre-induction forcedexercise appears sustainable for several weeks after cessation of treadmill running. The
mechanism by which this occurs was next addressed.
Effect of Pre-Induction Forced-Exercise and Severe EAN on Steady State Content
of Corticosterone
One mechanism by which pre-induction forced-exercise may attenuate
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Figure 13. Pre-induction forced-exercise attenuates severe EAN. Sedentary (open
circles) or forced-exercise (closed circles) trained rats were immunized with P2 peptide
fragment by injection in the hind left footpad at day 0 and were clinically evaluated for
signs of severe EAN. An adjuvant immunization control group (CFA control, open
squares) is shown for comparison. Data shown are the means + SEM (n = 5-24). *p<0.05
vs. sedentary, Mann-Whitney non-parametric U-test.

Table 3. Effect of pre-induction forced-exercise on development and clinical
severity of severe EAN induced by injection in the hind left footpad.
Severe EAN
Sedentary
(n = 12-24)

Forced-exercise
(n = 11-21)

Clinical onset
(post-induction day)

12.33 (12) ± 0.20

12.64 (12.5) ± 0.22

Clinical peak
(post-induction day)

17.00 (17.5) ± 0.33

15.70 (16) ± 0.15*

Peak clinical score

3.99 (4.25) ± 0.20

2.74 (2.83) ± 0.32*

Data shown are the means (median) + SEM. Clinical onset is defined as the first day a
minimum clinical score of 0.5 was reached. Clinical peak is defined as the first day a
clinical peak score was reached. *p<0.05 vs. sedentary, Mann-Whitney non-parametric
U-test. EAN, experimental autoimmune neuritis.
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Figure 14. Pre-induction forced-exercise attenuates severe EAN-induced loss of
body weight. Rats randomized to sedentary (open circles) or forced-exercise (closed
circles) were immunized with P2 peptide fragment by injection in the left hind footpad at
day 0 and were clinically evaluated for signs of EAN. An adjuvant immunization control
group (CFA control, open squares) is shown for comparison. Rats randomized to the
sedentary or forced-exercise groups both lost body weight beginning on post-induction
day 10. Data shown are the means + SEM (n = 5-24). *p<0.05 vs. sedentary control; twoway repeated measures ANOVA with post hoc Holm-Sidak multiple comparison test.
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development and severity of severe EAN in Lewis rats may involve exercise-dependent
increases in circulating levels of the stress hormone, corticosterone (Moraska et al., 2000;
Weishaupt et al., 2001; Ploughman et al., 2005; Brown et al., 2007; Ploughman et al.,
2007; Ke et al., 2011). The content of corticosterone and corticosterone-binding globulin
(CBG) (Figure 15) in plasma prepared from blood were quantified as described within
Material and Methods (Figure 6) between 0500 and 0800 hours.
Adjuvant control rats or sedentary or forced-exercise EAN rats were sacrificed by
CO2 asphyxiation either at post-induction day 14 or at post-induction day 18. Resting
levels of plasma corticosterone content in rats immunized with CFA without P2 peptide
(CFA control) were 71 ± 14 ng/ml (n = 6; post-injection day 14) and 177 ± 68 ng/ml (n =
5; post-injection day 18), consistent with previously reported values for adult male Lewis
rats at rest (Dhabhar et al., 1995; Martin et al., 2000; Duclos et al., 2001). By comparison,
circulating corticosterone levels in sedentary EAN rats were not significantly elevated at
post-induction day 14 (116 ± 51 ng/ml, n = 6) or day 18 (140 ± 62 ng/ml, n = 6) (Figure
15A). Interestingly, subjecting Lewis rats to pre-induction forced-exercise prior to severe
EAN induction did not appear to alter circulating corticosterone content at post- induction
day 14 (91 ± 29 ng/ml, n = 6) or day 18 (138 ± 57 ng/ml, n = 5) (Figure 15A). No
statistical differences in the content of plasma corticosterone were observed between
sedentary and forced-exercise EAN rats [F1, 19 = 0.06, p = 0.80] and between postinduction days 14 and day 18 [F1, 19 = 0.47, p = 0.50] for circulating corticosterone.
A limitation to quantifying circulating levels of corticosterone is its known
diurnal variation (Fediuc et al., 2006) and its propensity to change rapidly in response to
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Figure 15. Effect of pre-induction forced-exercise on circulating corticosterone and
CBG content. Plasma corticosterone (A) and corticosterone-binding globulin (CBG) (B)
content were quantified as described within Methods and Materials. Adjuvant (CFA
control) immunization control (gray bars), sedentary (white bars) or forced-exercise
(black bars) rats with severe EAN were sacrificed by CO2 asphyxiation at post-induction
day 14 or day 18. Data shown are the means + SEM (n = 4-6). These data were analyzed
by two-way repeated measures ANOVA with post hoc Holm-Sidak multiple comparison
test and were found to be statistically indistinguishable.

57
environmental challenges such as exercise (Moraska et al., 2000; Ploughman et al., 2005;
Brown et al., 2007; Ploughman et al., 2007; Ke et al., 2011). To determine if preinduction forced-exercise training used in this study chronically alters steady state levels
in corticosterone content, we quantified circulating levels of the carrier protein CBG
(Westphal, 1971; Moraska et al., 2000; Brown et al., 2007). When circulating
corticosterone is bound to CBG, the bound corticosterone cannot interact with its
receptor. A reduction in plasma CBG content would therefore suggest a net increase in
free circulating corticosterone that is able to interact with its receptor. As shown in
Figure 15B, the content of CBG in plasma of adjuvant (CFA control) immunized rats at
post-injection day 14 and day 18 were 162 ± 22 nM (n = 6) and 73 ± 13 nM (n = 5),
respectively. This is consistent with previously published values for adult male Lewis rats
at rest (Dhabhar et al., 1995). By comparison, circulating levels of CBG in sedentary
EAN rats at post-induction day 14 (140 ± 41 nM, n = 6) and day 18 (144 ± 50 nM, n = 6)
were similar to CFA controls (Figure 15B). Pre-induction forced-exercise did not alter
CBG content in severe EAN rats at post-induction day 14 (138 ± 23 nM, n = 6) and day
18 (54 ± 4 nM, n = 4) (Figure 15B). Similar to plasma corticosterone, there were no
differences in circulating CBG content between sedentary and forced-exercise EAN rats
[F1, 19 = 0.56, p = 0.47], and between post-induction days 14 and 18 [F1, 19 = 0.35, p =
0.56].
Collectively, these findings suggest that pre-induction forced-exercise attenuates
the development of severe EAN in adult male Lewis rats by a mechanism that occurs
independent of changes in circulating corticosterone content.
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Effect of Pre-Induction Forced-Exercise on Severe EAN-Induced Peripheral Nerve
Injury
Previous studies demonstrate measurable deficits in peripheral nerve function
following induction of severe EAN, supportive of an autoimmune-mediated
inflammatory demyelinating nerve injury (Gabriel et al., 1997; Taylor and Pollard, 2001,
2003; Lin et al., 2007; Sarkey et al., 2007). Whereas pre-induction forced-exercise
attenuates the clinical severity of severe EAN (Figure 13), we next determined whether
the pre-induction moderate training program used in this study would alter severe EANinduced changes in peripheral nerve large-fiber function in Lewis rats. The effect of preinduction forced-exercise on peripheral nerve function was determined by evokedresponse electrophysiology as described within Methods and Materials (Figure 6).
Sedentary control rats with severe EAN at post-induction day 18 (Figure 16)
exhibited a marked reduction in both ankle- (2.60 ± 0.74 mV, n = 6) [F1, 9 = 18.13, p =
0.002] and sciatic notch- (2.20 ± 0.64 mV, n = 6) [F1, 9 = 13.95, p = 0.005] evoked
CMAP amplitudes compared with pre-induction (day 0) responses (ankle 4.82 ± 0.38
mV, n = 6; notch 3.91 ± 0.39 mV, n = 6). Severe EAN rats undergoing pre-induction
forced-exercise exhibited similarly marked deficits in ankle- (3.10 ± 0.27 mV, n = 5) and
sciatic-notch- (1.99 ± 0.29 mV, n = 5) evoked CMAP amplitude responses compared
with their respective pre-induction (day 0) responses (Figure 16). Moreover, severe EAN
rats undergoing pre-induction forced-exercise exhibited significant decreases in R ratios
(ratio 0.64 ± 0.03, n = 5) compared with their respective pre-induction (day 0) responses
(ratio 0.84 ± 0.03, n = 5) and respective sedentary control responses (ratio 0.82 ± 0.11, n
= 6) [F1, 9 = 6.21, p = 0.03] consistent with injury to peripheral nerves that is not
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uniformly distributed in forced-exercised EAN rats (Figure 17). This has been previously
described in patients with GBS (van der Meche et al., 1988; Harvey and Pollard, 1992;
Lin et al., 2007; Daube and Rubin, 2009; Uncini et al., 2010).
Additionally, severe EAN rats undergoing sedentary or pre-induction forcedexercise training exhibited nearly identical rates of MNCV (46.94 ± 5.58 m/s, n=6) [F1, 9
= 0.02, p = 0.88] prior to immunization (Figure 18 day 0). By comparison, sedentary
rats with severe EAN exhibited marked slowing of MNCV (33.44 ± 1.63 m/s, n = 6) [F1, 9
= 5.65, p = 0.01] by post-induction day 18, consistent with previously published reports
(Sarkey et al., 2007). Forced-exercise EAN rats also experienced a similar slowing of
MNCV (35.00 ± 1.63 m/s, n = 6), though it did not reach significance.
Neuropathological changes in sciatic nerves from sedentary or forced-exercise
rats with severe EAN were semi-quantified as described within Methods and Materials
(Figure 6). Sciatic nerves harvested from sedentary and forced-exercise rats with severe
EAN sacrificed at post-induction day 18 exhibited marked histopathological changes
consistent with presence of inflammatory infiltrates, myelin ovoids, and axonal damage
(Figures 19 and 20). Nerves harvested from the footpad-injected limb (2.24 ± 0.20, n =
5) of sedentary EAN rats exhibited more neuropathological changes compared with the
non-injected limb (1.27 ± 0.38, n = 6) (Figure 19 top and Figure 20). The same
neuropathological changes between footpad-injected (1.58 ± 0.41, n = 5) and noninjected limb (0.88 ± 0.20, n = 5) was seen in forced-exercise EAN rats (Figure 19
bottom and Figure 20). Sciatic nerves harvested from footpad-injected and non-injected
limbs of EAN rats that underwent pre-induction forced-exercise training had lower scores
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Figure 16. Effect of pre-induction forced-exercise on evoked peripheral nerve
conduction amplitudes in rats with severe EAN. Relative changes in peripheral nerve
CMAP amplitudes were determined by evoke-response electrophysiology prior to and 18
days following immunization with P2 peptide fragment by injection into in the footpad as
described within Methods and Materials. An adjuvant-immunization control group (CFA
control, gray bars) is shown for comparison. Data shown are the means + SEM (n = 3-6)
of rats undergoing sedentary (white bars) or forced-exercise (black bars) training.
#
p<0.05 vs. respective day 0 responses; two-way repeated measures ANOVA with post
hoc Holm-Sidak multiple comparison test.
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Figure 17. Effect of pre-induction forced-exercise on R ratios in rats with severe
EAN. Relative changes in peripheral nerve conduction ankle and notch amplitudes were
determined by evoke-response electrophysiology, and R ratios calculated, prior to and 18
days following immunization with P2 peptide fragment by injection into the base of the
tail as described within Methods and Materials. An adjuvant-immunization control group
(CFA control, gray bars) is shown for comparison. Data shown are the means + SEM (n
= 3-6) of rats undergoing sedentary (white bars) or forced-exercise (black bars) training.
*p<0.05 vs. respective day 18 sedentary control responses demonstrating lengthdependent demyelination; two-way repeated measures ANOVA with post hoc HolmSidak multiple comparison test.
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Figure 18. Effect of pre-induction forced-exercise on peripheral nerve conduction
velocity in rats with severe EAN. Peripheral nerve conduction velocities were
calculated from the experimental data shown in Fig. 8. An adjuvant immunization control
group (CFA control, gray bars) is shown for comparison. Data shown are the means +
SEM (n = 3-6) of rats undergoing sedentary (white bars) or forced-exercise (black bars)
training. #p<0.05 vs. respective day 0 responses; two-way repeated measures ANOVA
with post hoc Holm-Sidak multiple comparison test.
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than sedentary EAN rats (Figure 19 and Figure 20); however, the neuropathological
scores between the two groups did not differ significantly (H3, 17 = 6.76, p = 0.08).
Collectively, these data suggest that while the pre-induction forced-exercise
training program used in this study significantly attenuates the clinical severity of severe
EAN; however, forced-exercise is most effective at protecting against mild EAN.
Pre-Induction Forced-Exercise Alters Immune Cell Function in Rats with Severe
EAN
To determine whether pre-induction forced-exercise attenuates clinical severe
EAN by altering cellular immunity, sedentary control or forced-exercise rats induced
with severe EAN were sacrificed near disease onset (post-induction day 14) or near peak
of disease (post-induction day 18), and splenic or nodal lymphocytes from spleen or
popliteal lymph nodes, respectively, were harvested, purified, and analyzed as described
within Material and Methods (Figure 6).
Pre-Induction Forced-Exercise Promotes Lymphocyte Retention
Significant differences in the total number of lymphocytes recovered from popliteal
lymph nodes of sedentary or forced-exercise EAN rats were observed [F1, 27 = 6.82, p =
0.02] (Figure 21). Near peak of severe EAN, the total number of nodal lymphocytes
recovered from forced-exercise EAN rats was significantly greater (~2-fold) compared
with sedentary EAN control rats (Figure 21), suggesting increased retention. Preinduction forced-exercise increased retention of lymphocytes near onset of severe EAN;
however, differences between sedentary and forced-exercise groups did not reach
statistical significance. Lymphocyte retention is summarized in Table 4.
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Figure 19. Effect of pre-induction forced-exercise on sciatic nerve neuropathology in
rats with severe EAN. Sciatic nerves from P2 peptide injected (left) and un-injected
(right) hind limbs were harvested from sedentary (top) and forced-exercise (bottom)
EAN rats near peak (post-induction day 18) of disease, and histologically processed and
imaged as described in Materials and Methods. Scale bar (red) = 25 μm.
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Figure 20. Pre-induction forced-exercise does not protect against severe EANinduced neuropathological changes in the sciatic nerves. Rats that were forcedexercised on a treadmill (black bars) or remained sedentary (white bars) were induced
with severe EAN in the hind left footpad. Sciatic nerves were harvested at post-induction
day 18 and prepared as described in Materials and Methods. Two blinded observers
scored the embedded nerves; the scores were averaged. Data shown are the means + SEM
(n = 5-6).
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Pre-Induction Forced-Exercise Promotes P2 Peptide-Stimulated Lymphocyte
Proliferation
Lymphocytes prepared from harvested popliteal lymph nodes were assayed in
vitro for non-specific (lectin-stimulated) and P2 peptide specific proliferation functional
capacity as described within Methods and Material (Figure 6). Stimulation indices (SI)
were obtained by dividing lectin- or P2-stimulated proliferation responses by mediastimulated control proliferation responses.
Significant differences in P2 peptide antigen stimulated proliferation of
lymphocytes harvested from sedentary or forced-exercise EAN rats were observed [F1, 15
= 4.55, p = 0.05]. Lymphocytes harvested near onset of disease from sedentary EAN
control rats exhibited a ~3-fold increase in P2 peptide-stimulated indices compared with
CFA-immunization controls (Figure 22), consistent with disease onset. Forced-exercise
EAN P2 peptide-stimulated proliferative responses were increased by ~2.5-fold
compared to CFA-immunization; however, these proliferative responses were not
significantly different from sedentary EAN control P2 peptide-stimulated proliferative
responses. This slightly blunted proliferative response may indicate that forced-exercise
alters the innate immune cell capacity to respond to P2 peptide and to initiate
proliferation of lymphocytes as the EAN develops. In contrast, lymphocytes harvested
from sedentary EAN control rats near peak of disease did not retain their ability to
respond to P2 peptide-stimulation (Figure 22), consistent with lymphocyte anergy.
Interestingly, lymphocytes harvested from forced-exercise EAN rats retained their ability
to respond to P2 peptide-stimulation (Figure 22). These findings suggest that preinduction forced-exercise retains autoreactive leukocytes to P2 peptide in the lymph
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node.
To determine if the effect of pre-induction forced-exercise on lymphocyte
proliferation is selective for P2 peptide-stimulation, parallel cultures of harvested and
prepared lymphocytes were challenged in vitro with concanavalin A (ConA). This lectin
potently non-selectively stimulates proliferation of leukocytes through toll-like receptors
(TLRs) (Rostami et al., 1990; Rostami and Gregorian, 1991; Stenger and Modlin, 2002;
Toubi and Shoenfeld, 2004; MacLeod and Wetzler, 2007; Yun et al., 2007; Unitt and
Hornigold, 2011). Our results show that nodal lymphocytes harvested and prepared from
CFA immunization control rats exhibited a robust (~40-fold) increase in stimulation
indices near onset and peak, respectively (Figure 23). Nodal lymphocytes harvested from
sedentary EAN control rats responded by exhibiting a ~13-fold and ~51-fold increase in
proliferation to ConA-stimulation at near onset and peak, respectively. In contrast, both
near onset (~5-fold) and near peak (~6-fold) of disease, lymphocytes harvested from
forced-exercise rats responded only minimally to ConA-stimulation (Figure 23).
Significant differences in ConA-stimulated lymphocyte proliferation were observed
between sedentary EAN rats versus forced-exercise EAN rats [F1, 16 = 5.24, p = 0.04]. No
differences, however, were observed between respective groups when comparing near
onset and near peak, respectively [F1, 16 = 2.95, p = 0.11]. Post hoc tests confirmed
significant decrease in ConA-stimulated proliferative responses of forced-exercise EAN
lymphocytes compared to sedentary EAN lymphocytes near peak of disease. Nonselective lectin-mediated activation of lymphocytes appears compromised by preinduction forced-exercise, possibly by influencing antigen-presenting cell (APC) TLR
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Figure 21. Pre-induction forced-exercise promotes nodal lymphocyte cell retention
in popliteal lymph nodes. Popliteal lymph nodes were harvested from each limb and
quantified from treated rats near onset (post-induction day 14) or near peak of disease
(post-induction day 18) as described within Methods and Materials. Data shown are the
means + SEM (n = 5-9) of rats undergoing sedentary (white bars) or forced-exercise
(black bars) training prior to severe EAN induction by footpad injection. An adjuvant
immunization control group (CFA control, gray bars) is shown for comparison. *p<0.05
vs. sedentary EAN controls; two-way ANOVA with post-hoc Holm-Sidak multiple
comparison analysis.
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Figure 22. Pre-induction forced-exercise promotes functional retention of P2
peptide-stimulated lymphocyte proliferation. Popliteal lymph nodes were harvested
from treated rats near onset (post-induction day 14) or near peak of disease (postinduction day 18) and P2 peptide-stimulated lymphocyte stimulation indices determined
in vitro as described within Methods and Materials. Data shown are the means + SEM (n
= 5-6) of rats undergoing sedentary (white bars) or forced-exercise (black bars) training
prior to EAN induction by footpad injection. An adjuvant immunization control group
(CFA control, gray bars) is shown for comparison. *p<0.05 vs. sedentary EAN controls;
two-way ANOVA with post-hoc Holm-Sidak multiple comparison analysis.
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Figure 23. Pre-induction forced-exercise attenuates lectin-stimulated lymphocyte
proliferation. Popliteal lymph nodes were harvested from treated rats near onset (postinduction day 14) or near peak of disease (post-induction day 18) and concanavalin A
(ConA)-stimulated lymphocyte stimulation indices determined in vitro as described
within Methods and Materials. Data shown are the means + SEM (n = 5-6) of rats
undergoing sedentary (white bars) or forced-exercise (black bars) training prior to severe
EAN induction by footpad injection. An adjuvant immunization control group (CFA
control, gray bars) is shown for comparison. *p<0.05 vs. sedentary EAN controls; twoway ANOVA with post-hoc Holm-Sidak multiple comparison analysis.
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dependence of lymphocyte proliferation (Flynn and McFarlin, 2006). Stimulated
lymphocyte proliferation is summarized in Table 4.
Pre-Induction Forced-Exercise Promotes Splenic Lymphocyte Retention
Immune responses of localized nodal lymphocytes may differ from splenic
lymphocytes. To determine if pre-induction forced-exercise alters splenic immune
responses, spleens were harvested from treated rats and splenic lymphocytes prepared as
described within Methods and Materials (Figure 6). When normalized to spleen wet
weight, significant differences in total recovered splenic lymphocytes were observed
between sedentary or forced-exercise EAN rats [F1, 34 = 10.40, p = 0.003]. The wet
weights of spleens harvested between experimental groups were not statistically different
[F1, 33 = 0.19, p = 0.67]. Near onset of disease, the total number of splenic lymphocytes
recovered from spleens harvested from sedentary EAN rats was approximately 20% less
compared with spleens from CFA immunization control or forced-exercised EAN rats
(Figure 24). A similar trend in recovered splenic lymphocyte count was seen from
spleens harvested near peak of disease. These data support the thesis that pre-induction
forced-exercise promotes retention of lymphocytes in secondary lymphoid organs.
Splenic lymphocyte retention is summarized in Table 4.
Pre-Induction Forced-Exercise Preserves Lectin-Stimulated Splenic Lymphocyte
Proliferation
Splenic lymphocytes prepared from harvested spleens were assayed in vitro for
non-specific (lectin-stimulated) and P2 peptide specific proliferation functional capacity
as described within Methods and Material (Figure 6). Stimulation indices (SI) were
obtained by dividing lectin- or P2-stimulated proliferation responses by media-stimulated
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control proliferation responses.
In marked contrast to nodal lymphocytes (Figure 22), splenic lymphocytes
prepared from spleens harvested from CFA immunized control, sedentary or forcedexercise EAN rats were found to be largely un-responsive to P2 peptide-stimulation
(stimulation index 1.11 ± 0.09, n = 48; combined from all groups), possibly due to
inefficient antigen presentation by APCs (DeFranco et al., 2007).
By comparison, significant differences in ConA-stimulated proliferation of
splenic lymphocytes harvested from sedentary or forced-exercise EAN rats were
observed [F1, 33 = 17.33, p < 0.001]. Splenic lymphocytes harvested near onset or near
peak of disease from sedentary EAN control rats exhibited a similar proliferative
response to ConA compared with splenic lymphocytes from CFA-immunization controls
(Figure 25). In contrast, splenic lymphocytes harvested from forced-exercise EAN rats
near onset or near peak of disease exhibited a ~2-fold increase in stimulation indices
compared with splenic lymphocytes from sedentary EAN control rats (Figure 25). In
marked difference to nodal lymphocytes, these data suggest that pre-induction forcedexercise promotes retention (Figure 24) and preserves proliferative functional capacity
(Figure 25) of splenic lymphocytes. Stimulated splenic lymphocyte proliferation is
summarized in Table 4.
Effect of Pre-Induction Forced-Exercise on Nodal Leukocyte Cytokine Production
To further elucidate the influence of forced-exercise on immune cell function, we
characterized the cytokine profile of nodal-derived leukocytes. We chose to evaluate
representative pro-inflammatory (IL-2, IL-6, IFN-γ, TNF-α) and anti-inflammatory

73

Splenic Lymphocytes
(cells/g spleen wet weight)

2,000

CFA Control
Sedentary
Forced-Exercise
1,500

1,000

*

500

0

Day 14

Day 18

Figure 24. Pre-induction forced-exercise promotes retention of splenic lymphocytes.
Spleens were harvested from treated rats near onset (post-induction day 14) or near peak
of disease (post-induction day 18), weighed, and total recovered splenic lymphocytes
quantified as described within Methods and Materials. Data shown are the means + SEM
(n = 5-19) of rats undergoing sedentary (white bars) or forced-exercise (black bars)
training prior to severe EAN induction by footpad injection. An adjuvant immunization
control group (CFA control, gray bars) is shown for comparison. *p<0.05 vs. sedentary
EAN controls; two-way ANOVA with post-hoc Holm-Sidak multiple comparison
analysis.

74

80

ConA Stimulation Index

70
60
50

CFA Control
Sedentary
Forced-Exercise

*

*

40
30
20
10
0

Day 14

Day 18

Figure 25. Pre-induction forced-exercise preserves lectin-stimulated splenic
lymphocyte proliferation. Spleens were harvested from treated rats near onset (postinduction day 14) or near peak of disease (post-induction day 18) and concanavalin A
(ConA)-stimulated splenic lymphocyte stimulation indices determined in vitro as
described within Methods and Materials. Data shown are the means + SEM (n = 5-6) of
rats undergoing sedentary (white bars) or forced-exercise (black bars) training prior to
severe EAN induction by footpad injection. An adjuvant immunization control group
(CFA control, gray bars) is shown for comparison. *p<0.05 vs. sedentary EAN controls;
two-way ANOVA with post-hoc Holm-Sidak multiple comparison analysis.
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Table 4. Summary of retention and proliferation of nodal and splenic
lymphocytes from pre-induction forced-exercise rats compared to sedentary
rats sacrificed near onset or near peak of severe EAN.

Retention

Severe Experimental Autoimmune Neuritis
Popliteal Lymph Nodes
Spleen
Onset

-

↑

Peak

↑

-

P2 Peptide

Concanavalin A

P2 Peptide

Concanavalin A

Onset

-

-

-

↑

Peak

↑

↓

-

↑

Proliferation

Stimulation

Forced-exercise EAN lymphocyte retention and proliferation was compared to respective
sedentary EAN control lymphocyte and gauged as follows: ↑, increased retention or
proliferation; ↓, decreased retention or proliferation; -, no change.
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cytokines (IL-6, IL-10) released by P2 peptide-stimulated cells in vitro from leukocytes
(Figures 26-30). Leukocytes were prepared from popliteal lymph nodes harvested from
CFA immunized control, sedentary or forced-exercise EAN rats and cytokines
simultaneously quantified using multiplex technology as described within Methods and
Materials (Figure 6).
Pre-Induction Forced-Exercise Alters Nodal Leukocyte IL-2 Cytokine Production
IL-2 is a proliferative cytokine used in the differentiation of pro-inflammatory Th1
cells and anti-inflammatory Th2 and Treg cells (La Cava, 2008; Zhu and Paul, 2008). The
content of IL-2 detected was significantly different in the culture media of un-stimulated
(quiescent) leukocytes prepared from nodes harvested from sedentary or forced-exercise
EAN rats near onset or peak of disease (Figure 26) [F1, 16 = 4.85, p = 0.04]. Near disease
peak, there was a significant decrease in IL-2 content from sedentary EAN leukocytes
compared to forced-exercise EAN leukocytes.
Due to changes in proliferative functional capacity (Figure 22), P2 peptidestimulated IL-2 production differed significantly from leukocytes prepared from nodes
harvested from sedentary or forced-exercise EAN rats near onset or peak of disease
(Figure 26) [F1, 16 = 22.54, p < 0.001]. IL-2 production near disease onset was
significantly decreased, and significantly increased near disease peak, in forced-exercise
EAN leukocytes (38 ± 13 pg/ml and 98 ± 13 pg/ml, n = 5, respectively) compared to
sedentary EAN leukocytes (87 ± 9 pg/ml and 31 ± 14 pg/ml, n = 5, respectively). The
decrease of IL-2 production near onset corresponds with a blunted proliferative capacity
of forced-exercise lymphocytes near disease onset. Moreover, the increase of IL-2
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production near peak corresponds with increased proliferative capacity of forced-exercise
lymphocytes near disease peak. Non-selective activation of nodal leukocytes with ConA
elicited a marked 10-fold increase in IL-2 production that was unaffected by forcedexercise or disease course (Figure 26) [F1, 16 = 0.37, p = 0.55; F1, 16 = 0.56, p = 0.47].
Pre-Induction Forced-Exercise Does Not Alter Nodal Leukocyte P2 Peptide-Stimulated
IL-6 Cytokine Production
IL-6 is a cytokine released from leukocytes that can induce pro-inflammatory or
anti-inflammatory differentiation of adaptive immune cells depending on the presence of
other pro-inflammatory or anti-inflammatory cytokines (Nielsen and Pedersen, 2008; Zhu
and Paul, 2008). IL-6 is increased in leukocyte proliferation assays from EAN rats (Bai et
al., 1997; Zhang et al., 2008a; Zhang et al., 2009a). There were minimal un-stimulated
(quiescent) and stimulated levels of IL-6 production from adjuvant control rats compared
to severe EAN rats (Figure 27). In contrast to IL-2, resting levels of IL-6 released near
onset or near peak of disease by nodal leukocytes prepared from nodes harvested from
sedentary EAN rats were not different [F1, 16 = 1.26, p = 0.28] compared to nodal
leukocytes prepared from nodes harvested from forced-exercise EAN rats, and were
unaffected by disease course[F1, 16 = 0.72, p = 0.41] (Figure 27). Stimulating these
prepared leukocytes with P2 peptide did not change the release of IL-6 between sedentary
control and forced-exercise EAN rats [F1, 16 = 0.60, p = 0.45], or between near disease
onset or peak [F1, 16 = 1.23, p = 0.20] (Figure 27). Changes in nodal leukocyte IL-6
release elicited by ConA were unaffected by forced-exercise or disease course [F1, 16 =
0.00, p = 0.95; F1, 16 = 0.02, p = 0.50].
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Pre-Induction Forced-Exercise Markedly Enhances Nodal Lymphocyte IL-10 Production
IL-10 is an anti-inflammatory cytokine released from Th2, regulatory T cells, and
sometimes Th1 cells (Belkaid and Oldenhove, 2008; La Cava, 2008; Zhu and Paul, 2008).
There were minimal levels of IL-10 production from un-stimulated (quiescent) and
stimulated lymphocytes prepared from nodes harvested from adjuvant control rats
compared to severe EAN rats (Figure 28), and the content of IL-10 detected in the
culture media of un-stimulated (quiescent) lymphocytes were similar to previously
published findings (Yun et al., 2007). The content of IL-10 detected in the culture media
of un-stimulated (quiescent) lymphocytes prepared from nodes harvested from sedentary
and forced-exercise EAN rats were indistinguishable [F1, 16 = 3.33, p = 0.09], and
unaffected by disease course [F1, 16 = 1.89, p = 0.19]. The content of IL-10 detected in
the culture media of P2 peptide-stimulated lymphocytes prepared from nodes harvested
from sedentary and forced-exercise EAN rats were markedly different [F1, 14 = 4.61, p =
0.05], and affected by disease course [F1, 14 = 7.34, p = 0.02]. P2 peptide-stimulation
increased levels of IL-10 released by nodal lymphocytes prepared from forced -exercise
EAN rats near disease onset (2904 ± 949 pg/ml, n = 5) by ~3-fold compared with
sedentary EAN controls (939 ± 427 pg/ml, n = 5) (Figure 28). However, only measurable
levels of P2 peptide-stimulated IL-10 production from severe EAN rats were detected
from lymphocytes harvested near peak of disease, consistent with antigen-stimulated cell
anergy. A similar enhancement [F1, 15 = 18.30, p < 0.001) of ConA-stimulated
lymphocyte production of IL-10 by forced-exercise (5304 ± 306 pg/ml, n = 4) was
observed compared with sedentary controls (2011 ± 699 pg/ml, n = 5) (Figure 28) that
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was unaffected by disease course [F1, 15 = 1.81, p = 0.20].
Pre-Induction Forced-Exercise Prolongs Nodal Leukocyte P2 Peptide-Stimulated IFN-γ
Production
IFN-γ is a cytokine released from leukocytes that induces differentiation of proinflammatory Th1 cells (Zhu and Paul, 2008) and is increased in leukocyte proliferation
assays from severe EAN rats (Bai et al., 1997; Zhang et al., 2008a; Zhang et al., 2009a).
There were minimal levels of IFN-γ production from un-stimulated (quiescent) and
stimulated lymphocytes prepared from nodes harvested from adjuvant control rats
compared to severe EAN rats (Figure 29), and the content of IFN-γ detected in the
culture media of un-stimulated (quiescent) lymphocytes were similar to previously
published findings (Yun et al., 2007). Resting [F1, 16 = 0.38, p = 0.55] and P2 peptidestimulated [F1, 15 = 3.52, p = 0.08] levels of IFN-γ from sedentary and forced-exercised
leukocytes were unaffected by disease course (Figure 29). Resting levels of this proinflammatory cytokine in media of nodal leukocytes harvested from forced-exercise EAN
rats was markedly elevated by ~8-fold (333 ± 95 pg/ml, n = 5) compared to sedentary
EAN controls (42 ± 12 pg/ml, n = 5) [F1, 16 = 10.20, p = 0.01] near disease onset.
Leukocytes from sedentary or forced-exercise EAN rats near disease onset exhibited a
robust IFN-γ response (6828 ± 3161 pg/ml and 11298 ± 3943 pg/ml, n = 5, respectively)
to P2 peptide antigen stimulation; however, there were no difference between these two
groups [F1, 15 = 4.09, p = 0.06] (Figure 29). Near peak of disease, leukocytes from
sedentary EAN control rats were unresponsive to subsequent P2 peptide-stimulation (68
± 53 pg/ml, n = 4) compared to forced-exercise EAN rats (7247 ± 1942 pg/ml, n = 5);
however, the difference does not reach significance [F1, 15 = 4.09, p = 0.06]. This trend
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can suggest that nodal leukocytes from forced-exercise EAN rats retained their ability to
respond to P2 peptide-stimulation.
Pre-Induction Forced-Exercise Does Not Alter Nodal Leukocyte TNF-α Cytokine
Production
TNF-α is a pro-inflammatory cytokine released from leukocytes (Leung et al.,
2008) and is increased in leukocyte proliferation assays from EAN rats (Bai et al., 1997;
Zhang et al., 2008a; Zhang et al., 2009a). The content TNF-α detected was not different
in the culture media of un-stimulated (quiescent) leukocytes prepared from nodes
harvested from sedentary or forced-exercise EAN rats near disease onset and was largely
unaffected by disease course (Figure 30) [group: F1, 16 = 0.07, p = 0.80; time: F1, 16 =
0.05, p = 0.83]. TNF-α production elicited by nodal leukocytes from sedentary (24 ± 6
pg/ml, n = 5) or forced-exercise (34 ± 9 pg/ml, n = 5) EAN rats near disease onset
stimulated by P2 peptide was not significantly different [F1, 16 = 3.00, p = 0.10] (Figure
30). Leukocytes harvested near peak of disease from sedentary or forced- exercise EAN
control rats exhibited reduced levels P2 peptide-stimulated TNF-α compared near onset
[F1, 16 = 4.79, p = 0.04]; however post hoc tests failed to reveal any significance. Nonselective activation of nodal leukocytes with ConA elicited no alterations in TNF-α
production between EAN groups [F1, 15 = 1.10, p = 0.31] that was also unaffected by
disease course [F1, 15 = 1.80, p = 0.20] (Figure 30).
Released cytokine changes from nodal leukocytes are summarized in Table 5.
Effect of Pre-Induction Forced-Exercise on Splenic Leukocyte Cytokine Production
To determine the influence of pre-induction forced-exercise on splenic immune
cell function, we characterized the cytokine profile of spleen-derived leukocytes (Figures
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Figure 26. Pre-induction forced-exercise alters nodal leukocyte resting or P2
peptide-stimulated IL-2 production. Popliteal lymph nodes were harvested from treated
rats near onset (post-induction day 14) or near peak of disease (post-induction day 18)
and resting (un-stimulated), P2 peptide-, or concanavalin A-stimulated leukocyte IL-2
cytokine production and/or release were quantified in vitro as described within Methods
and Materials. Data shown are the means + SEM (n = 5) of rats undergoing sedentary
(white bars) or forced-exercise (black bars) training prior to severe EAN induction by
footpad injection. An adjuvant immunization control group (CFA control, gray bars) is
shown for comparison. *p<0.05 vs. respective sedentary EAN controls, #p<0.05 vs.
respective post-induction day 14 values, two-way ANOVA with post hoc Holm-Sidak
multiple comparison analysis.
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Figure 27. Pre-induction forced-exercise does not alter nodal leukocyte IL-6
production. Popliteal lymph nodes were harvested from treated rats near onset (postinduction day 14) or near peak of disease (post-induction day 18) and resting (unstimulated), P2 peptide-, or concanavalin A-stimulated leukocyte IL-6 cytokine
production and/or release were quantified in vitro as described within Methods and
Materials. Data shown are the means + SEM (n = 5) of rats undergoing sedentary (white
bars) or forced-exercise (black bars) training prior to severe EAN induction by footpad
injection. An adjuvant immunization control group (CFA control, gray bars) is shown for
comparison. These data were analyzed by two-way ANOVA with post hoc Holm-Sidak
multiple comparison test and were found to be statistically indistinguishable.
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Figure 28. Pre-induction forced-exercise enhances nodal lymphocyte antigen- and
lectin-stimulated IL-10 production. Popliteal lymph nodes were harvested from treated
rats near onset (post-induction day 14) or near peak of disease (post-induction day 18)
and resting (un-stimulated), P2 peptide-, or concanavalin A-stimulated lymphocyte IL-10
cytokine production and/or release were quantified in vitro as described within Methods
and Materials. Data shown are the means + SEM (n = 4-5) of rats undergoing sedentary
(white bars) or forced-exercise (black bars) training prior to severe EAN induction by
footpad injection. An adjuvant immunization control group (CFA control, gray bars) is
shown for comparison. *p<0.05 vs. respective sedentary EAN controls, #p<0.05 vs.
respective post-induction day 14 values; two-way ANOVA with post hoc Holm-Sidak
multiple comparison analysis.
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Figure 29. Pre-induction forced-exercise prolongs nodal leukocyte P2 peptidestimulated IFN-γ production. Popliteal lymph nodes were harvested from treated rats
near onset (post-induction day 14) or near peak of disease (post-induction day 18) and
resting (un-stimulated), P2 peptide-, or concanavalin A-stimulated leukocyte IFN-γ
cytokine production and/or release were quantified in vitro as described within Methods
and Materials. Data shown are the means + SEM (n = 4-5) of rats undergoing sedentary
(white bars) or forced-exercise (black bars) training prior to severe EAN induction by
footpad injection. An adjuvant immunization control group (CFA control, gray bars) is
shown for comparison. *p<0.05 vs. respective sedentary EAN controls; two-way
ANOVA with post hoc Holm-Sidak multiple comparison analysis.

85

125

TNF- (pg/ml)

100

CFA Control
Sedentary
Forced-Exercise

75

50

25

0

Day 14

Day 18

Un-Stimulated

Day 14

Day 18

P2 Peptide

Day 14

Day 18

Concanavalin A

Figure 30. Pre-induction forced-exercise does not alter nodal leukocyte TNF-α
production. Popliteal lymph nodes were harvested from treated rats near onset (postinduction day 14) or near peak of disease (post-induction day 18) and resting (unstimulated), P2 peptide-, or concanavalin A-stimulated leukocyte TNF-α cytokine
production and/or release were quantified in vitro as described within Methods and
Materials. Data shown are the means + SEM (n = 4-5) of rats undergoing sedentary
(white bars) or forced-exercise (black bars) training prior to severe EAN induction by
footpad injection. An adjuvant immunization control group (CFA control, gray bars) is
shown for comparison. These data were analyzed by two-way ANOVA with post hoc
Holm-Sidak multiple comparison test and were found to be statistically indistinguishable.
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31-35). We once again evaluated representative pro-inflammatory (IL-2, IL-6, IL-12p70,
IFN-γ, TNF-α) and anti-inflammatory cytokines (IL-4, IL-6, IL-10) released by splenic
lymphocytes in vitro. Splenic lymphocytes were prepared from spleens harvested from
CFA immunized control, sedentary or forced-exercise EAN rats and cytokines
simultaneously quantified using multiplex technology as described within Methods and
Materials (Figure 6).
Resting Splenic Leukocyte Cytokine Levels
Despite measurable changes in lectin-stimulated cell proliferation (Figure 25), we
were unable to detect resting or P2 peptide-stimulated changes in splenic lymphocyte
production of IL-4 or IL-12p70 among spleens harvested from CFA immunization
control, sedentary or forced-exercise EAN rats.
Culturing resting splenic lymphocytes harvested from sedentary or forcedexercise EAN rats near onset or near peak of disease did not significantly alter levels of
IL-2 (Figure 31) [group: F1, 8 = 0.83, p = 0.39; time: F1, 8 = 0.22, p = 0.65], IL-10
(Figure 33) [group: F1, 20 = 2.51, p = 0.13; time: F1, 20 = 0.11, p = 0.74], or IFN-γ
(Figure 34) [group: F1, 19 = 1.05, p = 0.32; time: F1, 19 = 2.42, p = 0.14), or TNF-α
(Figure 35) [group: F1, 20 = 0.93, p = 0.35; time: F1, 20 = 1.66, p = 0.21).
A significant effect of group was observed for resting levels of IL-6 [F1, 20 = 5.47,
p = 0.03], but a post-hoc analysis suggested no significance between experimental groups
(Figure 32). Disease course had no effect for resting levels of IL-6 [F1, 20 = 2.15, p =
0.16]. These statistical findings suggest that changes in IL-6 most likely reflect
experimental noise due to low resting levels of this cytokine.
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P2 Peptide-Stimulated Splenic Leukocyte Cytokine Levels
Culturing P2 peptide-stimulated splenic lymphocytes harvested from sedentary or
forced-exercise EAN rats near onset or near peak of disease with P2 peptide did not
significantly alter levels of IL-2 (Figure 31) [group: F1, 8 = 3.20, p = 0.11; time: F1, 8 =
0.47, p = 0.51] or IL-10 (Figure 33) [group: F1, 20 = 0.52, p = 0.48; time: F1, 20 = 0.79, p
= 0.39].
There were no alterations of IL-6 levels from P2 peptide-stimulation of splenic
lymphocytes from sedentary and forced-exercise EAN rats near disease onset or peak [F1,
19

= 0.04, p = 0.84] (Figure 32). Near disease peak, however, splenic lymphocytes from

sedentary and forced-exercise EAN rats exhibited a decrease in P2 peptide-stimulated IL6 production (0 ± 0 pg/ml and 6 ± 3 pg/ml, n = 6, respectively) compared with splenic
lymphocytes from disease onset (76 ± 27 pg/ml and 62 ± 24 pg/ml, n = 6, respectively)
[F1, 19 = 11.88, p = 0.003], indicative of immune cell anergy (Figure 32).
P2 peptide-stimulation of splenic lymphocytes from sedentary and forced-exercise
EAN rats harvested near disease onset failed to elicit pro-inflammatory TNF-α cytokine
production (Figure 35). Near disease peak, however, splenic lymphocytes from forcedexercise EAN rats exhibited a measurable P2 peptide-stimulated increase in TNF-α
production (85 ± 36 pg/ml, n = 6) compared with splenic lymphocytes from sedentary
EAN control rats (2 ± 0.4 pg/ml, n = 6), and from splenic lymphocytes from forcedexercised EAN rats sacrificed at disease onset (9 ± 2 pg/ml, n = 6) [F1, 20 = 5.33, p =
0.03].
In contrast to TNF-α, splenic lymphocytes harvested from sedentary or forced-

88
exercise EAN rats near disease onset responded to P2 peptide-stimulation by increasing
the release of pro-inflammatory cytokine IFN-γ (1965 ± 851 pg/ml and 1730 ± 822
pg/ml, n = 6, respectively) (Figure 34), though there were no differences between groups
[F1, 20 = 0.01, p = 0.92]. Near peak of disease, the IFN-γ response to P2 peptide was
diminished in sedentary control rats (187 ± 95 pg/ml, n = 6) [F1, 20 = 7.29, p = 0.01],
consistent with anergy of autoreactive T-cells and the beginning of disease recovery.
There was a similar decrease near disease peak of P2-peptide stimulated splenic
lymphocyte production of IFN-γ by forced-exercise leukocytes (298 ± 74 pg/ml, n = 6)
compared to near onset levels (1730 ± 822 pg/ml, n = 6) [F1, 20 = 7.29, p = 0.01],
however, post hoc tests failed to reveal significance (Figure 35).
ConA-Stimulated Splenic Leukocyte Cytokine Levels
Splenic lymphocytes harvested from all experimental groups responded quite
robustly to ConA-stimulation with some unique distinctions influenced by disease course
(Figures 31-35). Compared with resting levels, ConA elicited a ~200-fold increase in IL2 release from splenic lymphocytes harvested near disease onset from CFA immunization
control rats (8468 ± 715 pg/ml, n = 4) (Figure 31). Pre-induction forced-exercise
attenuated ConA-stimulated release of IL-2 (3928 ± 598 pg/ml, n = 3) compared to
sedentary EAN control (6551 ± 376 pg/ml, n = 3) from splenic lymphocytes harvested
near disease onset [F1, 11 = 10.20, p = 0.01] (Figure 31). Compared with respective onset
values, a decrease in IL-2 production was observed [F1, 11 = 10.20, p = 0.01] near peak of
disease for sedentary EAN control rats (4107 ± 605 pg/ml, n = 3) that was
indistinguishable to peak forced-exercise EAN IL-2 levels, indicating anergy of sedentary
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EAN immune cells.
With regard to IL-6, splenic lymphocytes harvested from CFA immunization
control rats responded to ConA-stimulation (194 ± 32 pg/ml, n = 4) by modestly
increasing the production of this cytokine ~2-fold (Figure 32). By comparison, splenic
lymphocytes from sedentary or forced-exercise EAN rats similarly responded to ConAstimulation by enhancing IL-6 release ~9-fold (538 ± 115 pg/ml and 464 ± 145, n = 6,
respectively). Near peak of disease, splenic lymphocytes from sedentary EAN rats (33 ±
15 pg/ml, n = 6) exhibited marked reduction in ConA-stimulated IL-6 release compared
with respective onset values [F1, 20 = 11.21, p = 0.003] (Figure 32).
Similar to IL-2, ConA elicited a marked ~15-fold release of TNF-α from splenic
lymphocytes harvested near disease onset from all three experimental groups (Figure
35). In contrast, splenic lymphocytes from sedentary EAN control rats harvested near
peak of disease responded only marginally (4 ± 1 pg/ml, n = 6) to ConA-stimulation
compared with splenic lymphocytes harvested onset sedentary (191 ± 27 pg/ml, n = 6) or
from peak forced-exercise (169 ± 19 pg/ml, n = 6) EAN rats (Figure 35) [F1, 20 = 9.33, p
= 0.01].
Pre-induction forced-exercise had little effect on ConA-stimulated release of IL10 from splenic lymphocytes as shown in Figure 33. Splenic lymphocytes harvested near
onset of disease from sedentary (1585 ± 246 pg/ml, n = 6) and forced-exercise (1838 ±
360 pg/ml, n = 6) EAN rats did not differ significantly [F1, 20 = 1.61, p = 0.21]. This
response was affected by disease course [F1, 20 = 8.07, p = 0.01], with peak sedentary
EAN IL-10 production (684 ± 327 pg/ml, n = 6) decreasing compared to onset sedentary
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EAN. However, this is probably attributed to experimental noise.
Released cytokine changes from splenic lymphocytes are summarized in Table 5.
Effect of Pre-Induction Forced-Exercise on severe EAN-Induced T Cell Bias
Changes in nodal autoreactive lymphocyte cytokine profiling with pre-induction
forced-exercise (Figures 28 and 29) suggest a possible localized shift from proinflammatory type 1 helper T (Th1) cellular immunity toward a more protective type 2
helper T (Th2) cellular immune response. To determine if pre-induction forced-exercise
influences T cell bias, spleens and popliteal lymph nodes were harvested from severe
EAN rats and prepared splenic and nodal lymphocytes, respectively, and lymphocytes
obtained from blood collected from severe EAN rats, were fluorescently labeled as
described within Methods and Materials (Figure 6). Using flow cytometry (Figure 36),
relative changes in the percent distribution of helper T (Th), Th1, Th2, cytotoxic T (Tc), or
activated Tc cells were quantified.
Pre-Induction Forced-Exercise Attenuates Severe EAN-Induced Nodal Th1 Cell Bias
The total percent distribution of helper T cells (Figure 37) recovered from
popliteal lymph nodes harvested from sedentary or forced-exercise EAN rats was
statistically indistinguishable [F1, 28 = 3.27, p = 0.08] and unaffected by disease course
[F1, 28 = 0.05, p = 0.83], demonstrating that pre-induction forced-exercise does not by
itself alter localized helper T cell distribution.
By comparison, the percent distribution of Th1 cells present in nodes harvested
near disease onset from sedentary EAN control rats was found to be significantly [F1, 28
=6.57, p = 0.02] elevated (5.10 ± 0.87 %, n = 8) compared with forced-exercise EAN
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Figure 31. Pre-induction forced-exercise attenuates splenic lymphocyte lectinstimulated IL-2 production. Splenic lymphocytes were harvested from treated rats near
onset (post-induction day 14) or near peak of disease (post-induction day 18) and resting
(un-stimulated), P2 peptide-, or concanavalin A (ConA)-stimulated splenic lymphocyte
IL-2 cytokine production and/or release were quantified in vitro as described within
Methods and Materials. Data shown are the means + SEM (n = 3-4) of rats undergoing
sedentary (white bars) or forced-exercise (black bars) training prior to severe EAN
induction by footpad injection. An adjuvant immunization control group (CFA control,
gray bars) is shown for comparison. *p<0.05 vs. respective sedentary EAN controls,
#
p<0.05 vs. respective post induction day 14 values; two-way ANOVA with post hoc
Holm-Sidak multiple comparison analysis.
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Figure 32. Pre-induction forced-exercise alters splenic lymphocyte lectin-stimulated
IL-6 production. Splenic lymphocytes were harvested from treated rats near onset (postinduction day 14) or near peak of disease (post-induction day 18) and resting (unstimulated), P2 peptide-, or concanavalin A (ConA)-stimulated splenic lymphocyte IL-6
cytokine production and/or release were quantified in vitro as described within Methods
and Materials. Data shown are the means + SEM (n = 4-6) of rats undergoing sedentary
(white bars) or forced-exercise (black bars) training prior to severe EAN induction by
footpad injection. An adjuvant immunization control group (CFA control, gray bars) is
shown for comparison. #p<0.05 vs. respective post induction day 14 values; two-way
ANOVA with post hoc Holm-Sidak multiple comparison analysis.
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Figure 33. Pre-induction forced-exercise does not alter splenic lymphocyte IL-10
production. Splenic lymphocytes were harvested from treated rats near onset (postinduction day 14) or near peak of disease (post-induction day 18) and resting (unstimulated), P2 peptide-, or concanavalin A (ConA)-stimulated splenic lymphocyte IL-10
cytokine production and/or release were quantified in vitro as described within Methods
and Materials. Data shown are the means + SEM (n = 4-6) of rats undergoing sedentary
(white bars) or forced-exercise (black bars) training prior to severe EAN induction by
footpad injection. An adjuvant immunization control group (CFA control, gray bars) is
shown for comparison. #p<0.05 vs. respective post induction day 14 values; two-way
ANOVA with post hoc Holm-Sidak multiple comparison analysis.
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Figure 34. Pre-induction forced-exercise does not alter splenic lymphocyte IFN-γ
production. Splenic lymphocytes were harvested from treated rats near onset (postinduction day 14) or near peak of disease (post-induction day 18) and resting (unstimulated) or P2 peptide-stimulated splenic lymphocyte IFN-γ cytokine production
and/or release were quantified in vitro as described within Methods and Materials. Data
shown are the means + SEM (n = 4-6) of rats undergoing sedentary (white bars) or
forced-exercise (black bars) training prior to severe EAN induction by footpad injection.
An adjuvant immunization control group (CFA control, gray bars) is shown for
comparison. #p<0.05 vs. respective post induction day 14 values; two-way ANOVA with
post hoc Holm-Sidak multiple comparison analysis.
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Figure 35. Pre-induction forced-exercise enhances splenic lymphocyte P2 peptideand lectin-stimulated TNF-α production. Splenic lymphocytes were harvested from
treated rats near onset (post-induction day 14) or near peak of disease (post-induction day
18) and resting (un-stimulated), P2 peptide-, or concanavalin A (ConA)-stimulated
splenic lymphocyte TNF-α cytokine production and/or release were quantified in vitro as
described within Methods and Materials. Data shown are the means + SEM (n = 4-6) of
rats undergoing sedentary (white bars) or forced-exercise (black bars) training prior to
severe EAN induction by footpad injection. An adjuvant immunization control group
(CFA control, gray bars) is shown for comparison. *p<0.05 vs. respective sedentary
EAN controls, #p<0.05 vs. respective post induction day 14 values; two-way ANOVA
with post hoc Holm-Sidak multiple comparison analysis.
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rats (2.91 ± 0.55 %, n = 8) (Figure 38). Near disease peak, the percentage of Th1 cells
was still elevated in nodes harvested from sedentary EAN control rats (4.15 ± 0.70 %, n =
8) [F1, 28 = 0.40, p = 0.53] (Figure 38).
Pre-Induction Forced-Exercise Does Not Affect Nodal Th2 Cell Bias
In marked difference to Th1 cell bias, no statistical distinctions were apparent between the
percent distribution of Th2 cells present in nodes harvested from sedentary and forcedexercise EAN groups [F1, 19 = 2.60, p = 0.12]; however, there was a statistical distinction
in lymphocyte percentage between near onset and peak of disease in forced-exercise
EAN rats [F1, 19 = 5.78, p = 0.03] (Figure 39). This slight increase in Th2 cells obtained
from peak forced-exercise EAN rats was indistinguishable from peak sedentary EAN
rats. These findings strongly suggest that pre-induction forced-exercise does not protect
against the clinical development of severe EAN by a mechanism involving a localized
Th1/Th2 shift in the cell bias of autoreactive lymphocytes, but instead decreasing the proinflammatory Th1 response.
Pre-Induction Forced-Exercise Does Not Affect Nodal Tc Cells
The total percent distribution of Tc cells (Figure 40) recovered from popliteal
lymph nodes harvested from sedentary or forced-exercise EAN rats was statistically
indistinguishable [F1, 16 = 0.17, p = 0.68] and unaffected by disease course [F1, 16 = 1.32,
p = 0.27], demonstrating that pre-induction forced-exercise does not alter Tc cell
distribution.
Similarly, no effect of experimental group [F1, 16 = 0.30, p = 0.59] or disease
course [F1, 16 = 0.33, p = 0.58] was apparent regarding the percent distribution of
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Figure 36. Representative flow cytometric dot plots of nodal T cell bias from severe
EAN rats. Popliteal lymph nodes were harvested from sedentary or forced-exercise EAN
rats induced in the footpad near onset of disease. Lymphocytes were identified by gating
against the forward and side scatter (A). The percentage (red box) of Th1 cells were
further quantified by staining cells (B, top) with fluorescently tagged monoclonal
antibodies to cell surface markers CD4 and CD212 compared with (B, bottom)
corresponding isotype controls.
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activated Tc cells (Figure 40).
Pre-Induction Forced-Exercise Attenuates Severe EAN-Induced Splenic Th1 Cell Bias
Whereas pre-induction forced-exercise prevented a localized bias in Th1 cell
distribution (Figure 38) consistent with a lessening of disease severity, we sought to
determine if such a protective effect by pre-induction forced-exercise was similarly
evident in the spleen.
The total percent distribution of Th cells recovered from spleens harvested from
sedentary or forced-exercise EAN rats were statistically indistinguishable [F1, 32 = 1.14, p
= 0.29], and unaffected by disease course [F1, 29 = 0.22, p = 0.65] (Figure 40). These
findings agree well with localized changes in nodal T cell responses (Figure 37) and
further support the thesis that pre-induction forced-exercise does not by itself alter helper
T cell distribution.
Similar to that observed for nodal T cells (Figure 38), the percent distribution of
Th1 cells present in spleens harvested near disease onset from sedentary EAN control rats
(11.41 ± 1.47 %, n = 6) was found to be elevated compared to forced-exercise EAN rats
(8.63 ± 0.19 %, n = 6), though failed to reach statistical significance [F1, 20 = 6.21, p =
0.07] (Figure 43). Near disease peak, the percentage of Th1 cells in spleens harvested
from sedentary and forced-exercise EAN rats were significantly reduced [F1, 20 = 27.09, p
< 0.001], consistent with the beginning of disease recovery (Figure 43).
Pre-Induction Forced-Exercise Does Not Affect Splenic Th2 Cell Bias
No meaningful statistical distinctions were apparent between the percent
distribution of Th2 cells present in spleens harvested from sedentary and forced-exercise
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EAN rats [F1, 19 = 0.06, p = 0.81], and was unaffected by disease course [F1, 19 = 0.80, p
= 0.38] (Figure 44). These splenic findings strongly suggest that pre-induction forcedexercise does not protect against the clinical development of severe EAN by a
mechanism involving a Th1/Th2 shift in the cell bias of autoreactive lymphocytes, but
instead protects against a pro-inflammatory Th1 response.
Pre-Induction Forced-Exercise Affects the Percent Distribution of Splenic Activated Tc
cells
The total percent distribution of Tc cells recovered from spleens harvested from
sedentary or forced-exercise EAN rats (Figure 45) was statistically indistinguishable [F1,
20

= 0.16, p = 0.69], but was affected by disease course [F2, 20 = 5.49, p = 0.03]. A

reduction in the percent distribution of Tc cells from spleens of peak forced-exercise EAN
rats (17.33 ± 1.11 %, n = 6) compared to onset forced-exercise EAN rats (12.77 ± 0.91%,
n = 6) was noted, but this was most likely due to experimental noise. These findings
suggest that pre-induction forced-exercise does not alter splenic cytotoxic T cell
distribution.
The effect of pre-induction forced-exercise on the percent distribution of activated
splenic Tc cells is shown in Figure 46. Spleens harvested near disease onset from
sedentary EAN control rats (6.07 ± 0.35 %, n = 6) exhibited an elevated percent
distribution of activated Tc cells compared to forced-exercise EAN rats (4.86 ± 0.19 %,
n= 6) [F1, 20 = 4.45, p = 0.05]. Near peak of disease, spleens harvested from both groups
exhibited a similar percent distribution of activated Tc cells, and were significantly
reduced compared to near onset of disease [F1, 20 = 67.08, p < 0.001], consistent with
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Figure 37. Pre-induction forced-exercise does not affect nodal helper T cell bias.
Popliteal lymph nodes were harvested from treated rats near onset (post-induction day
14) or near peak of disease (post-induction day 18) and gated lymphocytes were stained
with fluorescently tagged monoclonal antibody to cell surface marker CD4 or isotype
control. Data shown are the means + SEM (n = 5-8). These data were analyzed by twoway ANOVA with post hoc Holm-Sidak multiple comparison test and were found to be
statistically indistinguishable.
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Figure 38. Pre-induction forced-exercise attenuates severe EAN-induced nodal Th1
cell bias. Popliteal lymph nodes were harvested from treated rats near onset (postinduction day 14) or near peak of disease (post-induction day 18) and gated lymphocytes
were stained with fluorescently tagged monoclonal antibodies to cell surface markers
CD4 and CD212, or isotype control. Data shown are the means + SEM (n = 5-8).
*p<0.05 vs. sedentary EAN control; two-way ANOVA with post hoc Holm-Sidak
multiple comparison analysis.
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Figure 39. Pre-induction forced-exercise modestly affects nodal Th2 cell bias.
Popliteal lymph nodes were harvested from treated rats near onset (post-induction day
14) or near peak of disease (post-induction day 18) and gated lymphocytes were stained
with fluorescently tagged monoclonal antibodies to cell surface markers CD4 and
CD278, or isotype control. Data shown are the means + SEM (n = 5-6). #p<0.05 vs.
respective post induction day 14 values; two-way ANOVA with post hoc Holm-Sidak
multiple comparison analysis.
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Figure 40. Pre-induction forced-exercise does not affect nodal Tc cell bias. Popliteal
lymph nodes were harvested from treated rats near onset (post-induction day 14) or near
peak of disease (post-induction day 18) and gated lymphocytes were stained with
fluorescently tagged monoclonal antibody to cell surface marker CD8 or isotype control.
Data shown are the means + SEM (n = 5-6). These data were analyzed by two-way
ANOVA with post hoc Holm-Sidak multiple comparison test and were found to be
statistically indistinguishable.
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Figure 41. Pre-induction forced-exercise does not affect activated nodal Tc cell bias.
Popliteal lymph nodes were harvested from treated rats near onset (post-induction day
14) or near peak of disease (post-induction day 18) and gated lymphocytes were stained
with fluorescently tagged monoclonal antibodies to cell surface markers CD8 and
CD212, or isotype control. Data shown are the means + SEM (n = 5-6). These data were
analyzed by two-way ANOVA with post hoc Holm-Sidak multiple comparison test and
were found to be statistically indistinguishable.
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Figure 42. Pre-induction forced-exercise does not affect splenic helper T cell bias.
Spleens were harvested from treated rats near onset (post-induction day 14) or near peak
of disease (post-induction day 18) and gated lymphocytes were stained with fluorescently
tagged monoclonal antibody to cell surface marker CD4 or isotype control. Data shown
are the means + SEM (n = 5-9). *p<0.05 vs. CFA immunization control; two-way
ANOVA with post hoc Holm-Sidak multiple comparison analysis. These data were
analyzed by two-way ANOVA with post hoc Holm-Sidak multiple comparison test and
were found to be statistically indistinguishable.
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Figure 43. Pre-induction forced-exercise attenuates severe EAN-induced splenic Th1
cell bias. Spleens were harvested from treated rats near onset (post-induction day 14) or
near peak of disease (post-induction day 18) and gated lymphocytes were stained with
fluorescently tagged monoclonal antibodies to cell surface markers CD4 and CD212, or
isotype control. Data shown are the means + SEM (n = 5-6). #p<0.05 vs. respective postinduction day 14 values; two-way ANOVA with post hoc Holm-Sidak multiple
comparison analysis.
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Figure 44. Pre-induction forced-exercise does not affect splenic Th2 cell bias. Spleens
were harvested from treated rats near onset (post-induction day 14) or near peak of
disease (post-induction day 18) and gated lymphocytes were stained with fluorescently
tagged monoclonal antibodies to cell surface markers CD4 and CD278, or isotype
control. Data shown are the means + SEM (n = 5-6). These data were analyzed by twoway ANOVA with post hoc Holm-Sidak multiple comparison test and were found to be
statistically indistinguishable.
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Figure 45. Pre-induction forced-exercise does not affect splenic Tc cell bias. Spleens
were harvested from treated rats near onset (post-induction day 14) or near peak of
disease (post-induction day 18) and gated lymphocytes were stained with fluorescently
tagged monoclonal antibody to cell surface marker CD8 or isotype control. Data shown
are the means + SEM (n = 5-6). #p<0.05 vs. respective post-induction day 14 values;
two-way ANOVA with post hoc Holm-Sidak multiple comparison analysis.
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Figure 46. Pre-induction forced-exercise does not affect activated splenic Tc cell
bias. Spleens were harvested from treated rats near onset (post-induction day 14) or near
peak of disease (post-induction day 18) and gated T lymphocytes were stained with
fluorescently tagged monoclonal antibodies to cell surface markers CD8, CD212, or
isotype control. Data shown are the means + SEM (n = 5-6). *p<0.05 vs. sedentary EAN
control; #p<0.05 vs. respective post-induction day 14 values; two-way ANOVA with post
hoc Holm-Sidak multiple comparison analysis.
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disease recovery.
Pre-Induction Forced-Exercise Attenuates Severe EAN-Induced Circulating Th1 Cell
Bias
Whereas pre-induction forced-exercise prevented a localized and splenic bias in
Th1 cell distribution (Figures 38 and 43) consistent with a lessening of disease severity,
we sought to determine if such a protective effect by pre-induction forced-exercise was
similarly evident in circulation.
The total percent distribution of Th cells in blood collected from sedentary or
forced-exercise EAN rats near disease onset was statistically indistinguishable [F1, 18 =
2.21, p = 0.16] (Figure 47). By comparison, blood collected from sedentary control
(55.97 ± 0.98 %, n = 6) and forced-exercise (57.50 ± 2.42%, n = 5) EAN rats near disease
peak exhibited a modest increase [F1, 18 = 14.23, p = 0.001] in Th cells compared to near
disease onset (50.87 ± 0.30 % and 53.08 ± 0.61%, n = 5-6, respectively) that was most
likely due to return of normal immune surveillance by Th cells ] (Figure 47). These
findings agree well with changes in nodal and splenic T cell responses (Figures 35 and
40) and further support the thesis that pre-induction forced-exercise does not by itself
alter helper T cell distribution.
Similar to that observed for nodal and splenic T cells (Figure 48), the percent
distribution of Th1 cells present in blood collected from sedentary EAN control rats was
found to be significantly [F1, 18 = 7.61, p = 0.01] elevated compared forced-exercise EAN
rats (Figure 48). At disease onset, sedentary (7.01 ± 0.94 %, n = 6) and forced-exercise
(5.04 ± 0.32 %, n = 5) EAN rats had similar percentages of blood Th1 cells (Figure 48).
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Near disease peak, the percentage of Th1 cells in blood collected from sedentary EAN
rats (6.21 ± 0.95 %, n = 6) was sustained compared to sedentary onset levels, and
significantly increased compared to forced-exercise EAN rats (3.58 ± 0.81 %, n = 5)
signifying continued disease status. There was a modest reduction in Th1 cells in blood
collected from forced-exercise EAN rats which consistent with the beginning of disease
recovery (Figure 48).
Pre-Induction Forced-Exercise Does Not Affect Circulating Th2 Cell Bias
In marked difference to Th1 cell bias, no meaningful statistical distinctions were
apparent between the percent distribution of Th2 cells present in blood collected from
sedentary or forced-exercise EAN groups [F1, 16 = 0.59, p = 0.45] or between near onset
or peak of disease [F1, 16 = 0.19, p = 0.67] (Figure 49). Similar to nodal and splenic
findings (Figures 39 and 44), these circulatory findings strongly suggest that preinduction forced-exercise does not protect against the clinical development of severe
EAN by a mechanism involving a Th1/Th2 shift in the cell bias of autoreactive
lymphocytes, but instead protects against a pro-inflammatory Th1 response.
Pre-Induction Forced-Exercise Does Not Affect Circulating Tc Cell Bias
The total percent distribution of Tc cells recovered from blood collected from
sedentary or forced-exercise EAN rats (Figure 50) was statistically indistinguishable[F1,
18

= 1.38, p = 0.26], but was affected by disease course [F1, 18 = 110.0, p < 0.001]. Near

disease peak, all groups had a ~35% decrease in Tc cell percentages compared to near
disease onset, signifying the beginning of disease recovery.
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Figure 47. Pre-induction forced-exercise does not affect circulating helper T cell
bias. Blood was collected from treated rats near onset (post-induction day 14) or near
peak of disease (post-induction day 18) and gated lymphocytes were stained with
fluorescently tagged monoclonal antibody to cell surface marker CD4 or isotype control.
Data shown are the means + SEM (n = 3-6). #p<0.05 vs. respective post-induction day 14
values; two-way ANOVA with post hoc Holm-Sidak multiple comparison analysis.
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Figure 48. Pre-induction forced-exercise attenuates severe EAN-induced circulating
Th1 cell bias. Blood was collected from treated rats near onset (post-induction day 14) or
near peak of disease (post-induction day 18) and gated lymphocytes were stained with
fluorescently tagged monoclonal antibodies to cell surface markers CD4 and CD212, or
isotype control. Data shown are the means + SEM (n = 3-6). *p<0.05 vs. sedentary EAN
control; two-way ANOVA with post hoc Holm-Sidak multiple comparison analysis.
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Figure 49. Pre-induction forced-exercise does not affect circulating Th2 cell bias.
Blood was collected from treated rats near onset (post-induction day 14) or near peak of
disease (post-induction day 18) and gated lymphocytes were stained with fluorescently
tagged monoclonal antibodies to cell surface markers CD4 and CD278, or isotype
control. Data shown are the means + SEM (n = 3-6). These data were analyzed by twoway ANOVA with post hoc Holm-Sidak multiple comparison test and were found to be
statistically indistinguishable.
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Figure 50. Pre-induction forced-exercise does not affect circulating Tc cell bias.
Blood was collected from treated rats near onset (post-induction day 14) or near peak of
disease (post-induction day 18) and gated lymphocytes were stained with fluorescently
tagged monoclonal antibody to cell surface marker CD8 or isotype control. Data shown
are the means + SEM (n = 3-6). p<0.05 vs. respective post-induction day 14 values; twoway ANOVA with post hoc Holm-Sidak multiple comparison analysis.

CHAPTER V
DISCUSSION
Guillain-Barré Syndrome (GBS) is an acute acquired autoimmune mediated
human peripheral neuropathy with an incidence of about four cases per 100,000 people.
In North America and Europe, GBS typically presents in the form of acute inflammatory
demyelinating polyneuropathy (AIDP), where autoreactive pro-inflammatory
lymphocytes and macrophages invade the myelin, thus demyelinating and damaging the
axon, leading to paraparesis, paralysis, and areflexia of the limbs. The treatment of
AIDP/GBS is currently palliative and utilizes non-specific immune-modulating therapies.
However, these benefits are generally observed only if treatment is administered early in
the course of the disease (Hughes and Cornblath, 2005; Vucic et al., 2009). A better
understanding of the autoimmune pathogenesis is crucial for development of better
treatments for this peripheral neuropathy.
A major finding of this dissertation is that a three-week regimen of moderate
forced-exercise attenuates the clinical severity, weight loss, and peripheral nerve damage
of P2 peptide induced experimental autoimmune neuritis (EAN) in Lewis rats, an animal
model of GBS. EAN is an inducible autoimmune disease that involves the activation,
proliferation, and differentiation of the pro-inflammatory autoreactive adaptive immune
cells in the secondary lymphoid organs. These autoreactive adaptive immune cells then
egress from the secondary lymphoid organs (e.g. lymph nodes and spleen) to home and
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demyelinate peripheral nerves leading to weakness and paralysis in the hind limbs.
Exercise has been shown to have anti-inflammatory effects on innate and adaptive
immune cells. Our results show for the first time that in forced-exercise EAN rats, there
is increased retention of adaptive immune cells in the popliteal lymph nodes and spleens.
Lymphocytes obtained from popliteal lymph nodes of forced-exercise EAN rats have an
increased capacity to proliferate near peak of disease when stimulated with P2 peptide,
and a decreased capacity to proliferate near peak of disease when stimulated with
concanavalin A (ConA). Moreover, the supernatant obtained from the lymphocyte
proliferation assays of forced-exercise EAN rats near onset and peak of disease show a
marked increase in the anti-inflammatory cytokine interleukin-10 (IL-10). Splenic
lymphocytes obtained from spleens of forced-exercise EAN rats have an increase
capacity to proliferate when stimulated with ConA. Flow cytometric analysis of adaptive
immune cells obtained from popliteal lymph nodes, spleen, and blood of forced-exercise
EAN rats showed a clear decrease in pro-inflammatory type 1 helper T (Th1) cells. These
results illustrate that forced-exercise has anti-inflammatory effects that can attenuate
EAN in rats. To our knowledge, this is the first study to showed attenuation of the clinical
severity of EAN by moderate forced-exercise.
Forced-exercise via treadmill allows for strict control of when, how long, and how
far the rats run. A voluntary wheel-running paradigm was tried, but the male Lewis rats
we used ran very little distances. Lewis rats that had access to wheels ran about 2 km per
24-hour period (data not shown). This was judged an unsatisfactory distance, so a 10%
food restriction was implemented to increase the running distance of the Lewis rats
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(Holloszy et al., 1985; Holloszy and Schechtman, 1991; Sherwin, 1998; Duclos et al.,
2005). After food restriction, half the rats ran 8 km per a 24-hour period, while the other
half of rats ran about 4 km per 24-hour period (data not shown). This phenomenon of
high-capacity and low-capacity runners is described in the literature, and most likely due
to individual genetic differences between the rats (Britton and Koch, 2005). Due to the
extra variability from the food restriction and voluntary wheel-running distances, it was
decided that treadmill training would be best exercise model.
However, forced-exercise via treadmill has a negative aspect; rats run against
their will, which can be stressful. Studies have shown that, acutely, treadmill training can
increase the glucocorticoid corticosterone, and decrease corticosteroid-binding globulin
(CBG), the carrier protein for corticosterone (Moraska et al., 2000; Ploughman et al.,
2005; Brown et al., 2007; Ploughman et al., 2007; Ke et al., 2011). However, voluntary
exercise can also lead to acute rise in corticosterone (Fediuc et al., 2006). In other studies,
corticosterone and CBG normalize to physiological levels after eight weeks of chronic
treadmill exercise (Leasure and Jones, 2008). In the present study, levels of
corticosterone and CBG were not measured during exercise, and were only measured
near onset and peak of EAN. Near onset and peak of EAN, there were no difference in
stress hormone between sedentary and forced-exercise groups, or between non-EAN rats,
but a glucocorticoid difference might have appeared if measurements were taken early in
the exercise regimen. The levels of corticosterone and CBG in this study were similar to
non-stressed Lewis rats (Dhabhar et al., 1995; Martin et al., 2000; Duclos et al., 2001).
EAN is an autoimmune disease mediated by pro-inflammatory autoreactive Th1
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cells (Constantinescu et al., 1998; Gold et al., 2000; Maurer and Gold, 2002). However,
EAN is not the only autoimmune disease mediated by Th1 cells (Gold et al., 1997;
Constantinescu et al., 1998; Elenkov et al., 2000; Gold et al., 2000), and there have been
studies on how exercise affects these similar autoimmune diseases. For example, the
effects of forced-exercise were studied in rats with experimental autoimmune
encephalomyelitis (EAE), an animal model of multiple sclerosis (MS). In these studies
(Le Page et al., 1994; Le Page et al., 1996), forced-exercise was shown to decrease
overall clinical severity and delay the onset, but did not decrease peak severity, of EAE in
rats. However, these studies implemented a different exercise regimen. In these studies,
the rats underwent acute severe exercise; the rats exercised either two days before or a
few days after the induction of EAE. In another study (Rossi et al., 2009), mice with EAE
had access to a voluntary wheel after induction. This acute voluntary exercise attenuated
the course of EAE. In the present study, a chronic moderate forced-exercise regimen was
used three weeks before induction of EAN. This pre-induction chronic exercise has been
shown to have additional beneficial systemic effects, such as decreased inflammation,
compared to acute exercise (Flynn et al., 2007; Gleeson, 2007; Haaland et al., 2008;
Campbell et al., 2009; Lira et al., 2009; Rosa Neto et al., 2010; Teixeira-Lemos et al.,
2011b). In our study, chronic pre-induction exercise led to a decrease in clinical severity
of EAN. Moreover, chronic exercise caused the forced-exercise rats to peak in clinical
severity 1.3 days earlier than sedentary rats. This could be attributed to exercise
attenuating the clinical severity of EAN and stunting EAN development.
In our study, we used two methods of EAN induction in the rat: induction of
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severe EAN using P2 peptide emulsified in complete Freund’s adjuvant (CFA) injected
into the left footpad or induction of mild EAN using P2 peptide emulsified in CFA
injected into the base of the tail. Injection of P2 peptide emulsified in CFA in either the
footpad or base of the tail causes a local inflammatory response, edema, and tissue
necrosis. We induced mild EAN in the base of the tail because our preliminary
experimental design involved rats exercising throughout the course of EAN. Injecting in
the footpad would have inhibited these rats from running after induction due to the local
inflammatory response. After these preliminary experiments, we investigated whether
pre-induction exercise alone could attenuate EAN. Our clinical data show that inducing
EAN by footpad injection leads to a more severe disease state than inducing in the base
of the tail. In fact, previous reports about the severity of EAN induced in the base of the
tail (Zhang et al., 2008b) or in the footpad (Weishaupt et al., 1997; Stienekemeier et al.,
1999; Stienekemeier et al., 2001; Ahn et al., 2010) correspond with our data. In other
reports, base of the tail injections with twice the amount of antigenic P2 peptide was used
to obtain clinical scores on par with footpad injections (Moalem-Taylor et al., 2007;
Lonigro and Devaux, 2009).
It is known that the dosage of antigen used to induce EAN will change the clinical
severity of EAN (Hahn et al., 1988). In this study, the same dose of P2 peptide was used
in the footpad and base of the tail injection. The difference of clinical severity between
the two injection sites could be explained by a difference in lymphatics at the injection
site and the injection method. Regarding lymphatics, somatic areas subject to
environmental hazards, such as the footpads, possess a diffuse regional drainage pattern,
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while the base of the tail does not share this lymphatics feature. In addition, the footpad
injections (popliteal lymph nodes) are closer to lymphoid organs than the base of the tail
injections (gluteal lymph nodes) (Tilney, 1971). Moreover, there were two injection
methods used: intradermal or subcutaneous injection. The tail involves an intradermal
injection, which allows the immediate uptake of the injected material by the lymphatics.
This shortens the time that antigen-presenting cells (APCs) have to process and present
the antigen, which causes a less robust innate and adaptive immune response, leading to
an attenuated disease course (Tilney, 1970; Romagnani, 2006; Waldner, 2009; TorresAguilar et al., 2010). In contrast, the footpad involves a subcutaneous injection, which
allows for a far slower uptake of the injected material by the lymphatics and systemic
circulation. The popliteal lymph nodes, as a result, receive a steady influx of the injected
material (Tilney, 1971). The slow uptake of subcutaneous injection allows for ample time
for the uptake, processing, and presentation of the injected material by APCs, which then
migrate to the draining lymph to initiate the adaptive immune response (Romagnani,
2006; Waldner, 2009; Torres-Aguilar et al., 2010). Coupled with the diffuse lymphatics,
the proximity of popliteal lymph nodes, and the subcutaneous injection, the footpad is
optimal for an innate and adaptive immune response leading to robust EAN disease.
In the present study, there was a significant difference in weight gain between
sedentary and forced-exercised rats. Both groups gained weight during the weeks before
EAN induction, but the forced-exercise group gained significantly less weight. This has
been reported in other studies, both in treadmill (Martin et al., 2000; Moraska et al., 2000;
Leasure and Jones, 2008) and voluntary wheel-running (Fediuc et al., 2006; Droste et al.,

123
2007). However, we did not test whether the weight loss was due to changes in metabolic
adaptations or food intake (Sherwin, 1998). Weight loss is a symptom of EAN, and the
greater the clinical severity of EAN the greater the weight loss (Rostami et al., 1990;
Gabriel et al., 1997; Kafri et al., 2005; Lin et al., 2007; Moalem-Taylor et al., 2007;
Sarkey et al., 2007; Zhang et al., 2008b; Tran et al., 2010). Both forced-exercise and
sedentary rats with severe EAN lost weight, but the forced-exercise rats loss significantly
less weight. The attenuated weight loss is consistent with the attenuated clinical severity
observed in forced-exercise EAN rats.
Peripheral nerve conduction studies were used to measure the EAN-induced
changes of compound muscle action potential (CMAP) amplitudes and motor nerve
conduction velocities (MNCVs) in the sciatic and tibial nerves (Gabriel et al., 1997;
Taylor and Pollard, 2001, 2003; Lin et al., 2007; Sarkey et al., 2007). CMAP amplitudes
and MNCV deficits are indicative of axonal damage and demyelination (Hughes and
Cornblath, 2005; Daube and Rubin, 2009). The clinical severity of EAN is associated
with deficits of CMAP amplitudes and MNCVs, with the more severe EAN
corresponding with greater deficits (Taylor and Pollard, 2001, 2003; Lin et al., 2007;
Sarkey et al., 2007). However, in one study, the clinical severity of EAN was not
correlated with deficits of CMAP amplitudes and MNCVs; a greater clinical score did not
lead to greater CMAP amplitudes deficits (Gabriel et al., 1997). These conflicting reports
could be due to the size and body temperature of the rats, type of stimulating and
recording electrodes used, and the clinical severity of EAN (Taylor and Pollard, 2001,
2003; Kurokawa et al., 2004). Small but significant changes in clinical severity of EAN
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(Gabriel et al., 1997) might be indistinguishable, but large changes can be distinguished
(Taylor and Pollard, 2001, 2003; Lin et al., 2007; Sarkey et al., 2007), by peripheral
nerve conduction studies.
Exercise is also known to protect from CMAP and MNCV deficits in peripheral
neuropathies (Fisher et al., 2003; Balducci et al., 2006; Fisher et al., 2007). Forcedexercise protected against CMAP amplitude deficits in rats induced with mild EAN in the
base of the tail. However, pre-induction forced-exercise did not protect against CMAP
amplitude deficits in rats induced with severe EAN in the footpad. Exercise also did not
protect against MNCV deficits in either EAN induction method. The difference in CMAP
amplitude protection between induction methods could be attributed to the more
clinically severe EAN in footpad injection than base of the tail. A previous study showed
that CMAP amplitude deficits were not observed until after the clinical score revealed
paraparesis or paraplegia in the hind legs (Taylor and Pollard, 2001, 2003). EAN
induction in the base of the tail leads to a less severe course of disease compared to
footpad injection, and forced-exercise decreases clinical severity in both injection
methods. Due to the combined effect of injection method and exercise, forced-exercise
rats induced in the base of tail never developed paraparesis of the hind legs, a
manifestation of severe clinical disease that has been associated with CMAP amplitude
deficits. Even though pre-induction forced-exercise decreased clinical severity of severe
EAN compared to sedentary rats, both groups developed paraparesis, which were
revealed in the nerve conduction studies. A lack of change in CMAP amplitudes between
the forced-exercise and sedentary rats with severe EAN injected in the footpad, and a
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lack of change in MNCV between the forced-exercise and sedentary rats in both injection
methods, could be due to the insensitivity of nerve conduction studies to distinguish small
even if meaningful differences in clinical severity of EAN (Gabriel et al., 1997).
CMAP amplitudes stimulated from the rat hip (proximal) or ankle (distal), and
recorded from the plantar muscle demonstrate physiological temporal dispersion, which
is calculated as an R ratio (proximal to distal ratio, normal ratio > 0.7). A low R ratio
(abnormal ratio < 0.7) can signify that abnormal temporal dispersion or conduction block
is occurring, signifying segmental or multifocal demyelination (van der Meche et al.,
1988; Harvey and Pollard, 1992; Lin et al., 2007; Daube and Rubin, 2009; Uncini et al.,
2010). This decrease in R ratio has been described in patients with GBS, suggesting that
demyelination of peripheral nerves is not uniformly distributed (van der Meche et al.,
1988; Brown and Snow, 1991; Uncini et al., 2010). Specifically, in AIDP, this decrease
of R ratios has been shown to occur early in the disease when the proximal CMAP
amplitudes have decreased substantially while distal CMAP amplitudes have decreased
minimally, while later in the disease both proximal and distal CMAP amplitudes have
decreased substantially (Uncini et al., 2010). Even though both proximal and distal
CMAP amplitudes were decreased in forced-exercise and sedentary rats with severe EAN
there was a decrease of R ratios near peak of disease in forced-exercise EAN rats, but not
in sedentary EAN rats. This could signify in forced-exercise EAN rats the distal tibial
nerves were relatively spared in comparison to the proximal sciatic nerves while this was
not true for sedentary EAN rats. The proximal ends of peripheral nerves are known to be
more deficient in the blood-nerve barrier compared to other segments of the nerve, and
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are more susceptible to cellular and humoral infiltrates of the immune system (Jacobs et
al., 1976; Brown and Snow, 1991). Attenuation of the clinical severity of severe EAN
due to pre-induction forced-exercise could be explained by an attenuation of the
immunological injury of the distal tibial nerves. In contrast, there were no differences in
R ratios between forced-exercise and sedentary rats with mild EAN injected in the base
of the tail. This is probably due to decreased clinical severity of the base of tail injection.
Clinical severity of EAN has been correlated with neuropathological changes in
sciatic nerves, with greater clinical severity corresponding to greater immune cell
infiltrates, edema, demyelination, and axonal damage (Harvey and Pollard, 1992;
Gregorian and Rostami, 1994; Spies et al., 1995b; Araga et al., 1999; Pelidou et al., 2000;
Laura et al., 2006; Castro et al., 2007; Deng and Zhou, 2007; Sarkey et al., 2007; Yun et
al., 2007; Zhang et al., 2008a; Tan et al., 2009; Zhang et al., 2009a; Zhang et al., 2009d;
Zhang et al., 2009e; Tran et al., 2010). However, there is a conflicting report of
attenuation of clinical severity of EAN without changes in neuropathological score. In
this study, there were significant but small changes in EAN clinical severity (difference
of about clinical score of 1 to 1.5) (Gabriel et al., 1997). In the studies that reported
neuropathological score differences, the differences of EAN clinical severity were much
larger (difference of a clinical score of > 2) (Gregorian and Rostami, 1994; Spies et al.,
1995b; Araga et al., 1999; Pelidou et al., 2000; Laura et al., 2006; Castro et al., 2007;
Deng and Zhou, 2007; Sarkey et al., 2007; Yun et al., 2007; Zhang et al., 2008a; Tan et
al., 2009; Zhang et al., 2009a; Zhang et al., 2009d; Zhang et al., 2009e; Tran et al., 2010).
The difference in attenuation of EAN could explain the discrepancy in neuropathological
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score. In addition, neuropathological changes are also greater in the sciatic nerve of the
leg that was injected compared to the sciatic nerve of the un-injected foot (Harvey and
Pollard, 1992). In our study, we did not observe a difference in neuropathological score
between forced-exercise and sedentary rats with severe EAN injected in the footpad,
which correlates with the observed lack of change in CMAP amplitudes and MNCVs. As
reported elsewhere (Harvey and Pollard, 1992), we did observe a difference in
neuropathological score between injected (left) and un-injected (right) in sedentary and
forced-exercise EAN rats, although these difference never reached significance.
EAN is an autoimmune disorder mediated by the pro-inflammatory autoreactive
Th1 immune cells of the adaptive immune system (Rostami et al., 1990; Rostami and
Gregorian, 1991; Takai et al., 1995; Fujioka et al., 2000; Gold et al., 2000; Maurer and
Gold, 2002; Schmidt et al., 2003). When the P2 peptide and CFA emulsion is injected
into the rat, the innate immune response is activated. APCs, through activation of toll-like
receptors (TLRs), phagocytose the emulsion, process and present the P2 peptide in the
context of major histocompatibility complex class (MHC) II with co-stimulatory signals
CD80 and CD86, and migrate to secondary lymphoid tissue to activate autoreactive naïve
T cells, which then proliferate and differentiate into pro-inflammatory autoreactive Th1
cells (Stenger and Modlin, 2002; Toubi and Shoenfeld, 2004; Deng and Zhou, 2007;
Israeli et al., 2009; Waldner, 2009; Zhang et al., 2009c). These cells then egress from the
lymphoid tissue to migrate to and cross the blood-nerve barrier to home in on the P2
protein on the myelin of the peripheral nerves, clonally expand again, release proinflammatory cytokines, activating macrophages and inducing Schwann cell apoptosis,
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leading to demyelination and axonal damage (Hartung et al., 1995a, b; Fujioka et al.,
2000).
Exercise increases circulating APCs (Ho et al., 2001; Chiang et al., 2010;
Suchanek et al., 2010), decreases TLRs and alters APC function (Woods et al., 1999;
Flynn and McFarlin, 2006; Gleeson et al., 2006; McFarlin et al., 2006; Lambert et al.,
2008; Timmerman et al., 2008; Simpson et al., 2009; Oliveira and Gleeson, 2010),
increase (Sugiura et al., 2000; Rogers et al., 2008) or decreases (Moraska et al., 2000;
Nielsen, 2003; Gleeson et al., 2006; Gleeson, 2007; Rosa Neto et al., 2010) lymphocyte
proliferation, increases differentiation of anti-inflammatory T cells and anti-inflammatory
cytokines while decreasing pro-inflammatory T cells and cytokines (Lancaster et al.,
2004; Pastva et al., 2004; Yeh et al., 2006; Flynn et al., 2007; Gleeson, 2007; da Silva
Krause and de Bittencourt, 2008; Donnikov et al., 2008; Haaland et al., 2008; Yeh et al.,
2008; Hewitt et al., 2009b; Lowder et al., 2010; Rosa Neto et al., 2010), impairs T cellmediated induction phase of an in vivo immune response (Harper Smith et al., 2011), and
promotes lymphocyte egress into peripheral tissues (Chen et al., 2010; Turner et al.,
2010; Adams et al., 2011).
In this study, we quantified immune cells of two lymphoid organs: the popliteal
lymph nodes, which are close to, and receive direct lymphatics from, the sight of
injection; and the spleen, which receives indirect lymphatics through the circulatory
system (Cesta, 2006; Willard-Mack, 2006; DeFranco et al., 2007). We observed increases
in lymphocyte number near disease peak and splenic lymphocyte concentration near
disease onset in forced-exercise EAN rat popliteal lymph nodes and spleens, respectively.
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An increase in splenic lymphocyte concentration due to exercise has been previously
reported (Ferry et al., 1992). We did not observe an increase in lymphocyte number or
splenic lymphocyte concentration in sedentary EAN rat popliteal lymph nodes and
spleen, respectively, for the same time points. Both sedentary and forced-exercise EAN
rats developed clinical signs, although the forced-exercise rats had attenuated clinical
signs of EAN. A probable explanation of the decreased quantity of immune cells in
lymph nodes and spleens, and thus a more severe clinical severity, of sedentary EAN rats
is an increased egress of these immune cells from these lymphoid organs into the
periphery where the cells can home in on peripheral nerve myelin (Fujioka et al., 2000).
Exercise has been shown to affect egress and the migration process of immune cells
(Chen et al., 2010; Turner et al., 2010; Adams et al., 2011), and our data might support
decreased egress of immune cells from lymphoid organs from forced-exercise EAN rats.
Sphingosine-1-phosphate is a major mediator in immune cell egress, but currently there
are few reports on the effects exercise on sphingosine-1-phosphate which remain
equivocal (Schwab and Cyster, 2007; Blachnio-Zabielska et al., 2008; Dube et al., 2011).
Further research needs to be conducted to clarify the increased retention of immune cells
in forced-exercise animals.
We normalized (2.0 × 106 cells/ml) and quantified the in vitro stimulated
proliferative capacity and cytokine secretion of nodal and splenic lymphocytes from the
popliteal lymph nodes and spleens, respectively, of rats with severe EAN. Proliferation
assays serve to assess the functional capacity of immune cells (Nielsen, 2003). We also
stained specific cell surface markers for lymphocytes from lymph nodes, spleens, and

130
blood, and performed flow cytometry to quantify T cell subsets involved in severe EAN
(Hartung et al., 1995a, b) and altered in exercise (Lancaster et al., 2004; Flynn et al.,
2007; Gleeson, 2007; da Silva Krause and de Bittencourt, 2008; Donnikov et al., 2008;
Haaland et al., 2008; Lowder et al., 2010; Rosa Neto et al., 2010). Specifically, we
looked at helper T (Th) cells, which are CD4+ (Zhu and Paul, 2008), and cytotoxic T (Tc)
cells, which are CD8+ (Andersen et al., 2006). From the Th cells, we further divided this
group into pro-inflammatory Th1 cells, which are CD212+ (Yamane et al., 2000; Ozenci
et al., 2001; McQuaid et al., 2003; Kano et al., 2008), and anti-inflammatory Th2 cells,
which are CD278+ (Rojo et al., 2008; Zhu and Paul, 2008; Simpson et al., 2010). We
further divided Tc cells into activated Tc cells, which are CD212+ (McQuaid et al., 2003;
Bontkes et al., 2005).
Consistent with previous reports (Rostami and Gregorian, 1991; Yun et al., 2007),
nodal and splenic lymphocytes from sedentary CFA control rats did not proliferate to P2
peptide and there were a small amount of pro-inflammatory Th1 cells in the lymph nodes,
spleen, and blood.
Sedentary EAN rats near onset of disease had increases in P2 peptide-stimulated
lymphocyte proliferation and in pro-inflammatory Th1 cytokine IFN-γ (Yun et al., 2007;
Zhu and Paul, 2008; Bennett and Stuve, 2009). This proliferation data is expected since
EAN sedentary rats have pro-inflammatory autoreactive Th1 cells primed to P2 peptide
and will proliferate when stimulated with the antigen (Hughes et al., 1981; Rostami et al.,
1990; Rostami and Gregorian, 1991; Yun et al., 2007). We also showed that this
increased proliferative capacity returns to baseline with a concomitant decrease of IFN-γ

131
near peak of disease in sedentary EAN rats. Through flow cytometry, we showed an
increase in Th1 cells in lymph nodes near onset of disease consistent with EAN as Th1mediated autoimmune disease (Takai et al., 1995; Fujioka et al., 2000; Gold et al., 2000;
Maurer and Gold, 2002; Schmidt et al., 2003), and that Th1 cells return to normal levels
near peak of disease. Near peak of disease, most effector T cells will undergo apoptosis
or regulatory T cell-induced anergy, and lymphocytes will not proliferate or secrete
cytokines when stimulated with P2 peptide antigen (Veldman et al., 2006; DeFranco et
al., 2007; Vignali et al., 2008).
There have been reports of blunted proliferation (Moraska et al., 2000) or
increased proliferation (Sugiura et al., 2000; Rogers et al., 2008) of immune cells, and
increased differentiation of anti-inflammatory T cells and secretion of anti-inflammatory
cytokines while decreasing pro-inflammatory T cells and cytokines (Jankord and
Jemiolo, 2004; Lancaster et al., 2004; Goldhammer et al., 2005; Flynn et al., 2007;
Gleeson, 2007; da Silva Krause and de Bittencourt, 2008; Donnikov et al., 2008; Haaland
et al., 2008; Rosa Neto et al., 2010) due exercise training. However, there have been no
reports on effects of exercise and autoimmune disease on immune cell proliferation.
Forced-exercise slightly blunted the capacity of lymphocytes to proliferate to P2 peptide
antigen and with a concomitant increase in IL-10 and IFN-γ and a decrease in IL-2 near
onset of severe EAN. In contrast, we observed sustained P2 peptide-stimulated
lymphocyte proliferation near peak of disease in forced-exercise EAN rats with only a
concomitant increase in IFN-γ and IL-2. We also observed in forced-exercise rats
decreased differentiation of Th1 cells near disease onset in lymph nodes, and that Th1
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cells levels returned to normal near peak of disease.
We observed no differences near onset or peak of disease of Th (Takai et al.,
1995; Yun et al., 2007), Tc (Takai et al., 1995), and activated Tc cells in lymph nodes
among the forced-exercised and sedentary EAN rats. We observed a modest increase near
peak of disease in Th2 cells in forced-exercise rats.
Exercise, by releasing IL-6 from contracting muscles, has the capacity to increase
dendritic cells (DCs) in circulation and to decrease TLRs on APCs, therefore imposing an
anti-inflammatory immature or semi-mature activation status on the innate immune
system (Figure 51) (Ho et al., 2001; Flynn and McFarlin, 2006; Gleeson et al., 2006;
McFarlin et al., 2006; Belkaid and Oldenhove, 2008; Lambert et al., 2008; Nielsen and
Pedersen, 2008; Timmerman et al., 2008; Simpson et al., 2009; Chiang et al., 2010; Frick
et al., 2010; Oliveira and Gleeson, 2010; Suchanek et al., 2010). This change in status of
activation of APCs, which activate naïve Th cells, induces a subset of Th1 cells to secrete
both the pro-inflammatory cytokine IFN-γ and the anti-inflammatory cytokine IL-10
(Trinchieri, 2001; Belkaid and Oldenhove, 2008). This unusual secretion of IL-10 is
thought to occur by recently activated Th1 cells. However, IL-10 secretion is transient,
and Th1 cells will then only secrete IFN-γ. This could be a regulatory mechanism to keep
in check the pro-inflammatory immune response (Belkaid and Oldenhove, 2008), thus
attenuating the clinical severity of EAN. Within the scope of our immune data, when
stimulated with P2 peptide, lymphocytes from forced-exercise rats obtained near onset
secrete both IL-10 and IFN-γ, and these lymphocytes obtained from popliteal lymph
nodes are differentiated into Th1 cells. These Th1 cells limit their own proliferation and
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differentiation by secreting the anti-inflammatory cytokine IL-10 (Zhu and Paul, 2008).
Near peak of disease (Figure 52), these Th1 cells lose their ability to secrete the large
amounts of IL-10 observed near disease onset. These Th1 cells continue to secrete IFN-γ
leading to proliferation of lymphocytes. This transient secretion of IL-10 near onset of
disease could account for the decreased amount of Th1, and the slight increase in Th2,
cells in the lymph nodes.
Another possibility is that near onset of disease, there is an increase of both Th1
cells and IL-10-producing type 1 T regulatory 1 (Tr1) cells, and these cells account for
the increase in IFN-γ and IL-10, respectively (Figure 51). Tr1 cells are crucial in
regulating pro-inflammatory immune response in autoimmune diseases (Fehervari and
Sakaguchi, 2004; Veldman et al., 2006). Tr1 cells are differentiated and activated by
immature DCs, and Tr1 cells blunt the proliferation of Th1 cells by secreting the antiinflammatory cytokine IL-10 (Fehervari and Sakaguchi, 2004; Veldman et al., 2006;
Belkaid and Oldenhove, 2008). In fact, previous reports have shown a small quantity of
regulatory T cells in EAN rats (Yun et al., 2007; Zhang et al., 2009b). Moreover, it has
been shown that there are decreased percentages of circulating anti-inflammatory
regulatory T cells in GBS patients insinuating dysregulation of pro-inflammatory T cells
(Pritchard et al., 2007; Vucic et al., 2009). Exercise has been shown to increase immature
DCs (Suchanek et al., 2010) which are implicated in inducing regulatory T cells
(Fehervari and Sakaguchi, 2004; Veldman et al., 2006; Frick et al., 2010). Exercise has
been shown to increase regulatory T cells (Lowder et al., 2010). It could be possible that
after onset of disease the Tr1 cells have migrated into circulation and into the peripheral

134
nerves (Figure 52) (Gillen et al., 1998; Iellem et al., 2001), thus attenuating the clinical
severity of the disease. When near peak of disease, Th1 lymphocytes no longer have
regulation by Tr1 cells, thus Th1 cells continue to proliferate and release IFN-γ. Tr1 cell
secretion of IL-10 near onset of disease could account for the decreased amount of Th1,
and the slight increase in Th2, cells in the lymph nodes.
Both of these explanations also account for the decreased secretion of IL-2 in preinduction forced-exercised. IL-10 producing Th1 or Tr1 cells induced from immature or
semi-mature DCs decrease the pro-inflammatory Th1 cell response, and thus decrease IL2 in our proliferation assays (Fehervari and Sakaguchi, 2004; Veldman et al., 2006; Zhu
and Paul, 2008; Frick et al., 2010). An increase in IL-2 seen near disease peak can be due
to a decrease in IL-10 production from Th1 cells, or the egress of IL-10-producing Tr1
cells from secondary lymphoid organs.
We also showed increased levels of TNF-α from severe EAN lymphocytes
compared to non-EAN lymphocytes, but were no differences compared to forcedexercise and sedentary EAN lymphocytes. The most likely contributor of TNF-α are
proliferating macrophages (Elenkov and Chrousos, 2002) or Tc cells (Johnson et al.,
2010). Macrophages and Tc cells contribute to EAN pathogenesis (Constantinescu et al.,
1998; Pelidou et al., 2000; Hughes and Cornblath, 2005; Yun et al., 2007).
Concerning splenic lymphocyte proliferation, we saw no increase in the capacity
of immune cells to proliferate when stimulated with P2 peptide in EAN rats. Lymph
nodes contain resident dendritic cells (DCs), APCs that are dedicated to presenting
antigen to T cells. The resident DCs are naive until they encounter the immunogenic P2
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peptide antigen, and these DCs contribute to stimulated lymphocyte proliferation. The
spleen does not contain naïve DCs, but instead contains macrophages that are intended to
encounter antigen from the blood and activated DCs that migrated to the spleen.
Macrophages are APCs, but are not as efficient as DCs at processing and presenting the
antigen to T cells (DeFranco et al., 2007). In some reports, there were increases in P2
peptide-stimulated splenic lymphocyte proliferation because irradiated thymocytes were
used as APCs to activate the adaptive immune cells (Rostami et al., 1990; Rostami and
Gregorian, 1991). Thymus has a large population of DCs used for positive and negative
selection of autoreactive T cells (DeFranco et al., 2007), so irradiated thymocytes would
contain naïve DCs. We believe that the macrophages in our splenic lymphocyte
proliferation assays were incapable of efficiently presenting the P2 peptide to the T cells,
and that we might have had increases in proliferation if we had used irradiated
thymocytes. We would also note that although we did not see P2 peptide-stimulated
splenic lymphocyte proliferation, we did observe P2 peptide-stimulated splenic
lymphocyte production of TNF-α in the forced-exercise rats. This P2 peptide-stimulated
exercise-induced production of TNF-α is probably secreted by CD8+ T cells that have
migrated to the spleen (Sipos et al., 2008). TNF-α is also produced by macrophages since
exercise is known to increase macrophage function (Elenkov and Chrousos, 2002; Chen
et al., 2010).
Nodal and splenic lymphocytes were also stimulated with ConA, a plant lectin
that increases T cell subset proliferation through activation of macrophages and immature
dendritic cells through signaling of TLRs (Rostami et al., 1990; Rostami and Gregorian,
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1991; Stenger and Modlin, 2002; Toubi and Shoenfeld, 2004; MacLeod and Wetzler,
2007; Yun et al., 2007; Unitt and Hornigold, 2011). Our data show no difference between
forced-exercise and sedentary EAN rats in ConA lymphocyte proliferation near onset,
even though there were more Th1 cells in sedentary EAN lymph nodes. In contrast, our
data show an increase in ConA lymphocyte proliferation in sedentary EAN rats near peak
of disease, even though there were equal levels of Th1 cells between sedentary and
forced-exercise EAN rats. The decreased lymphocyte proliferation in forced-exercised
EAN rats correlates with an observed increase in the anti-inflammatory cytokine IL-10.
Activation of TLRs on APCs, depending on the activation status of APCs, is known to
differentiate and activate naïve T cells to either a pro-inflammatory or an antiinflammatory immune state (Kapsenberg, 2003; MacLeod and Wetzler, 2007). For
example, exercise, by releasing heat shock proteins into the blood, decreases expression
of TLR1, 2, and 4 on APCs (Flynn and McFarlin, 2006), and this increases the antiinflammatory effects of immature DCs that leads to an anti-inflammatory immune state
(IL-10 production) (Ozdemir et al., 2009). Hence, we see in our results decreased
proliferation with corresponding production of IL-10 in forced-exercise EAN
lymphocytes. However, we saw a decrease in proliferation in sedentary EAN
lymphocytes near onset. A simple explanation of these data is that there are decreased
amounts of immature DCs in the lymph nodes in which to react to ConA and to activate
naïve T cells; mature DCs, in contrast, do not react to ConA due to a decrease in TLR
signaling (MacLeod and Wetzler, 2007). Near peak of disease, immature DCs could
reappear due to clearance of the P2 peptide, and when stimulated with ConA, DCs can
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cause robust proliferation of lymphocytes.
In regards to the splenic lymphocytes, we observed an increase in ConAstimulated proliferation and decreased quantity of Th1 cells in forced-exercise rats near
onset and peak. Sedentary EAN rats have an increased quantity of Th1 cells. The spleen
contains resident macrophages, and not naïve DCs, and ConA is a potent activator of
macrophages and naïve DCs through TLRs (Toubi and Shoenfeld, 2004; DeFranco et al.,
2007; MacLeod and Wetzler, 2007). Moreover, naïve T cells are unresponsive to TLR
ligands, and TLRs are only up-regulated with T cell receptor activation (MacLeod and
Wetzler, 2007). Since sedentary EAN rats have more Th1 differentiation, it is feasible that
macrophages have activated by T cells through the T cell receptor, and macrophages have
egressed from the spleen and are not available to proliferate to ConA or to activate naïve
T cells. In fact, exercise is known to suppress macrophage migration, and increase
macrophage function and secretion of IL-6 and TNF-α (Sugiura et al., 2000; Chen et al.,
2010; Teixeira-Lemos et al., 2011a), as has been observed in our experiments. The
increased proliferation observed in forced-exercise EAN splenic lymphocytes could be
attributed to an increase in basal levels of macrophages in the spleen, but also to
increased capacity of the macrophages to proliferate and activate T cells. The increase in
TNF-α and IL-6 in ConA-stimulated splenic lymphocytes from forced-exercise EAN rats
could be due to production of TNF-α by macrophages or CD8+ cells (Elenkov and
Chrousos, 2002; Sipos et al., 2008; Chen et al., 2010), and IL-6 by macrophages (Figure
53) (Teixeira-Lemos et al., 2011a).
We observed no differences near onset or peak of disease of Th (Takai et al.,
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1995), Tc (Takai et al., 1995), and Th2 cells in the spleen among the forced-exercised and
sedentary EAN rats. We did, however, observed near onset an increase in activated Tc
cells in the spleen in sedentary EAN rats. In patients with MS, and in animal models of
MS, there is an increase in these effector CD8+ cells (Johnson et al., 2010), and an
increase in activated Tc cells is correlated with an increase in Th1 cells (Joshi and Kaech,
2008). As observed in our study, the increase of Th1 cells corresponds with an increase in
activated Tc cells.
Differentiated T cells in the lymph nodes and spleen must egress to the blood to
home in on nerves (Hartung et al., 1995a, b; Fujioka et al., 2000). Exercise has been
shown to increase egress of lymphocytes from the blood into peripheral tissues (Chen et
al., 2010; Turner et al., 2010; Adams et al., 2011). We observed no differences near onset
or peak of disease of Th (Takai et al., 1995), Tc (Takai et al., 1995) and Th2 cells in the
blood among the forced-exercised and sedentary EAN rats. We observed near onset and
peak an increase in Th1 cells in the blood in sedentary EAN rats, similar to what we
observed in the lymph nodes and spleen.
A weakness of this study is that innate immune cell quantity, type, TLR surface
expression, and function were not measured. In our study, we used molecular mimicry to
activate the innate immune response against the P2 peptide antigen, which then activated
the adaptive immune system (Romagnani, 2006; Waldner, 2009; Torres-Aguilar et al.,
2010). The innate immune system is crucial for the development of EAN. The innate
immune system also undergoes changes to exercise (Ho et al., 2001; Flynn and McFarlin,
2006; Gleeson et al., 2006; McFarlin et al., 2006; Lambert et al., 2008; Timmerman et al.,
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2008; Simpson et al., 2009; Chiang et al., 2010; Oliveira and Gleeson, 2010; Suchanek et
al., 2010), which can lead to anti-inflammatory state of the adaptive immune system
(Lancaster et al., 2004; Flynn et al., 2007; Gleeson, 2007; da Silva Krause and de
Bittencourt, 2008; Donnikov et al., 2008; Haaland et al., 2008; Rosa Neto et al., 2010).
The attenuation of EAN in forced-exercised rats is due to immunological changes
occurring in these rats, but only the adaptive arm of the immune response was studied.
The hypothesis that the anti-inflammatory effect of exercise is due to decreased TLR
signaling on APCs that leads to secretion of IL-10 by either Th1 or Tr1 cells at the onset
of disease needs to be further studied.
In summary, we show an attenuation of the clinical severity of EAN by forcedexercise. Lymphocytes obtained from popliteal lymph nodes of forced-exercise EAN rats
are in an anti-inflammatory immune state demonstrated by their secretion of the antiinflammatory cytokine IL-10. Flow cytometric analysis of adaptive immune cells
obtained from popliteal lymph nodes, spleens, and blood of forced-exercise EAN rats
showed a clear decrease in pro-inflammatory Th1 cells. These results illustrate that
forced-exercise has anti-inflammatory effects that can attenuate EAN in rats.
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Figure 51. Pre-induction forced-exercise attenuates severe EAN by decreasing nodal
Th1 differentiation, and secretion of IL-2, while increasing IL-10 near disease onset.
At onset of experimental autoimmune neuritis (EAN), mature dendritic cells (mDCs)
have high expression of MHCII, CD80, and CD86, which leads to robust proliferation
and differentiation of type 1 helper T (Th1) cells and secretion of interferon-γ (IFN-γ)
and interleukin-2 (IL-2). Exercise, by decreasing toll-like receptors (TLRs), and
increasing circulating interleukin-6 (IL-6), increases immature (iDCs) and semi-mature
(smDCs) dendritic cells that induce transient interleukin-10 (tIL-10)-producing Th1 cells,
and/or IL-10-producing type 1 regulatory T (Tr1) cells, which causes decreased
differentiation of Th1 cells and secretion of IL-2, while secreting of IFN-γ and IL-10.
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Figure 52. Pre-induction forced-exercise alters severe EAN-production of nodal
lymphocyte IFN-γ near disease peak. Near peak of experimental autoimmune neuritis
(EAN), type 1 helper T (Th1) cells are undergoing apoptosis or anergy, thus decreasing
immune cells proliferation and interferon-γ (IFN-γ) secretion. Exercise, by decreasing
toll-like receptors (TLRs), and increasing interleukin-6 (IL-6), induced transient
interleukin-10 (tIL-10)-producing Th1 cells. At peak, these tIL-10 Th1 cells become Th1
cells that no longer secrete IL-10, but only secrete IFN-γ and interleukin-2 (IL-2), which
increases immune cell proliferation. Another possibility is that IL-10-producing type 1
regulatory T cells have egressed from the lymph nodes, thus disinhibiting Th1 cells that
secrete IFN-γ and interleukin-2 (IL-2), which increases immune cell proliferation

142

Figure 53. Pre-induction forced-exercise alters severe EAN-induced splenic
lymphocyte proliferation and cytokine secretion near disease onset and peak. Near
onset or peak of experimental autoimmune neuritis (EAN), type 1 helper T (Th1) cells
activate macrophages. Exercise decreases macrophage migration from the spleen, and
increases cytokine secretions of IL-6 and TNF-α, which leads to further activation of T
cells and proliferation near disease onset and peak.

REFERENCES
Adams GR, Zaldivar FP, Nance DM, Cooper DM (2011) Exercise and leukocyte
interchange among central circulation, lung, spleen, and muscle. Brain Behav
Immun.
Ahn M, Jin JK, Moon C, Matsumoto Y, Koh CS, Shin T (2010) Glial cell line-derived
neurotrophic factor is expressed by inflammatory cells in the sciatic nerves of
Lewis rats with experimental autoimmune neuritis. J Peripher Nerv Syst 15:104112.
Alter M (1990) The epidemiology of Guillain-Barre syndrome. Ann Neurol 27 Suppl:S712.
Andersen MH, Schrama D, Thor Straten P, Becker JC (2006) Cytotoxic T cells. J Invest
Dermatol 126:32-41.
Araga S, Kishimoto M, Doi S, Nakashima K (1999) A complementary peptide vaccine
that induces T cell anergy and prevents experimental allergic neuritis in Lewis
rats. J Immunol 163:476-482.
Asbury AK, Arnason BG, Adams RD (1969) The inflammatory lesion in idiopathic
polyneuritis. Its role in pathogenesis. Medicine (Baltimore) 48:173-215.
Asbury AK, Arnason BGW, Karp HR, McFarlin DF (1978) Criteria for diagnosis of
Guillain-Barre syndrome. Annals of Neurology 3:565-566.
Bai XF, Zhu J, Zhang GX, Kaponides G, Hojeberg B, van der Meide PH, Link H (1997)
IL-10 suppresses experimental autoimmune neuritis and down-regulates TH1type immune responses. Clin Immunol Immunopathol 83:117-126.

Balducci S, Iacobellis G, Parisi L, Di Biase N, Calandriello E, Leonetti F, Fallucca F
143

144
(2006) Exercise training can modify the natural history of diabetic peripheral
neuropathy. J Diabetes Complications 20:216-223.
Belkaid Y, Oldenhove G (2008) Tuning microenvironments: induction of regulatory T
cells by dendritic cells. Immunity 29:362-371.
Bennett JL, Stuve O (2009) Update on inflammation, neurodegeneration, and
immunoregulation in multiple sclerosis: therapeutic implications. Clin
Neuropharmacol 32:121-132.
Blachnio-Zabielska A, Baranowski M, Zabielski P, Gorski J (2008) Effect of exercise
duration on the key pathways of ceramide metabolism in rat skeletal muscles. J
Cell Biochem 105:776-784.
Bontkes HJ, Ruizendaal JJ, Kramer D, Meijer CJ, Schreurs MW, Hooijberg E (2005)
Interleukin-12 increases proliferation and interferon-gamma production but not
cytolytic activity of human antigen-specific effector memory cytotoxic T
lymphocytes: power of the effect depends on the functional avidity of the T cell
and the antigen concentration. Hum Immunol 66:1137-1145.
Britton SL, Koch LG (2005) Animal models of complex diseases: an initial strategy.
IUBMB Life 57:631-638.
Brown DA, Johnson MS, Armstrong CJ, Lynch JM, Caruso NM, Ehlers LB, Fleshner M,
Spencer RL, Moore RL (2007) Short-term treadmill running in the rat: what kind
of stressor is it? J Appl Physiol 103:1979-1985.
Brown WF, Snow R (1991) Patterns and severity of conduction abnormalities in
Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 54:768-774.
Campbell JE, Rakhshani N, Fediuc S, Bruni S, Riddell MC (2009) Voluntary wheel
running initially increases adrenal sensitivity to adrenocorticotrophic hormone,
which is attenuated with long-term training. J Appl Physiol 106:66-72.
Castellano V, Patel DI, White LJ (2008) Cytokine responses to acute and chronic
exercise in multiple sclerosis. J Appl Physiol 104:1697-1702.

145
Castro FR, Farias AS, Proenca PL, de La Hoz C, Langone F, Oliveira EC, Toyama MH,
Marangoni S, Santos LM (2007) The effect of treatment with crotapotin on the
evolution of experimental autoimmune neuritis induced in Lewis rats. Toxicon
49:299-305.
Cesta MF (2006) Normal structure, function, and histology of the spleen. Toxicol Pathol
34:455-465.
Chen MF, Chen HI, Jen CJ (2010) Exercise training upregulates macrophage MKP-1 and
affects immune responses in mice. Med Sci Sports Exerc 42:2173-2179.
Chiang J, Chen YY, Akiko T, Huang YC, Hsu ML, Jang TR, Chen YJ (2010) Tai Chi
Chuan increases circulating myeloid dendritic cells. Immunol Invest 39:863-873.
Constantinescu CS, Hilliard B, Fujioka T, Bhopale MK, Calida D, Rostami AM (1998)
Pathogenesis of neuroimmunologic diseases. Experimental models. Immunol Res
17:217-227.
Cortese I, Chaudhry V, So YT, Cantor F, Cornblath DR, Rae-Grant A (2011) Evidencebased guideline update: Plasmapheresis in neurologic disorders: report of the
Therapeutics and Technology Assessment Subcommittee of the American
Academy of Neurology. Neurology 76:294-300.
Cosi V, Versino M (2006) Guillain-Barre syndrome. Neurol Sci 27 Suppl 1:S47-51.
da Silva Krause M, de Bittencourt PI, Jr. (2008) Type 1 diabetes: can exercise impair the
autoimmune event? The L-arginine/glutamine coupling hypothesis. Cell Biochem
Funct 26:406-433.
Daube JR, Rubin DI (2009) Clinical neurophysiology, 3rd Edition. Oxford ; New York:
Oxford University Press.
DeFranco AL, Locksley RM, Robertson M (2007) Immunity : the immune response in
infectious and inflammatory disease. London
Sunderland, Me.: New Science Press ;
Sinauer Associates.

146
Deng YN, Zhou WB (2007) Expression of TLR4 and TLR9 mRNA in Lewis rats with
experimental allergic neuritis. Neuroimmunomodulation 14:337-343.
Dhabhar FS, Miller AH, McEwen BS, Spencer RL (1995) Differential activation of
adrenal steroid receptors in neural and immune tissues of Sprague Dawley,
Fischer 344, and Lewis rats. J Neuroimmunol 56:77-90.
Donnikov AE, Shkurnikov MU, Akimov EB, Tonevitsky AG (2008) Relationship
between the degree of cardiovascular adaptation and Th1/Th2 polarization of
immune response. Bull Exp Biol Med 146:462-465.
Droste SK, Chandramohan Y, Hill LE, Linthorst AC, Reul JM (2007) Voluntary exercise
impacts on the rat hypothalamic-pituitary-adrenocortical axis mainly at the
adrenal level. Neuroendocrinology 86:26-37.
Dube JJ, Amati F, Toledo FG, Stefanovic-Racic M, Rossi A, Coen P, Goodpaster BH
(2011) Effects of weight loss and exercise on insulin resistance, and
intramyocellular triacylglycerol, diacylglycerol and ceramide. Diabetologia
54:1147-1156.
Duclos M, Bouchet M, Vettier A, Richard D (2005) Genetic differences in hypothalamicpituitary-adrenal axis activity and food restriction-induced hyperactivity in three
inbred strains of rats. J Neuroendocrinol 17:740-752.
Duclos M, Martin C, Malgat M, Mazat JP, Chaouloff F, Mormede P, Letellier T (2001)
Relationships between muscle mitochondrial metabolism and stress-induced
corticosterone variations in rats. Pflugers Arch 443:218-226.
El Mhandi L, Calmels P, Camdessanche JP, Gautheron V, Feasson L (2007) Muscle
strength recovery in treated Guillain-Barre syndrome: a prospective study for the
first 18 months after onset. Am J Phys Med Rehabil 86:716-724.
Elenkov IJ, Chrousos GP (2002) Stress hormones, proinflammatory and
antiinflammatory cytokines, and autoimmunity. Ann N Y Acad Sci 966:290-303.
Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES (2000) The sympathetic nerve--an
integrative interface between two supersystems: the brain and the immune system.

147
Pharmacol Rev 52:595-638.
Engelhardt B (2006) Molecular mechanisms involved in T cell migration across the
blood-brain barrier. J Neural Transm 113:477-485.
Fathman CG, Lineberry NB (2007) Molecular mechanisms of CD4+ T-cell anergy. Nat
Rev Immunol 7:599-609.
Fediuc S, Campbell JE, Riddell MC (2006) Effect of voluntary wheel running on
circadian corticosterone release and on HPA axis responsiveness to restraint stress
in Sprague-Dawley rats. J Appl Physiol 100:1867-1875.
Fehervari Z, Sakaguchi S (2004) CD4+ Tregs and immune control. J Clin Invest
114:1209-1217.
Ferry A, Rieu P, Laziri F, el Habazi A, Le Page C, Rieu M (1992) Effect of moderate
exercise on rat T-cells. Eur J Appl Physiol Occup Physiol 65:464-468.
Fisher M, Langbein WE, Collins EG, Williams K, Barder L (2003) Moderate exercise in
the treatment of type 2 diabetic neuropathy. Muscle and Nerve 12:S15.
Fisher MA, Langbein WE, Collins EG, Williams K, Corzine L (2007) Physiological
improvement with moderate exercise in type II diabetic neuropathy. Electromyogr
Clin Neurophysiol 47:23-28.
Flynn MG, McFarlin BK (2006) Toll-like receptor 4: link to the anti-inflammatory
effects of exercise? Exerc Sport Sci Rev 34:176-181.
Flynn MG, McFarlin BK, Markofski MM (2007) The anti-inflammatory actions of
exercise training. Amer J of Lifestyle Med 1:220-235.
Frick JS, Grunebach F, Autenrieth IB (2010) Immunomodulation by semi-mature
dendritic cells: a novel role of Toll-like receptors and interleukin-6. Int J Med
Microbiol 300:19-24.

148
Fujioka T, Purev E, Kremlev SG, Ventura ES, Rostami A (2000) Flow cytometric
analysis of infiltrating cells in the peripheral nerves in experimental allergic
neuritis. J Neuroimmunol 108:181-191.
Gabriel CM, Gregson NA, Redford EJ, Davies M, Smith KJ, Hughes RA (1997) Human
immunoglobulin ameliorates rat experimental autoimmune neuritis. Brain 120 ( Pt
9):1533-1540.
Garssen MP, Bussmann JB, Schmitz PI, Zandbergen A, Welter TG, Merkies IS, Stam HJ,
van Doorn PA (2004) Physical training and fatigue, fitness, and quality of life in
Guillain-Barre syndrome and CIDP. Neurology 63:2393-2395.
Gillen C, Jander S, Stoll G (1998) Sequential expression of mRNA for proinflammatory
cytokines and interleukin-10 in the rat peripheral nervous system: comparison
between immune-mediated demyelination and Wallerian degeneration. J Neurosci
Res 51:489-496.
Gleeson M (2007) Immune function in sport and exercise. J Appl Physiol 103:693-699.
Gleeson M, McFarlin B, Flynn M (2006) Exercise and Toll-like receptors. Exerc
Immunol Rev 12:34-53.
Gold R, Hartung HP, Lassmann H (1997) T-cell apoptosis in autoimmune diseases:
termination of inflammation in the nervous system and other sites with
specialized immune-defense mechanisms. Trends Neurosci 20:399-404.
Gold R, Hartung HP, Toyka KV (2000) Animal models for autoimmune demyelinating
disorders of the nervous system. Mol Med Today 6:88-91.
Goldhammer E, Tanchilevitch A, Maor I, Beniamini Y, Rosenschein U, Sagiv M (2005)
Exercise training modulates cytokines activity in coronary heart disease patients.
Int J Cardiol 100:93-99.
Goodnow CC, Sprent J, Fazekas de St Groth B, Vinuesa CG (2005) Cellular and genetic
mechanisms of self tolerance and autoimmunity. Nature 435:590-597.

149
Gregorian SK, Rostami A (1994) Delayed-type hypersensitivity response in experimental
autoimmune neuritis treated with peptide-coupled spleen cells. J Neuroimmunol
51:69-75.
Guo M, Lin V, Davis W, Huang T, Carranza A, Sprague S, Reyes R, Jimenez D, Ding Y
(2008) Preischemic induction of TNF-alpha by physical exercise reduces bloodbrain barrier dysfunction in stroke. J Cereb Blood Flow Metab.
Haaland DA, Sabljic TF, Baribeau DA, Mukovozov IM, Hart LE (2008) Is regular
exercise a friend or foe of the aging immune system? A systematic review. Clin J
Sport Med 18:539-548.
Hadden RD, Cornblath DR, Hughes RA, Zielasek J, Hartung HP, Toyka KV, Swan AV
(1998) Electrophysiological classification of Guillain-Barre syndrome: clinical
associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barre
Syndrome Trial Group. Ann Neurol 44:780-788.
Hahn AF, Feasby TE, Steele A, Lovgren DS, Berry J (1988) Demyelination and axonal
degeneration in Lewis rat experimental allergic neuritis depend on the myelin
dosage. Lab Invest 59:115-125.
Harper Smith AD, Coakley SL, Ward MD, Macfarlane AW, Friedmann PS, Walsh NP
(2011) Exercise-induced stress inhibits both the induction and elicitation phases
of in vivo T-cell-mediated immune responses in humans. Brain Behav Immun.
Hartung HP, Pollard JD, Harvey GK, Toyka KV (1995a) Immunopathogenesis and
treatment of the Guillain-Barre syndrome--Part II. Muscle Nerve 18:154-164.
Hartung HP, Pollard JD, Harvey GK, Toyka KV (1995b) Immunopathogenesis and
treatment of the Guillain-Barre syndrome--Part I. Muscle Nerve 18:137-153.
Harvey GK, Pollard JD (1992) Patterns of conduction impairment in experimental
allergic neuritis. An electrophysiological and histological study. J Neurol
Neurosurg Psychiatry 55:909-915.
Hewitt M, Estell K, Davis IC, Schwiebert LM (2009a) Repeated bouts of moderateintensity aerobic exercise reduce airway reactivity in a murine asthma model. Am

150
J Respir Cell Mol Biol 42:243-249.
Hewitt M, Creel A, Estell K, Davis IC, Schwiebert LM (2009b) Acute exercise decreases
airway inflammation, but not responsiveness, in an allergic asthma model. Am J
Respir Cell Mol Biol 40:83-89.
Ho CS, Lopez JA, Vuckovic S, Pyke CM, Hockey RL, Hart DN (2001) Surgical and
physical stress increases circulating blood dendritic cell counts independently of
monocyte counts. Blood 98:140-145.
Ho TW, McKhann GM, Griffin JW (1998) Human autoimmune neuropathies. Annu Rev
Neurosci 21:187-226.
Holloszy JO, Schechtman KB (1991) Interaction between exercise and food restriction:
effects on longevity of male rats. J Appl Physiol 70:1529-1535.
Holloszy JO, Smith EK, Vining M, Adams S (1985) Effect of voluntary exercise on
longevity of rats. J Appl Physiol 59:826-831.
Hopps E, Canino B, Caimi G (2011) Effects of exercise on inflammation markers in type
2 diabetic subjects. Acta Diabetol.
Hughes RA, Rees JH (1997) Clinical and epidemiologic features of Guillain-Barre
syndrome. J Infect Dis 176 Suppl 2:S92-98.
Hughes RA, Cornblath DR (2005) Guillain-Barre syndrome. Lancet 366:1653-1666.
Hughes RA, Kadlubowski M, Gray IA, Leibowitz S (1981) Immune responses in
experimental allergic neuritis. J Neurol Neurosurg Psychiatry 44:565-569.
Hughes RA, Swan AV, Raphael JC, Annane D, van Koningsveld R, van Doorn PA
(2007) Immunotherapy for Guillain-Barre syndrome: a systematic review. Brain
130:2245-2257.
Hurley BF, Hanson ED, Sheaff AK (2011) Strength training as a countermeasure to aging

151
muscle and chronic disease. Sports Med 41:289-306.
Iellem A, Mariani M, Lang R, Recalde H, Panina-Bordignon P, Sinigaglia F, D'Ambrosio
D (2001) Unique chemotactic response profile and specific expression of
chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J
Exp Med 194:847-853.
Ilha J, Araujo RT, Malysz T, Hermel EE, Rigon P, Xavier LL, Achaval M (2008)
Endurance and Resistance Exercise Training Programs Elicit Specific Effects on
Sciatic Nerve Regeneration After Experimental Traumatic Lesion in Rats.
Neurorehabil Neural Repair.
Institute for Laboratory Animal Research (2010) Guide for the care and use of laboratory
animals, 8th Edition. Washington, DC: National Academy Press.
Israeli E, Agmon-Levin N, Blank M, Shoenfeld Y (2009) Adjuvants and autoimmunity.
Lupus 18:1217-1225.
Jacobs JM, Macfarlane RM, Cavanagh JB (1976) Vascular leakage in the dorsal root
ganglia of the rat, studied with horseradish peroxidase. J Neurol Sci 29:95-107.
Jankord R, Jemiolo B (2004) Influence of physical activity on serum IL-6 and IL-10
levels in healthy older men. Med Sci Sports Exerc 36:960-964.
Johnson TA, Jirik FR, Fournier S (2010) Exploring the roles of CD8(+) T lymphocytes in
the pathogenesis of autoimmune demyelination. Semin Immunopathol 32:197209.
Joshi NS, Kaech SM (2008) Effector CD8 T cell development: a balancing act between
memory cell potential and terminal differentiation. J Immunol 180:1309-1315.
Kafri M, Kloog Y, Korczyn AD, Ferdman-Aronovich R, Drory V, Katzav A, Wirguin I,
Chapman J (2005) Inhibition of Ras attenuates the course of experimental
autoimmune neuritis. J Neuroimmunol 168:46-55.
Kaida K, Kusunoki S (2009) Guillain-Barre syndrome: update on immunobiology and

152
treatment. Expert Rev Neurother 9:1307-1319.
Kano S, Sato K, Morishita Y, Vollstedt S, Kim S, Bishop K, Honda K, Kubo M,
Taniguchi T (2008) The contribution of transcription factor IRF1 to the
interferon-gamma-interleukin 12 signaling axis and TH1 versus TH-17
differentiation of CD4+ T cells. Nat Immunol 9:34-41.
Kapsenberg ML (2003) Dendritic-cell control of pathogen-driven T-cell polarization. Nat
Rev Immunol 3:984-993.
Ke Z, Yip SP, Li L, Zheng XX, Tong KY (2011) The effects of voluntary, involuntary,
and forced exercises on brain-derived neurotrophic factor and motor function
recovery: a rat brain ischemia model. PLoS One 6:e16643.
Kurokawa K, de Almeida DF, Zhang Y, Hebert CD, Page JG, Schweikart KM, Oh SJ
(2004) Sensory nerve conduction of the plantar nerve compared with other nerve
conduction tests in rats. Clin Neurophysiol 115:1677-1682.
Kuwabara S (2004) Guillain-Barre syndrome: epidemiology, pathophysiology and
management. Drugs 64:597-610.
Kuwabara S (2007) Guillain-barre syndrome. Curr Neurol Neurosci Rep 7:57-62.
La Cava A (2008) Tregs are regulated by cytokines: implications for autoimmunity.
Autoimmun Rev 8:83-87.
Lambert CP, Wright NR, Finck BN, Villareal DT (2008) Exercise but not diet-induced
weight loss decreases skeletal muscle inflammatory gene expression in frail obese
elderly persons. J Appl Physiol 105:473-478.
Lancaster GI, Khan Q, Drysdale P, Wallace F, Jeukendrup AE, Drayson MT, Gleeson M
(2005) The physiological regulation of toll-like receptor expression and function
in humans. J Physiol 563:945-955.
Lancaster GI, Halson SL, Khan Q, Drysdale P, Wallace F, Jeukendrup AE, Drayson MT,
Gleeson M (2004) Effects of acute exhaustive exercise and chronic exercise

153
training on type 1 and type 2 T lymphocytes. Exerc Immunol Rev 10:91-106.
Laura M, Mazzeo A, Aguennouz M, Santoro M, Catania MA, Migliorato A, Calapai G,
Vita G (2006) Immunolocalization and activation of nuclear factor-kappaB in the
sciatic nerves of rats with experimental autoimmune neuritis. J Neuroimmunol
174:32-38.
Lawlor MW, Richards MP, Fisher MA, Stubbs EB, Jr. (2001) Sensory nerve conduction
deficit in experimental monoclonal gammopathy of undetermined significance
(MGUS) neuropathy. Muscle Nerve 24:809-816.
Le Page C, Ferry A, Rieu M (1994) Effect of muscular exercise on chronic relapsing
experimental autoimmune encephalomyelitis. J Appl Physiol 77:2341-2347.
Le Page C, Bourdoulous S, Beraud E, Couraud PO, Rieu M, Ferry A (1996) Effect of
physical exercise on adoptive experimental auto-immune encephalomyelitis in
rats. Eur J Appl Physiol Occup Physiol 73:130-135.
Leasure JL, Jones M (2008) Forced and voluntary exercise differentially affect brain and
behavior. Neuroscience 156:456-465.
Leung FP, Yung LM, Laher I, Yao X, Chen ZY, Huang Y (2008) Exercise, vascular wall
and cardiovascular diseases: an update (Part 1). Sports Med 38:1009-1024.
Li CY, Xue P, Tian WQ, Liu RC, Yang C (1996) Experimental Campylobacter jejuni
infection in the chicken: an animal model of axonal Guillain-Barre syndrome. J
Neurol Neurosurg Psychiatry 61:279-284.
Lin HH, Wang MX, Spies JM, Pollard JD (2007) Effective treatment of experimental
autoimmune neuritis with Fc fragment of human immunoglobulin. J
Neuroimmunol 186:133-140.
Lira FS, Koyama CH, Yamashita AS, Rosa JC, Zanchi NE, Batista ML, Jr., Seelaender
MC (2009) Chronic exercise decreases cytokine production in healthy rat skeletal
muscle. Cell Biochem Funct 27:458-461.

154
Lonigro A, Devaux JJ (2009) Disruption of neurofascin and gliomedin at nodes of
Ranvier precedes demyelination in experimental allergic neuritis. Brain 132:260273.
Lowder T, Dugger K, Deshane J, Estell K, Schwiebert LM (2010) Repeated bouts of
aerobic exercise enhance regulatory T cell responses in a murine asthma model.
Brain Behav Immun 24:153-159.
Lu MO, Zhu J (2010) The role of cytokines in Guillain-Barre syndrome. J Neurol
258:533-548.
Lucas SR, Platts-Mills TA (2005) Physical activity and exercise in asthma: relevance to
etiology and treatment. J Allergy Clin Immunol 115:928-934.
Luongo L, Sajic M, Grist J, Clark AK, Maione S, Malcangio M (2008) Spinal changes
associated with mechanical hypersensitivity in a model of Guillain-Barre
syndrome. Neurosci Lett 437:98-102.
Mackay IR (2008) Autoimmunity since the 1957 clonal selection theory: a little acorn to
a large oak. Immunol Cell Biol 86:67-71.
MacLeod H, Wetzler LM (2007) T cell activation by TLRs: a role for TLRs in the
adaptive immune response. Sci STKE 2007:pe48.
Martin CL, Duclos M, Aguerre S, Mormede P, Manier G, Chaouloff F (2000)
Corticotropic and serotonergic responses to acute stress with/without prior
exercise training in different rat strains. Acta Physiol Scand 168:421-430.
Martyn CN, Hughes RA (1997) Epidemiology of peripheral neuropathy. J Neurol
Neurosurg Psychiatry 62:310-318.
Maurer M, Gold R (2002) Animal models of immune-mediated neuropathies. Curr Opin
Neurol 15:617-622.
McFarlin BK, Flynn MG, Campbell WW, Craig BA, Robinson JP, Stewart LK,
Timmerman KL, Coen PM (2006) Physical activity status, but not age, influences

155
inflammatory biomarkers and toll-like receptor 4. J Gerontol A Biol Sci Med Sci
61:388-393.
McQuaid A, Tormey VJ, Trafford B, Webster AD, Bofill M (2003) Evidence for
increased expression of regulatory cytokine receptors interleukin-12R and
interleukin-18R in common variable immunodeficiency. Clin Exp Immunol
134:321-327.
Metsios GS, Stavropoulos-Kalinoglou A, Sandoo A, van Zanten JJ, Toms TE, John H,
Kitas GD (2010) Vascular function and inflammation in rheumatoid arthritis: the
role of physical activity. Open Cardiovasc Med J 4:89-96.
Moalem-Taylor G, Allbutt HN, Iordanova MD, Tracey DJ (2007) Pain hypersensitivity in
rats with experimental autoimmune neuritis, an animal model of human
inflammatory demyelinating neuropathy. Brain Behav Immun 21:699-710.
Moraska A, Deak T, Spencer RL, Roth D, Fleshner M (2000) Treadmill running
produces both positive and negative physiological adaptations in Sprague-Dawley
rats. Am J Physiol Regul Integr Comp Physiol 279:R1321-1329.
Navarro F, Bacurau AV, Almeida SS, Barros CC, Moraes MR, Pesquero JL, Ribeiro SM,
Araujo RC, Costa Rosa LF, Bacurau RF (2010) Exercise prevents the effects of
experimental arthritis on the metabolism and function of immune cells. Cell
Biochem Funct 28:266-273.
Nielsen HB (2003) Lymphocyte responses to maximal exercise: a physiological
perspective. Sports Med 33:853-867.
Nielsen S, Pedersen BK (2008) Skeletal muscle as an immunogenic organ. Curr Opin
Pharmacol.
Oliveira M, Gleeson M (2010) The influence of prolonged cycling on monocyte Toll-like
receptor 2 and 4 expression in healthy men. Eur J Appl Physiol 109:251-257.
Ortega E, Giraldo E, Hinchado MD, Martin L, Garcia JJ, De la Fuente M (2007)
Neuroimmunomodulation during exercise: role of catecholamines as 'stress
mediator' and/or 'danger signal' for the innate immune response.

156
Neuroimmunomodulation 14:206-212.
Ozdemir C, Akdis M, Akdis CA (2009) T regulatory cells and their counterparts: masters
of immune regulation. Clin Exp Allergy 39:626-639.
Ozenci V, Pashenkov M, Kouwenhoven M, Rinaldi L, Soderstrom M, Link H (2001) IL12/IL-12R system in multiple sclerosis. J Neuroimmunol 114:242-252.
Parish IA, Heath WR (2008) Too dangerous to ignore: self-tolerance and the control of
ignorant autoreactive T cells. Immunol Cell Biol 86:146-152.
Pastva A, Estell K, Schoeb TR, Schwiebert LM (2005) RU486 blocks the antiinflammatory effects of exercise in a murine model of allergen-induced
pulmonary inflammation. Brain Behav Immun 19:413-422.
Pastva A, Estell K, Schoeb TR, Atkinson TP, Schwiebert LM (2004) Aerobic exercise
attenuates airway inflammatory responses in a mouse model of atopic asthma. J
Immunol 172:4520-4526.
Pelidou SH, Zou LP, Deretzi G, Oniding C, Mix E, Zhu J (2000) Enhancement of acute
phase and inhibition of chronic phase of experimental autoimmune neuritis in
Lewis rats by intranasal administration of recombinant mouse interleukin 17:
potential immunoregulatory role. Exp Neurol 163:165-172.
Pentland B, Donald SM (1994) Pain in the Guillain-Barre syndrome: a clinical review.
Pain 59:159-164.
Plasma Exchange/Sandoglobulin Guillain-Barre Syndrome Trial Group (1997)
Randomised trial of plasma exchange, intravenous immunoglobulin, and
combined treatments in Guillain-Barre syndrome. . Lancet 349:225-230.
Ploughman M, Granter-Button S, Chernenko G, Tucker BA, Mearow KM, Corbett D
(2005) Endurance exercise regimens induce differential effects on brain-derived
neurotrophic factor, synapsin-I and insulin-like growth factor I after focal
ischemia. Neuroscience 136:991-1001.

157
Ploughman M, Granter-Button S, Chernenko G, Attwood Z, Tucker BA, Mearow KM,
Corbett D (2007) Exercise intensity influences the temporal profile of growth
factors involved in neuronal plasticity following focal ischemia. Brain Res
1150:207-216.
Pritchard J, Makowska A, Gregson NA, Hayday AC, Hughes RA (2007) Reduced
circulating CD4+CD25+ cell populations in Guillain-Barre syndrome. J
Neuroimmunol 183:232-238.
Roberts CK, Won D, Pruthi S, Lin SS, Barnard RJ (2006) Effect of a diet and exercise
intervention on oxidative stress, inflammation and monocyte adhesion in diabetic
men. Diabetes Res Clin Pract 73:249-259.
Rogers CJ, Zaharoff DA, Hance KW, Perkins SN, Hursting SD, Schlom J, Greiner JW
(2008) Exercise enhances vaccine-induced antigen-specific T cell responses.
Vaccine 26:5407-5415.
Rojo JM, Pini E, Ojeda G, Bello R, Dong C, Flavell RA, Dianzani U, Portoles P (2008)
CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate
autoimmune encephalitis 'in vivo'. Int Immunol 20:577-589.
Romagnani S (2006) Immunological tolerance and autoimmunity. Intern Emerg Med
1:187-196.
Romagnani S (2008) Human Th17 cells. Arthritis Res Ther 10:206.
Rosa Neto JC, Lira FS, de Mello MT, Santos RV (2010) Importance of exercise
immunology in health promotion. Amino Acids.
Rose NR, Mackay IR (2000) Molecular mimicry: a critical look at exemplary instances in
human diseases. Cell Mol Life Sci 57:542-551.
Rossi S, Furlan R, De Chiara V, Musella A, Lo Giudice T, Mataluni G, Cavasinni F,
Cantarella C, Bernardi G, Muzio L, Martorana A, Martino G, Centonze D (2009)
Exercise attenuates the clinical, synaptic and dendritic abnormalities of
experimental autoimmune encephalomyelitis. Neurobiol Dis 36:51-59.

158
Rostami A, Gregorian SK (1991) Peptide 53-78 of myelin P2 protein is a T cell epitope
for the induction of experimental autoimmune neuritis. Cell Immunol 132:433441.
Rostami A, Gregorian SK, Brown MJ, Pleasure DE (1990) Induction of severe
experimental autoimmune neuritis with a synthetic peptide corresponding to the
53-78 amino acid sequence of the myelin P2 protein. J Neuroimmunol 30:145151.
Ryan KR, Patel SD, Stephens LA, Anderton SM (2007) Death, adaptation and regulation:
the three pillars of immune tolerance restrict the risk of autoimmune disease
caused by molecular mimicry. J Autoimmun 29:262-271.
Sabatier MJ, Redmon N, Schwartz G, English AW (2008) Treadmill training promotes
axon regeneration in injured peripheral nerves. Exp Neurol.
Salkind NJ, Rasmussen K (2007) Encyclopedia of measurement and statistics. Thousand
Oaks, Calif.: SAGE Publications.
Sarkey JP, Richards MP, Stubbs EB, Jr. (2007) Lovastatin attenuates nerve injury in an
animal model of Guillain-Barre syndrome. J Neurochem 100:1265-1277.
Schmidt J, Elflein K, Stienekemeier M, Rodriguez-Palmero M, Schneider C, Toyka KV,
Gold R, Hunig T (2003) Treatment and prevention of experimental autoimmune
neuritis with superagonistic CD28-specific monoclonal antibodies. J
Neuroimmunol 140:143-152.
Schulz KH, Gold SM, Witte J, Bartsch K, Lang UE, Hellweg R, Reer R, Braumann KM,
Heesen C (2004) Impact of aerobic training on immune-endocrine parameters,
neurotrophic factors, quality of life and coordinative function in multiple
sclerosis. J Neurol Sci 225:11-18.
Schwab SR, Cyster JG (2007) Finding a way out: lymphocyte egress from lymphoid
organs. Nat Immunol 8:1295-1301.
Sherwin CM (1998) Voluntary wheel running: a review and novel interpretation. Anim
Behav 56:11-27.

159
Shokouhi G, Tubbs RS, Shoja MM, Roshangar L, Mesgari M, Ghorbanihaghjo A,
Ahmadi N, Sheikhzadeh F, Rad JS (2008) The effects of aerobic exercise training
on the age-related lipid peroxidation, Schwann cell apoptosis and ultrastructural
changes in the sciatic nerve of rats. Life Sci 82:840-846.
Simpson RJ, McFarlin BK, McSporran C, Spielmann G, o Hartaigh B, Guy K (2009)
Toll-like receptor expression on classic and pro-inflammatory blood monocytes
after acute exercise in humans. Brain Behav Immun 23:232-239.
Simpson TR, Quezada SA, Allison JP (2010) Regulation of CD4 T cell activation and
effector function by inducible costimulator (ICOS). Curr Opin Immunol 22:326332.
Sipos W, Rauner M, Skalicky M, Viidik A, Hofbauer G, Schett G, Redlich K, Lang S,
Pietschmann P (2008) Running has a negative effect on bone metabolism and
proinflammatory status in male aged rats. Exp Gerontol 43:578-583.
Spies JM, Westland KW, Bonner JG, Pollard JD (1995a) Intraneural activated T cells
cause focal breakdown of the blood-nerve barrier. Brain 118 ( Pt 4):857-868.
Spies JM, Pollard JD, Bonner JG, Westland KW, McLeod JG (1995b) Synergy between
antibody and P2-reactive T cells in experimental allergic neuritis. J
Neuroimmunol 57:77-84.
Stenger S, Modlin RL (2002) Control of Mycobacterium tuberculosis through
mammalian Toll-like receptors. Curr Opin Immunol 14:452-457.
Steward-Tharp SM, Song YJ, Siegel RM, O'Shea JJ (2010) New insights into T cell
biology and T cell-directed therapy for autoimmunity, inflammation, and
immunosuppression. Ann N Y Acad Sci 1183:123-148.
Stienekemeier M, Falk K, Rotzschke O, Weishaupt A, Schneider C, Toyka KV, Gold R,
Strominger JL (2001) Vaccination, prevention, and treatment of experimental
autoimmune neuritis (EAN) by an oligomerized T cell epitope. Proc Natl Acad
Sci U S A 98:13872-13877.
Stienekemeier M, Herrmann T, Kruse N, Weishaupt A, Weilbach FX, Giegerich G,

160
Theofilopoulos A, Jung S, Gold R (1999) Heterogeneity of T-cell receptor usage
in experimental autoimmune neuritis in the Lewis rat. Brain 122 ( Pt 3):523-535.
Suchanek O, Podrazil M, Fischerova B, Bocinska H, Budinsky V, Stejskal D, Spisek R,
Bartunkova J, Kolar P (2010) Intensive physical activity increases peripheral
blood dendritic cells. Cell Immunol 266:40-45.
Sugiura H, Nishida H, Inaba R, Mirbod SM, Iwata H (2000) Immunomodulation by 8week voluntary exercise in mice. Acta Physiol Scand 168:413-420.
Takai H, Araga S, Funamoto K, Nakayasu H, Takahashi K (1995) The two-color analysis
of the T-lymphocyte subsets in experimental allergic neuritis in rats. Intern Med
34:347-351.
Tan XD, Dou YC, Shi CW, Duan RS, Sun RP (2009) Administration of
dehydroepiandrosterone ameliorates experimental autoimmune neuritis in Lewis
rats. J Neuroimmunol 207:39-44.
Taylor JM, Pollard JD (2001) Dominance of autoreactive T cell-mediated delayed-type
hypersensitivity or antibody-mediated demyelination results in distinct forms of
experimental autoimmune neuritis in the Lewis rat. J Neuropathol Exp Neurol
60:637-646.
Taylor JM, Pollard JD (2003) Neurophysiological changes in demyelinating and axonal
forms of acute experimental autoimmune neuritis in the Lewis rat. Muscle Nerve
28:344-352.
Teixeira-Lemos E, Nunes S, Teixeira F, Reis F (2011a) Regular physical exercise
training assists in preventing type 2 diabetes development: focus on its
antioxidant and anti-inflammatory properties. Cardiovasc Diabetol 10:12.
Teixeira-Lemos E, Nunes S, Teixeira F, Reis F (2011b) Regular physical exercise
training assists in preventing type 2 diabetes development: focus on its
antioxidant and anti-inflammatory properties. Cardiovasc Diabetol 10:12.
Teixeira de Lemos E, Reis F, Baptista S, Pinto R, Sepodes B, Vala H, Rocha-Pereira P,
Correia da Silva G, Teixeira N, Silva AS, Carvalho L, Teixeira F, Das UN (2009)

161
Exercise training decreases proinflammatory profile in Zucker diabetic (type 2)
fatty rats. Nutrition 25:330-339.
The Autoimmune Diseases Coordinating Committee (2005) Progress in Autoimmune
Diseases Research. National Institutes of Health Publication.
Tilney NL (1970) The systemic distribution of soluble antigen injected into the footpad
of the laboratory rat. Immunology 19:181-184.
Tilney NL (1971) Patterns of lymphatic drainage in the adult laboratory rat. J Anat
109:369-383.
Timmerman KL, Flynn MG, Coen PM, Markofski MM, Pence BD (2008) Exercise
training-induced lowering of inflammatory (CD14+CD16+) monocytes: a role in
the anti-inflammatory influence of exercise? J Leukoc Biol 84:1271-1278.
Torres-Aguilar H, Blank M, Jara LJ, Shoenfeld Y (2010) Tolerogenic dendritic cells in
autoimmune diseases: crucial players in induction and prevention of
autoimmunity. Autoimmun Rev 10:8-17.
Toubi E, Shoenfeld Y (2004) Toll-like receptors and their role in the development of
autoimmune diseases. Autoimmunity 37:183-188.
Tran GT, Hodgkinson SJ, Carter NM, Killingsworth M, Nomura M, Verma ND, Plain
KM, Boyd R, Hall BM (2010) Membrane attack complex of complement is not
essential for immune mediated demyelination in experimental autoimmune
neuritis. J Neuroimmunol 229:98-106.
Trinchieri G (2001) Regulatory role of T cells producing both interferon gamma and
interleukin 10 in persistent infection. J Exp Med 194:F53-57.
Turner JE, Aldred S, Witard OC, Drayson MT, Moss PM, Bosch JA (2010) Latent
cytomegalovirus infection amplifies CD8 T-lymphocyte mobilisation and egress
in response to exercise. Brain Behav Immun 24:1362-1370.
Uncini A, Manzoli C, Notturno F, Capasso M (2010) Pitfalls in electrodiagnosis of

162
Guillain-Barre syndrome subtypes. J Neurol Neurosurg Psychiatry 81:1157-1163.
Unitt J, Hornigold D (2011) Plant Lectins are Novel Toll-Like Receptor Agonists.
Biochem Pharmacol.
van der Meche FG, Meulstee J, Vermeulen M, Kievit A (1988) Patterns of conduction
failure in the Guillain-Barre syndrome. Brain 111 ( Pt 2):405-416.
Veldhoen M (2009) The role of T helper subsets in autoimmunity and allergy. Curr Opin
Immunol 21:606-611.
Veldman C, Nagel A, Hertl M (2006) Type I regulatory T cells in autoimmunity and
inflammatory diseases. Int Arch Allergy Immunol 140:174-183.
Vignali DA, Collison LW, Workman CJ (2008) How regulatory T cells work. Nat Rev
Immunol 8:523-532.
von Boehmer H, Melchers F (2010) Checkpoints in lymphocyte development and
autoimmune disease. Nat Immunol 11:14-20.
Vucic S, Kiernan MC, Cornblath DR (2009) Guillain-Barre syndrome: an update. J Clin
Neurosci 16:733-741.
Waldner H (2009) The role of innate immune responses in autoimmune disease
development. Autoimmun Rev 8:400-404.
Weishaupt A, Schonrock LM, Stienekemeier M, Toyka KV, Gold R (2001)
Glucocorticosteroids modulate antigen-induced T cell apoptosis in experimental
autoimmune neuritis and cause T cell proliferation in situ. Acta Neuropathol
102:75-82.
Weishaupt A, Gold R, Gaupp S, Giegerich G, Hartung HP, Toyka KV (1997) Antigen
therapy eliminates T cell inflammation by apoptosis: effective treatment of
experimental autoimmune neuritis with recombinant myelin protein P2. Proc Natl
Acad Sci U S A 94:1338-1343.

163
Westphal U (1971) Steroid-protein interactions. Monogr Endocrinol 4:1-567.
White CM, Pritchard J, Turner-Stokes L (2004) Exercise for people with peripheral
neuropathy. Cochrane Database Syst Rev:CD003904.
White LJ, Castellano V, Mc Coy SC (2006a) Cytokine responses to resistance training in
people with multiple sclerosis. J Sports Sci 24:911-914.
White LJ, McCoy SC, Castellano V, Ferguson MA, Hou W, Dressendorfer RH (2006b)
Effect of resistance training on risk of coronary artery disease in women with
multiple sclerosis. Scand J Clin Lab Invest 66:351-355.
Willard-Mack CL (2006) Normal structure, function, and histology of lymph nodes.
Toxicol Pathol 34:409-424.
Woods JA, Davis JM, Smith JA, Nieman DC (1999) Exercise and cellular innate immune
function. Med Sci Sports Exerc 31:57-66.
Yamane H, Igarashi O, Kato T, Nariuchi H (2000) Positive and negative regulation of IL12 receptor expression of naive CD4(+) T cells by CD28/CD152 co-stimulation.
Eur J Immunol 30:3171-3180.
Yeh SH, Chuang H, Lin LW, Hsiao CY, Eng HL (2006) Regular tai chi chuan exercise
enhances functional mobility and CD4CD25 regulatory T cells. Br J Sports Med
40:239-243.
Yeh SH, Chuang H, Lin LW, Hsiao CY, Wang PW, Liu RT, Yang KD (2008) Regular
Tai Chi Chuan exercise improves T cell helper function of type 2 DM patients
with an increase in T-bet transcription factor and IL-12 production. Br J Sports
Med.
Yun W, Hua-bing W, Wei-zhi W (2007) A study of associated cell-mediated immune
mechanisms in experimental autoimmune neuritis rats. J Neuroimmunol 185:8794.
Zhang Z, Zhang ZY, Schluesener HJ (2009a) Compound A, a plant origin ligand of

164
glucocorticoid receptors, increases regulatory T cells and M2 macrophages to
attenuate experimental autoimmune neuritis with reduced side effects. J Immunol
183:3081-3091.
Zhang Z, Zhang ZY, Fauser U, Schluesener HJ (2008a) Valproic acid attenuates
inflammation in experimental autoimmune neuritis. Cell Mol Life Sci 65:40554065.
Zhang Z, Zhang ZY, Fauser U, Schluesener HJ (2008b) Mechanical allodynia and spinal
up-regulation of P2X4 receptor in experimental autoimmune neuritis rats.
Neuroscience 152:495-501.
Zhang Z, Zhang ZY, Fauser U, Schluesener HJ (2009b) Distribution of Foxp3(+) Tregulatory cells in experimental autoimmune neuritis rats. Exp Neurol 216:75-82.
Zhang ZY, Zhang Z, Schluesener HJ (2009c) Toll-like receptor-2, CD14 and heat-shock
protein 70 in inflammatory lesions of rat experimental autoimmune neuritis.
Neuroscience 159:136-142.
Zhang ZY, Zhang Z, Schluesener HJ (2009d) FTY720 attenuates lesional interleukin17(+) cell accumulation in rat experimental autoimmune neuritis. Neuropathol
Appl Neurobiol 35:487-495.
Zhang ZY, Zhang Z, Zug C, Nuesslein-Hildesheim B, Leppert D, Schluesener HJ
(2009e) AUY954, a selective S1P(1) modulator, prevents experimental
autoimmune neuritis. J Neuroimmunol 216:59-65.
Zhu J, Paul WE (2008) CD4 T cells: fates, functions, and faults. Blood 112:1557-1569.

VITA
Michael W. Calik was born on December 1, 1982, in Oak Lawn, Illinois, along
with his monozygotic twin, Martin O. Calik, and is the son of Polish immigrants, Henryk
and Barbara Calik. He attended Loyola University Chicago in Illinois, where he earned a
Bachelor of Science degree in Biology in 2005 and gained his interest in the
interdisciplinary field of neuroscience.
Michael entered the Neuroscience Graduate Program at Loyola University
Chicago in August of 2005. He joined the laboratory of Dr. Evan B. Stubbs, Jr. in 2006,
where he began his work on the effects of forced-exercise on experimental autoimmune
neuritis, a rat model of the human autoimmune disease Guillain-Barré Syndrome. During
his time at Loyola, Michael has presented his research at the Society for Neuroscience
conferences in Chicago and San Diego and at the American Society of Neurochemistry
meeting in Santa Fe. He served as GSC co-president for the Graduate Student Council
and in 2008 and 2009 received the VA Pre-Doctoral Associated Health Rehabilitation
Research Fellowship to support his training.
After completing his doctorate, Michael will continue a research and academic
career as a postdoctoral fellow with the ultimate goal of becoming principal investigator
and professor at an academic institution. Michael married his wife, Marilyn, in 2007, and
since then has fathered a son, Tristan, and a daughter, Lyra. They currently reside in
Chicago, Illinois.
165

DISSERTATION APPROVAL SHEET

The dissertation submitted by Michael W. Calik has been read and approved by the
following committee:

Evan B. Stubbs, Jr., Ph.D., Director
Professor, Department of Ophthalmology
Loyola University Medical Center
Edward J. Neafsey, Ph.D.
Professor, Department of Molecular Pharmacology and Therapeutics
Loyola University Medical Center
John Clancy, Jr., Ph.D.
Professor, Department of Microbiology and Immunology
Loyola University Medical Center
John A. McNulty, Jr., Ph.D.
Professor, Department of Cell and Molecular Physiology
Loyola University Medical Center
Morris A. Fisher, M.D.
Professor, Department of Neurology
Loyola University Medical Center

The final copies have been examined by the director of the dissertation and the signature
which appears below verifies the fact that any necessary changes have been incorporated
and that the dissertation is now given final approval by the committee with the reference
to content and form.
The dissertation is therefore accepted in partial fulfillment of the requirements for the
degree of Doctor of Philosophy.

________________________
Date

____________________________________
Director’s Signature

